{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {},
   "outputs": [],
   "source": [
    "import numpy as np\n",
    "import pandas as pd"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [],
   "source": [
    "# off label example\n",
    "sctab_random = pd.read_json('../../Outputs/cellxgene_cutoff_random_10k/responses/short_prompt_r1/100genes_scTabClassifier/100genes_scTabClassifier.ndjson', lines=True)\n",
    "off_label_example = sctab_random[sctab_random['soma_joinid']==145845]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "# r1 reasoning example\n",
    "r1_response = pd.read_json('../../Outputs/scTab_10k/responses/short_prompt_r1/100genes/r1_100gene_10k_short_response.ndjson', lines=True)\n",
    "r1_results = pd.read_csv('../../Outputs/scTab_10k/responses/short_prompt_r1/100genes/r1_100gene_10k_short_comparison_results.csv')\n",
    "v3_response = pd.read_json('../../Outputs/scTab_10k/responses/short_prompt_v3/100genes/v3_100gene_short_response.ndjson', lines=True)\n",
    "v3_results = pd.read_csv('../../Outputs/scTab_10k/responses/short_prompt_v3/100genes/v3_100gene_10k_short_comparison_results.csv')\n",
    "# find index where v3 is wrong and r1 is right\n",
    "index = [i for i in range(10000) if r1_results['match_scTab'][i] and (not v3_results['match_scTab'][i])]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "application/vnd.microsoft.datawrangler.viewer.v0+json": {
       "columns": [
        {
         "name": "index",
         "rawType": "int64",
         "type": "integer"
        },
        {
         "name": "cell_name",
         "rawType": "object",
         "type": "string"
        },
        {
         "name": "ground_truth_label",
         "rawType": "object",
         "type": "string"
        },
        {
         "name": "predicted_label",
         "rawType": "object",
         "type": "string"
        },
        {
         "name": "verdict",
         "rawType": "object",
         "type": "string"
        },
        {
         "name": "match_scTab",
         "rawType": "object",
         "type": "string"
        }
       ],
       "conversionMethod": "pd.DataFrame",
       "ref": "e4586d4f-214b-4a83-9b5a-c97e0c148cb0",
       "rows": [
        [
         "3",
         "12826196",
         "T cell",
         "T cell",
         "SAME_LABEL",
         "True"
        ],
        [
         "10",
         "37809921",
         "kidney loop of Henle thick ascending limb epithelial cell",
         "kidney loop of Henle thick ascending limb epithelial cell",
         "SAME_LABEL",
         "True"
        ],
        [
         "19",
         "53765774",
         "endothelial cell",
         "lung endothelial cell",
         "PREDICTED_IS_CHILD_OF_GT",
         "True"
        ],
        [
         "22",
         "45007111",
         "B cell",
         "memory B cell",
         "PREDICTED_IS_CHILD_OF_GT",
         "True"
        ],
        [
         "24",
         "35895143",
         "naive thymus-derived CD4-positive, alpha-beta T cell",
         "naive thymus-derived CD4-positive, alpha-beta T cell",
         "SAME_LABEL",
         "True"
        ],
        [
         "28",
         "17494605",
         "oligodendrocyte",
         "oligodendrocyte",
         "SAME_LABEL",
         "True"
        ],
        [
         "37",
         "35644005",
         "memory B cell",
         "memory B cell",
         "SAME_LABEL",
         "True"
        ],
        [
         "46",
         "20331652",
         "plasmacytoid dendritic cell",
         "plasmacytoid dendritic cell",
         "SAME_LABEL",
         "True"
        ],
        [
         "51",
         "45166837",
         "CD14-positive, CD16-negative classical monocyte",
         "CD14-positive, CD16-negative classical monocyte",
         "SAME_LABEL",
         "True"
        ],
        [
         "88",
         "37417767",
         "CD8-positive, alpha-beta T cell",
         "CD8-positive, alpha-beta cytotoxic T cell",
         "PREDICTED_IS_CHILD_OF_GT",
         "True"
        ],
        [
         "98",
         "45086023",
         "CD8-positive, alpha-beta T cell",
         "CD8-positive, alpha-beta cytotoxic T cell",
         "PREDICTED_IS_CHILD_OF_GT",
         "True"
        ],
        [
         "107",
         "44640339",
         "CD14-positive, CD16-negative classical monocyte",
         "CD14-positive, CD16-negative classical monocyte",
         "SAME_LABEL",
         "True"
        ],
        [
         "112",
         "5736610",
         "luminal epithelial cell of mammary gland",
         "luminal epithelial cell of mammary gland",
         "SAME_LABEL",
         "True"
        ],
        [
         "116",
         "6683173",
         "oligodendrocyte",
         "oligodendrocyte",
         "SAME_LABEL",
         "True"
        ],
        [
         "118",
         "14363102",
         "oligodendrocyte",
         "oligodendrocyte",
         "SAME_LABEL",
         "True"
        ],
        [
         "129",
         "37597135",
         "natural killer cell",
         "mature natural killer cell",
         "PREDICTED_IS_CHILD_OF_GT",
         "True"
        ],
        [
         "130",
         "3605316",
         "CD14-positive monocyte",
         "CD14-positive, CD16-negative classical monocyte",
         "PREDICTED_IS_CHILD_OF_GT",
         "True"
        ],
        [
         "153",
         "42503598",
         "luminal epithelial cell of mammary gland",
         "luminal epithelial cell of mammary gland",
         "SAME_LABEL",
         "True"
        ],
        [
         "165",
         "53762469",
         "alveolar macrophage",
         "alveolar macrophage",
         "SAME_LABEL",
         "True"
        ],
        [
         "166",
         "30340997",
         "CD14-positive monocyte",
         "CD14-low, CD16-positive monocyte",
         "PREDICTED_IS_CHILD_OF_GT",
         "True"
        ],
        [
         "167",
         "7542355",
         "T cell",
         "intraepithelial lymphocyte",
         "PREDICTED_IS_CHILD_OF_GT",
         "True"
        ],
        [
         "171",
         "30449502",
         "CD14-positive monocyte",
         "CD14-low, CD16-positive monocyte",
         "PREDICTED_IS_CHILD_OF_GT",
         "True"
        ],
        [
         "183",
         "1004188",
         "T cell",
         "lung resident memory CD8-positive, alpha-beta T cell",
         "PREDICTED_IS_CHILD_OF_GT",
         "True"
        ],
        [
         "184",
         "44247302",
         "CD14-positive, CD16-negative classical monocyte",
         "CD14-positive, CD16-negative classical monocyte",
         "SAME_LABEL",
         "True"
        ],
        [
         "185",
         "11874016",
         "T cell",
         "lung resident memory CD8-positive, alpha-beta T cell",
         "PREDICTED_IS_CHILD_OF_GT",
         "True"
        ],
        [
         "187",
         "29005838",
         "lymphocyte",
         "exhausted T cell",
         "PREDICTED_IS_CHILD_OF_GT",
         "True"
        ],
        [
         "190",
         "15073125",
         "oligodendrocyte",
         "oligodendrocyte",
         "SAME_LABEL",
         "True"
        ],
        [
         "213",
         "34578862",
         "natural killer cell",
         "natural killer cell",
         "SAME_LABEL",
         "True"
        ],
        [
         "220",
         "25137652",
         "natural killer cell",
         "natural killer cell",
         "SAME_LABEL",
         "True"
        ],
        [
         "226",
         "27054257",
         "microglial cell",
         "microglial cell",
         "SAME_LABEL",
         "True"
        ],
        [
         "229",
         "3968085",
         "CD14-low, CD16-positive monocyte",
         "CD14-low, CD16-positive monocyte",
         "SAME_LABEL",
         "True"
        ],
        [
         "233",
         "38937500",
         "CD14-positive monocyte",
         "CD14-low, CD16-positive monocyte",
         "PREDICTED_IS_CHILD_OF_GT",
         "True"
        ],
        [
         "251",
         "25484772",
         "CD8-positive, alpha-beta T cell",
         "CD8-positive, alpha-beta cytotoxic T cell",
         "PREDICTED_IS_CHILD_OF_GT",
         "True"
        ],
        [
         "275",
         "34419233",
         "naive thymus-derived CD4-positive, alpha-beta T cell",
         "naive thymus-derived CD4-positive, alpha-beta T cell",
         "SAME_LABEL",
         "True"
        ],
        [
         "278",
         "25463332",
         "macrophage",
         "alveolar macrophage",
         "PREDICTED_IS_CHILD_OF_GT",
         "True"
        ],
        [
         "296",
         "44997243",
         "B cell",
         "memory B cell",
         "PREDICTED_IS_CHILD_OF_GT",
         "True"
        ],
        [
         "298",
         "16811996",
         "oligodendrocyte",
         "oligodendrocyte",
         "SAME_LABEL",
         "True"
        ],
        [
         "300",
         "4307469",
         "CD14-positive monocyte",
         "CD14-low, CD16-positive monocyte",
         "PREDICTED_IS_CHILD_OF_GT",
         "True"
        ],
        [
         "304",
         "45546223",
         "mature alpha-beta T cell",
         "activated type II NK T cell",
         "PREDICTED_IS_CHILD_OF_GT",
         "True"
        ],
        [
         "305",
         "37807796",
         "kidney loop of Henle thick ascending limb epithelial cell",
         "kidney loop of Henle thick ascending limb epithelial cell",
         "SAME_LABEL",
         "True"
        ],
        [
         "311",
         "29986319",
         "double-positive, alpha-beta thymocyte",
         "double-positive, alpha-beta thymocyte",
         "SAME_LABEL",
         "True"
        ],
        [
         "316",
         "42085866",
         "natural killer cell",
         "natural killer cell",
         "SAME_LABEL",
         "True"
        ],
        [
         "321",
         "17365913",
         "oligodendrocyte",
         "oligodendrocyte",
         "SAME_LABEL",
         "True"
        ],
        [
         "326",
         "20353853",
         "lymphoid lineage restricted progenitor cell",
         "pro-B cell",
         "PREDICTED_IS_CHILD_OF_GT",
         "True"
        ],
        [
         "336",
         "38066960",
         "kidney loop of Henle thick ascending limb epithelial cell",
         "kidney loop of Henle cortical thick ascending limb epithelial cell",
         "PREDICTED_IS_CHILD_OF_GT",
         "True"
        ],
        [
         "337",
         "42092161",
         "natural killer cell",
         "natural killer cell",
         "SAME_LABEL",
         "True"
        ],
        [
         "340",
         "25777779",
         "CD8-positive, alpha-beta T cell",
         "CD8-positive, alpha-beta cytotoxic T cell",
         "PREDICTED_IS_CHILD_OF_GT",
         "True"
        ],
        [
         "346",
         "330800",
         "luminal epithelial cell of mammary gland",
         "luminal epithelial cell of mammary gland",
         "SAME_LABEL",
         "True"
        ],
        [
         "357",
         "41581045",
         "non-classical monocyte",
         "CD14-low, CD16-positive monocyte",
         "PREDICTED_IS_CHILD_OF_GT",
         "True"
        ],
        [
         "358",
         "44354855",
         "CD14-positive, CD16-negative classical monocyte",
         "CD14-positive, CD16-negative classical monocyte",
         "SAME_LABEL",
         "True"
        ]
       ],
       "shape": {
        "columns": 5,
        "rows": 1439
       }
      },
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>cell_name</th>\n",
       "      <th>ground_truth_label</th>\n",
       "      <th>predicted_label</th>\n",
       "      <th>verdict</th>\n",
       "      <th>match_scTab</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>12826196</td>\n",
       "      <td>T cell</td>\n",
       "      <td>T cell</td>\n",
       "      <td>SAME_LABEL</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10</th>\n",
       "      <td>37809921</td>\n",
       "      <td>kidney loop of Henle thick ascending limb epit...</td>\n",
       "      <td>kidney loop of Henle thick ascending limb epit...</td>\n",
       "      <td>SAME_LABEL</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>19</th>\n",
       "      <td>53765774</td>\n",
       "      <td>endothelial cell</td>\n",
       "      <td>lung endothelial cell</td>\n",
       "      <td>PREDICTED_IS_CHILD_OF_GT</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>22</th>\n",
       "      <td>45007111</td>\n",
       "      <td>B cell</td>\n",
       "      <td>memory B cell</td>\n",
       "      <td>PREDICTED_IS_CHILD_OF_GT</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>24</th>\n",
       "      <td>35895143</td>\n",
       "      <td>naive thymus-derived CD4-positive, alpha-beta ...</td>\n",
       "      <td>naive thymus-derived CD4-positive, alpha-beta ...</td>\n",
       "      <td>SAME_LABEL</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9958</th>\n",
       "      <td>44984624</td>\n",
       "      <td>B cell</td>\n",
       "      <td>memory B cell</td>\n",
       "      <td>PREDICTED_IS_CHILD_OF_GT</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9967</th>\n",
       "      <td>41268000</td>\n",
       "      <td>amacrine cell</td>\n",
       "      <td>GABAergic amacrine cell</td>\n",
       "      <td>PREDICTED_IS_CHILD_OF_GT</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9969</th>\n",
       "      <td>14030343</td>\n",
       "      <td>astrocyte</td>\n",
       "      <td>protoplasmic astrocyte</td>\n",
       "      <td>PREDICTED_IS_CHILD_OF_GT</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9976</th>\n",
       "      <td>37179446</td>\n",
       "      <td>CD8-positive, alpha-beta T cell</td>\n",
       "      <td>effector memory CD8-positive, alpha-beta T cell</td>\n",
       "      <td>PREDICTED_IS_CHILD_OF_GT</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9982</th>\n",
       "      <td>35269729</td>\n",
       "      <td>natural killer cell</td>\n",
       "      <td>natural killer cell</td>\n",
       "      <td>SAME_LABEL</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>1439 rows × 5 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "     cell_name                                 ground_truth_label  \\\n",
       "3     12826196                                             T cell   \n",
       "10    37809921  kidney loop of Henle thick ascending limb epit...   \n",
       "19    53765774                                   endothelial cell   \n",
       "22    45007111                                             B cell   \n",
       "24    35895143  naive thymus-derived CD4-positive, alpha-beta ...   \n",
       "...        ...                                                ...   \n",
       "9958  44984624                                             B cell   \n",
       "9967  41268000                                      amacrine cell   \n",
       "9969  14030343                                          astrocyte   \n",
       "9976  37179446                    CD8-positive, alpha-beta T cell   \n",
       "9982  35269729                                natural killer cell   \n",
       "\n",
       "                                        predicted_label  \\\n",
       "3                                                T cell   \n",
       "10    kidney loop of Henle thick ascending limb epit...   \n",
       "19                                lung endothelial cell   \n",
       "22                                        memory B cell   \n",
       "24    naive thymus-derived CD4-positive, alpha-beta ...   \n",
       "...                                                 ...   \n",
       "9958                                      memory B cell   \n",
       "9967                            GABAergic amacrine cell   \n",
       "9969                             protoplasmic astrocyte   \n",
       "9976    effector memory CD8-positive, alpha-beta T cell   \n",
       "9982                                natural killer cell   \n",
       "\n",
       "                       verdict match_scTab  \n",
       "3                   SAME_LABEL        True  \n",
       "10                  SAME_LABEL        True  \n",
       "19    PREDICTED_IS_CHILD_OF_GT        True  \n",
       "22    PREDICTED_IS_CHILD_OF_GT        True  \n",
       "24                  SAME_LABEL        True  \n",
       "...                        ...         ...  \n",
       "9958  PREDICTED_IS_CHILD_OF_GT        True  \n",
       "9967  PREDICTED_IS_CHILD_OF_GT        True  \n",
       "9969  PREDICTED_IS_CHILD_OF_GT        True  \n",
       "9976  PREDICTED_IS_CHILD_OF_GT        True  \n",
       "9982                SAME_LABEL        True  \n",
       "\n",
       "[1439 rows x 5 columns]"
      ]
     },
     "execution_count": 16,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "r1_results.iloc[index]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 17,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "application/vnd.microsoft.datawrangler.viewer.v0+json": {
       "columns": [
        {
         "name": "index",
         "rawType": "int64",
         "type": "integer"
        },
        {
         "name": "cell_name",
         "rawType": "object",
         "type": "string"
        },
        {
         "name": "ground_truth_label",
         "rawType": "object",
         "type": "string"
        },
        {
         "name": "predicted_label",
         "rawType": "object",
         "type": "string"
        },
        {
         "name": "verdict",
         "rawType": "object",
         "type": "string"
        },
        {
         "name": "match_scTab",
         "rawType": "object",
         "type": "string"
        }
       ],
       "conversionMethod": "pd.DataFrame",
       "ref": "9734f74e-a02e-47fa-a2e6-467d4cbeb7ed",
       "rows": [
        [
         "3",
         "12826196",
         "T cell",
         "serous secreting cell",
         "NO_DIRECT_CHILD_RELATION",
         "False"
        ],
        [
         "10",
         "37809921",
         "kidney loop of Henle thick ascending limb epithelial cell",
         "epithelial cell of proximal tubule",
         "NO_DIRECT_CHILD_RELATION",
         "False"
        ],
        [
         "19",
         "53765774",
         "endothelial cell",
         "pulmonary alveolar type 2 cell",
         "NO_DIRECT_CHILD_RELATION",
         "False"
        ],
        [
         "22",
         "45007111",
         "B cell",
         "activated skeletal muscle satellite cell",
         "NO_DIRECT_CHILD_RELATION",
         "False"
        ],
        [
         "24",
         "35895143",
         "naive thymus-derived CD4-positive, alpha-beta T cell",
         "naive thymus-derived CD8-positive, alpha-beta T cell",
         "NO_DIRECT_CHILD_RELATION",
         "False"
        ],
        [
         "28",
         "17494605",
         "oligodendrocyte",
         "cerebral cortex neuron",
         "NO_DIRECT_CHILD_RELATION",
         "False"
        ],
        [
         "37",
         "35644005",
         "memory B cell",
         "naive B cell",
         "NO_DIRECT_CHILD_RELATION",
         "False"
        ],
        [
         "46",
         "20331652",
         "plasmacytoid dendritic cell",
         "myeloid lineage restricted progenitor cell",
         "NO_DIRECT_CHILD_RELATION",
         "False"
        ],
        [
         "51",
         "45166837",
         "CD14-positive, CD16-negative classical monocyte",
         "CD14-low, CD16-positive monocyte",
         "NO_DIRECT_CHILD_RELATION",
         "False"
        ],
        [
         "88",
         "37417767",
         "CD8-positive, alpha-beta T cell",
         "cytotoxic T cell",
         "NO_DIRECT_CHILD_RELATION",
         "False"
        ],
        [
         "98",
         "45086023",
         "CD8-positive, alpha-beta T cell",
         "cytotoxic T cell",
         "NO_DIRECT_CHILD_RELATION",
         "False"
        ],
        [
         "107",
         "44640339",
         "CD14-positive, CD16-negative classical monocyte",
         "monocyte-derived dendritic cell",
         "NO_DIRECT_CHILD_RELATION",
         "False"
        ],
        [
         "112",
         "5736610",
         "luminal epithelial cell of mammary gland",
         "luminal endometrial multiciliated epithelial cell",
         "NO_DIRECT_CHILD_RELATION",
         "False"
        ],
        [
         "116",
         "6683173",
         "oligodendrocyte",
         "glutamatergic neuron",
         "NO_DIRECT_CHILD_RELATION",
         "False"
        ],
        [
         "118",
         "14363102",
         "oligodendrocyte",
         "pyramidal neuron",
         "NO_DIRECT_CHILD_RELATION",
         "False"
        ],
        [
         "129",
         "37597135",
         "natural killer cell",
         "cytotoxic T cell",
         "NO_DIRECT_CHILD_RELATION",
         "False"
        ],
        [
         "130",
         "3605316",
         "CD14-positive monocyte",
         "classical monocyte",
         "NO_DIRECT_CHILD_RELATION",
         "False"
        ],
        [
         "153",
         "42503598",
         "luminal epithelial cell of mammary gland",
         "luminal endometrial multiciliated epithelial cell",
         "NO_DIRECT_CHILD_RELATION",
         "False"
        ],
        [
         "165",
         "53762469",
         "alveolar macrophage",
         "lung macrophage",
         "GT_IS_CHILD_OF_PREDICTED",
         "False"
        ],
        [
         "166",
         "30340997",
         "CD14-positive monocyte",
         "monocyte",
         "GT_IS_CHILD_OF_PREDICTED",
         "False"
        ],
        [
         "167",
         "7542355",
         "T cell",
         "enterocyte",
         "NO_DIRECT_CHILD_RELATION",
         "False"
        ],
        [
         "171",
         "30449502",
         "CD14-positive monocyte",
         "monocyte",
         "GT_IS_CHILD_OF_PREDICTED",
         "False"
        ],
        [
         "183",
         "1004188",
         "T cell",
         "hepatocyte",
         "NO_DIRECT_CHILD_RELATION",
         "False"
        ],
        [
         "184",
         "44247302",
         "CD14-positive, CD16-negative classical monocyte",
         "classical monocyte",
         "GT_IS_CHILD_OF_PREDICTED",
         "False"
        ],
        [
         "185",
         "11874016",
         "T cell",
         "alveolar macrophage",
         "NO_DIRECT_CHILD_RELATION",
         "False"
        ],
        [
         "187",
         "29005838",
         "lymphocyte",
         "macrophage",
         "NO_DIRECT_CHILD_RELATION",
         "False"
        ],
        [
         "190",
         "15073125",
         "oligodendrocyte",
         "glutamatergic neuron",
         "NO_DIRECT_CHILD_RELATION",
         "False"
        ],
        [
         "213",
         "34578862",
         "natural killer cell",
         "cytotoxic T cell",
         "NO_DIRECT_CHILD_RELATION",
         "False"
        ],
        [
         "220",
         "25137652",
         "natural killer cell",
         "cytotoxic T cell",
         "NO_DIRECT_CHILD_RELATION",
         "False"
        ],
        [
         "226",
         "27054257",
         "microglial cell",
         "border associated macrophage",
         "NO_DIRECT_CHILD_RELATION",
         "False"
        ],
        [
         "229",
         "3968085",
         "CD14-low, CD16-positive monocyte",
         "monocyte",
         "GT_IS_CHILD_OF_PREDICTED",
         "False"
        ],
        [
         "233",
         "38937500",
         "CD14-positive monocyte",
         "classical monocyte",
         "NO_DIRECT_CHILD_RELATION",
         "False"
        ],
        [
         "251",
         "25484772",
         "CD8-positive, alpha-beta T cell",
         "T cell",
         "GT_IS_CHILD_OF_PREDICTED",
         "False"
        ],
        [
         "275",
         "34419233",
         "naive thymus-derived CD4-positive, alpha-beta T cell",
         "primitive red blood cell",
         "NO_DIRECT_CHILD_RELATION",
         "False"
        ],
        [
         "278",
         "25463332",
         "macrophage",
         "macrophage dendritic cell progenitor",
         "NO_DIRECT_CHILD_RELATION",
         "False"
        ],
        [
         "296",
         "44997243",
         "B cell",
         "monocyte",
         "NO_DIRECT_CHILD_RELATION",
         "False"
        ],
        [
         "298",
         "16811996",
         "oligodendrocyte",
         "sst GABAergic neuron of the striatum",
         "NO_DIRECT_CHILD_RELATION",
         "False"
        ],
        [
         "300",
         "4307469",
         "CD14-positive monocyte",
         "monocyte",
         "GT_IS_CHILD_OF_PREDICTED",
         "False"
        ],
        [
         "304",
         "45546223",
         "mature alpha-beta T cell",
         "T cell",
         "GT_IS_CHILD_OF_PREDICTED",
         "False"
        ],
        [
         "305",
         "37807796",
         "kidney loop of Henle thick ascending limb epithelial cell",
         "epithelial cell of proximal tubule",
         "NO_DIRECT_CHILD_RELATION",
         "False"
        ],
        [
         "311",
         "29986319",
         "double-positive, alpha-beta thymocyte",
         "cortical thymic epithelial cell",
         "NO_DIRECT_CHILD_RELATION",
         "False"
        ],
        [
         "316",
         "42085866",
         "natural killer cell",
         "CD8-positive, alpha-beta cytotoxic T cell",
         "NO_DIRECT_CHILD_RELATION",
         "False"
        ],
        [
         "321",
         "17365913",
         "oligodendrocyte",
         "midbrain dopaminergic neuron",
         "NO_DIRECT_CHILD_RELATION",
         "False"
        ],
        [
         "326",
         "20353853",
         "lymphoid lineage restricted progenitor cell",
         "hematopoietic stem cell",
         "NO_DIRECT_CHILD_RELATION",
         "False"
        ],
        [
         "336",
         "38066960",
         "kidney loop of Henle thick ascending limb epithelial cell",
         "epithelial cell of proximal tubule",
         "NO_DIRECT_CHILD_RELATION",
         "False"
        ],
        [
         "337",
         "42092161",
         "natural killer cell",
         "cytotoxic T cell",
         "NO_DIRECT_CHILD_RELATION",
         "False"
        ],
        [
         "340",
         "25777779",
         "CD8-positive, alpha-beta T cell",
         "cytotoxic T cell",
         "NO_DIRECT_CHILD_RELATION",
         "False"
        ],
        [
         "346",
         "330800",
         "luminal epithelial cell of mammary gland",
         "luminal endometrial multiciliated epithelial cell",
         "NO_DIRECT_CHILD_RELATION",
         "False"
        ],
        [
         "357",
         "41581045",
         "non-classical monocyte",
         "classical monocyte",
         "NO_DIRECT_CHILD_RELATION",
         "False"
        ],
        [
         "358",
         "44354855",
         "CD14-positive, CD16-negative classical monocyte",
         "CD14-low, CD16-positive monocyte",
         "NO_DIRECT_CHILD_RELATION",
         "False"
        ]
       ],
       "shape": {
        "columns": 5,
        "rows": 1439
       }
      },
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>cell_name</th>\n",
       "      <th>ground_truth_label</th>\n",
       "      <th>predicted_label</th>\n",
       "      <th>verdict</th>\n",
       "      <th>match_scTab</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>12826196</td>\n",
       "      <td>T cell</td>\n",
       "      <td>serous secreting cell</td>\n",
       "      <td>NO_DIRECT_CHILD_RELATION</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10</th>\n",
       "      <td>37809921</td>\n",
       "      <td>kidney loop of Henle thick ascending limb epit...</td>\n",
       "      <td>epithelial cell of proximal tubule</td>\n",
       "      <td>NO_DIRECT_CHILD_RELATION</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>19</th>\n",
       "      <td>53765774</td>\n",
       "      <td>endothelial cell</td>\n",
       "      <td>pulmonary alveolar type 2 cell</td>\n",
       "      <td>NO_DIRECT_CHILD_RELATION</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>22</th>\n",
       "      <td>45007111</td>\n",
       "      <td>B cell</td>\n",
       "      <td>activated skeletal muscle satellite cell</td>\n",
       "      <td>NO_DIRECT_CHILD_RELATION</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>24</th>\n",
       "      <td>35895143</td>\n",
       "      <td>naive thymus-derived CD4-positive, alpha-beta ...</td>\n",
       "      <td>naive thymus-derived CD8-positive, alpha-beta ...</td>\n",
       "      <td>NO_DIRECT_CHILD_RELATION</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9958</th>\n",
       "      <td>44984624</td>\n",
       "      <td>B cell</td>\n",
       "      <td>activated skeletal muscle satellite cell</td>\n",
       "      <td>NO_DIRECT_CHILD_RELATION</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9967</th>\n",
       "      <td>41268000</td>\n",
       "      <td>amacrine cell</td>\n",
       "      <td>retinal ganglion cell</td>\n",
       "      <td>NO_DIRECT_CHILD_RELATION</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9969</th>\n",
       "      <td>14030343</td>\n",
       "      <td>astrocyte</td>\n",
       "      <td>glutamatergic neuron</td>\n",
       "      <td>NO_DIRECT_CHILD_RELATION</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9976</th>\n",
       "      <td>37179446</td>\n",
       "      <td>CD8-positive, alpha-beta T cell</td>\n",
       "      <td>cytotoxic T cell</td>\n",
       "      <td>NO_DIRECT_CHILD_RELATION</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9982</th>\n",
       "      <td>35269729</td>\n",
       "      <td>natural killer cell</td>\n",
       "      <td>cytotoxic T cell</td>\n",
       "      <td>NO_DIRECT_CHILD_RELATION</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>1439 rows × 5 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "     cell_name                                 ground_truth_label  \\\n",
       "3     12826196                                             T cell   \n",
       "10    37809921  kidney loop of Henle thick ascending limb epit...   \n",
       "19    53765774                                   endothelial cell   \n",
       "22    45007111                                             B cell   \n",
       "24    35895143  naive thymus-derived CD4-positive, alpha-beta ...   \n",
       "...        ...                                                ...   \n",
       "9958  44984624                                             B cell   \n",
       "9967  41268000                                      amacrine cell   \n",
       "9969  14030343                                          astrocyte   \n",
       "9976  37179446                    CD8-positive, alpha-beta T cell   \n",
       "9982  35269729                                natural killer cell   \n",
       "\n",
       "                                        predicted_label  \\\n",
       "3                                 serous secreting cell   \n",
       "10                   epithelial cell of proximal tubule   \n",
       "19                       pulmonary alveolar type 2 cell   \n",
       "22             activated skeletal muscle satellite cell   \n",
       "24    naive thymus-derived CD8-positive, alpha-beta ...   \n",
       "...                                                 ...   \n",
       "9958           activated skeletal muscle satellite cell   \n",
       "9967                              retinal ganglion cell   \n",
       "9969                               glutamatergic neuron   \n",
       "9976                                   cytotoxic T cell   \n",
       "9982                                   cytotoxic T cell   \n",
       "\n",
       "                       verdict match_scTab  \n",
       "3     NO_DIRECT_CHILD_RELATION       False  \n",
       "10    NO_DIRECT_CHILD_RELATION       False  \n",
       "19    NO_DIRECT_CHILD_RELATION       False  \n",
       "22    NO_DIRECT_CHILD_RELATION       False  \n",
       "24    NO_DIRECT_CHILD_RELATION       False  \n",
       "...                        ...         ...  \n",
       "9958  NO_DIRECT_CHILD_RELATION       False  \n",
       "9967  NO_DIRECT_CHILD_RELATION       False  \n",
       "9969  NO_DIRECT_CHILD_RELATION       False  \n",
       "9976  NO_DIRECT_CHILD_RELATION       False  \n",
       "9982  NO_DIRECT_CHILD_RELATION       False  \n",
       "\n",
       "[1439 rows x 5 columns]"
      ]
     },
     "execution_count": 17,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "v3_results.iloc[index]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 18,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "application/vnd.microsoft.datawrangler.viewer.v0+json": {
       "columns": [
        {
         "name": "index",
         "rawType": "int64",
         "type": "integer"
        },
        {
         "name": "index",
         "rawType": "int64",
         "type": "integer"
        },
        {
         "name": "soma_joinid",
         "rawType": "int64",
         "type": "integer"
        },
        {
         "name": "cell_type_ground_truth",
         "rawType": "object",
         "type": "string"
        },
        {
         "name": "prompt",
         "rawType": "object",
         "type": "string"
        },
        {
         "name": "reasoning",
         "rawType": "object",
         "type": "string"
        },
        {
         "name": "response",
         "rawType": "object",
         "type": "string"
        },
        {
         "name": "prompt_token",
         "rawType": "int64",
         "type": "integer"
        },
        {
         "name": "reasoning_token",
         "rawType": "int64",
         "type": "integer"
        },
        {
         "name": "completion_token",
         "rawType": "int64",
         "type": "integer"
        }
       ],
       "conversionMethod": "pd.DataFrame",
       "ref": "675c8d83-2057-4084-9fd6-5cd294219711",
       "rows": [
        [
         "3",
         "3",
         "12826196",
         "T cell",
         "You are an expert in single-cell biology.\n\nBelow is metadata for one cell, followed by a list of its genes in descending expression:\nTissue: omentum\nDisease: malignant ovarian serous tumor\nDevelopment stage: 63-year-old human stage\nGenes: MT-ND3 RPLP1 MT-CYB MT-ATP6 RPS27 MT-CO1 RPL13 EEF1A1 RPS29 RPL28 MT-CO3 RPS19 RPL37 RPL10 RPS18 RPL32 TPT1 B2M MT-CO2 RPS2 RPL3 RPL41 RPL34 MT-ND2 RPS28 RPS3A RPL30 RPS27A MT-ND4 RPL39 RPL19 RPS12 MT-ND1 RPS4X TXNIP TMSB4X RPL37A RPS14 RPL29 RPL15 RPS23 RPS3 RPL13A BTG1 RPL6 RPS15A PTMA RPS8 RPL9 RPS9 RPL21 RPLP2 RPL10A RPL35 RPL18A RPS6 RPS15 RPS13 RPL36 RPL18 IL7R TSC22D3 RPS16 RPL11 RPS5 NACA RPS7 ZFP36L2 RPS25 MT-ND5 RPL27A TOMM7 CD2 RPS20 HLA-B RPL7 FTH1 RPS24 RPL38 RPL14 RPL24 RPL5 RPSA RPL23A RPL12 RPL7A RPL22 RPL35A KLF2 RPL8 NPM1 HLA-A COX7C RPS11 FAU FOS RPL23 EEF1D TMA7 RPLP0\n\nPlease identify what cell type this might be, as granular and accurate as possible.\nKeep your response concise and clear.\nAt the end of your response, strictly place the final lines in this format:\n\nCell type: X\n",
         "Okay, let's try to figure out what cell type this is. The metadata says it's from the omentum of a 63-year-old human with a malignant ovarian serous tumor. So, the tissue is omentum, which is part of the peritoneal cavity and often involved in ovarian cancer metastases. The disease here is a malignant tumor, so maybe this cell is part of the tumor microenvironment or the cancer cells themselves.\n\nLooking at the genes, I see a lot of mitochondrial genes like MT-ND3, MT-CYB, MT-ATP6, MT-CO1, etc. High mitochondrial gene expression is often seen in metabolically active cells. Cancer cells are known for their high metabolic activity, so that's a hint. But also, some immune cells like T cells can have active metabolism. But let's check other genes.\n\nThere are ribosomal proteins (RPL and RPS genes), which are involved in protein synthesis. Both cancer cells and rapidly dividing cells, including immune cells, might upregulate these. But the combination with mitochondrial genes might suggest something else. Let's look for specific markers.\n\nI notice B2M (Beta-2-microglobulin), which is part of MHC class I molecules. Present in most nucleated cells, but maybe not specific. HLA-B and HLA-A are also MHC class I genes, so that's consistent with cells that present antigens, like many cell types, including cancer cells.\n\nTXNIP (Thioredoxin-interacting protein) is involved in redox regulation. High in some stressed cells. TMSB4X (Thymosin beta-4) is involved in actin sequestration, found in many cells but maybe high in certain immune cells or cancer cells.\n\nIL7R (Interleukin-7 receptor) is a marker for T cells, especially naive or memory T cells. But wait, is IL7R present here? Let me check the gene list again. Yes, IL7R is listed. That's a strong indicator of T cells. Also, CD2 is present, which is a T cell surface marker. So CD2 and IL7R together suggest T cells. But there's also KLF2, which is involved in T cell homeostasis and quiescence.\n\nHowever, the presence of FOS and ZFP36L2 (which are early response genes, maybe activated in T cells upon stimulation) and other genes like FTH1 (ferritin heavy chain, involved in iron storage, sometimes in macrophages but also in other cells). But the combination of IL7R and CD2 is pointing towards T cells.\n\nBut wait, the context is a malignant ovarian tumor in the omentum. The omentum is a site where tumor cells metastasize and where there's often an immune infiltrate. Tumor-infiltrating lymphocytes (TILs), including T cells, are common. However, cancer cells themselves might have some of these genes too. Let me check if there's any epithelial or cancer-specific markers. Ovarian serous carcinomas are typically epithelial (e.g., expressing EpCAM, MUC16/CA125), but those genes aren't listed here. Instead, the genes here are more about ribosomes, mitochondria, and some T cell markers.\n\nWait, the mitochondrial genes are very prominent. Activated T cells might have higher mitochondrial activity. However, cancer cells (like ovarian cancer cells) are also highly metabolic. But the presence of IL7R and CD2 is more specific. Let me think: if this were a cancer cell, would it express IL7R? Not typically. IL7R is more of a lymphocyte marker. So maybe this is a T cell in the tumor microenvironment. But why so many ribosomal proteins? Activated T cells do upregulate protein synthesis, so that makes sense.\n\nAlso, TPT1 (Tumor protein, translationally-controlled 1) is involved in cell growth and is expressed in various cells, including T cells. EEF1A1 is translation elongation factor, again protein synthesis.\n\nSo putting this together: High mitochondrial and ribosomal genes indicate a metabolically active cell. IL7R and CD2 point to T cells. The context is the omentum with ovarian cancer, so likely a tumor-infiltrating T cell. But what subtype? Let's see other markers. There's no CD3 listed here, but maybe other genes. KLF2 is expressed in naive T cells. TMSB4X is in many cells but also in T cells. ZFP36L2 is involved in mRNA degradation, seen in T cell activation.\n\nSo maybe this is a CD8+ T cell, or a memory T cell. But without more specific markers like CD4 or CD8, it's hard. But given IL7R and CD2, plus the context, the most probable cell type is a T lymphocyte, specifically a tumor-infiltrating T cell. Alternatively, given the high ribosomal and mitochondrial genes, could it be a plasma cell? But plasma cells typically express high immunoglobulins and markers like CD138, which aren't here. The presence of B2M and HLA suggests antigen presentation, but again, T cells are MHC class I positive.\n\nAlternatively, maybe a macrophage? But FTH1 is present, which is in macrophages, but also other cells. However, IL7R is not typical for macrophages. So T cell seems more likely.\n\nAnother check: Malignant cells often have copy number variations, but in single-cell data, mitochondrial genes can sometimes indicate stress. But combining with IL7R and CD2, which are immune markers, it's more likely an immune cell. So the answer is T cell. But how granular can we get? If KLF2 is high, maybe a naive T cell, but in the tumor microenvironment, they might be exhausted or activated. Alternatively, memory T cells. But without more markers, perhaps just T cell.\n\nWait, the genes include RPL and RPS, which are in all cells, but their high expression could indicate high protein synthesis, which is consistent with activated T cells. So, final answer: Tumor-infiltrating T cell. But maybe more specifically, CD8+ T cell? But without CD8A or CD8B in the gene list, can't confirm. So safest is T cell.",
         "The cell exhibits high expression of mitochondrial (e.g., MT-ND3, MT-CO1) and ribosomal genes (RPL/RPS), indicative of metabolic and translational activity. Immune-related markers IL7R (T cell receptor) and CD2 (T/NK cell marker) are present, alongside antigen presentation genes (B2M, HLA-A/B). These features align with tumor-infiltrating lymphocytes, particularly T cells, within the ovarian cancer microenvironment. The absence of epithelial cancer markers (e.g., EPCAM) and myeloid-specific genes further supports this. KLF2 and TMSB4X suggest a naive or resting T cell phenotype, though activation signals (ZFP36L2, FOS) may reflect tumor-driven stimulation.  \n\nCell type: Tumor-infiltrating T cell",
         "429",
         "1288",
         "1454"
        ],
        [
         "10",
         "8",
         "37809921",
         "kidney loop of Henle thick ascending limb epithelial cell",
         "You are an expert in single-cell biology.\n\nBelow is metadata for one cell, followed by a list of its genes in descending expression:\nTissue: kidney\nDisease: chronic kidney disease\nDevelopment stage: eighth decade human stage\nGenes: MT-ND3 MT-CO1 MT-ND4 MT-ATP6 MT-CO2 MT-CO3 MT-ND2 UMOD MT-ND4L MT-ND1 MT-CYB SLC12A1 MT-ND5 FXYD2 NDUFA4 ATP1B1 MT-ATP8 DEFB1 NDUFA13 FTH1 RPL41 COX8A PPP1R1A COX7C ATP1A1 RPL32 UQCRB RPS18 EEF1A1 KNG1 RPL39 COX6B1 RPS6 RPL26 S100A6 RPL34 POLR2L ATP5MG RPL15 RPL11 LDHB RPS27A RPL3 RPS28 RPS4X UBB COX7A2 TPT1 RPS7 EGF HNRNPU RPS24 NDUFB3 UQCR11 RPL12 RPS3A RPLP1 RPL18A MGST3 MAL RPL19 GPX4 RPLP2 MFSD4A GSTP1 ITM2B COX6C RPL28 B2M SF3B5 RPL21 PTK2 PPIA DSTN RPS12 FOLR3 CCDC47 ATP5PF MARCHF6 MPC1 TM9SF3 RPL10 MLF2 LDHA IMMT PNKD RPL36AL RPS13 RPS29 TPI1 ATP5MC1 ATP5F1D SERF2 IGFBP7 RPS15 RPS23 DUSP9 ATP5MC2 MRPL33 COX6A1\n\nPlease identify what cell type this might be, as granular and accurate as possible.\nKeep your response concise and clear.\nAt the end of your response, strictly place the final lines in this format:\n\nCell type: X\n",
         "Okay, let's try to figure out what cell type this is. The metadata says it's from the kidney of someone with chronic kidney disease in their eighth decade. The genes listed are in descending order of expression.\n\nFirst, looking at the top genes: MT-ND3, MT-CO1, MT-ND4, etc. These are mitochondrial genes involved in oxidative phosphorylation. High expression might suggest a cell type with high energy demands. But wait, mitochondrial genes can sometimes be artifacts in single-cell data, but given the context, maybe they're relevant here.\n\nNext, UMOD is the second non-mitochondrial gene. UMOD encodes uromodulin, which is produced by the thick ascending limb (TAL) cells of the kidney. That's a strong marker. Then SLC12A1 is also present. SLC12A1 is the sodium-potassium-chloride cotransporter (NKCC2), specific to TAL cells. So that's a big clue. FXYD2 is another gene associated with distal tubules, but maybe overlaps here.\n\nOther genes: ATP1B1 and ATP1A1 are subunits of the Na+/K+ ATPase, which is crucial for ion transport in TAL cells. DEFB1 (beta-defensin 1) is also expressed in the kidney, possibly in loop of Henle. KNG1 (kininogen) might relate to inflammation, which makes sense with chronic kidney disease.\n\nLooking at ribosomal proteins (RPL and RPS genes) – these are often housekeeping genes, so maybe high expression here is normal. But combined with the mitochondrial genes, maybe the cell is stressed or has high metabolic activity. But the key markers here are UMOD and SLC12A1, which are very specific to the thick ascending limb of the loop of Henle. \n\nIn chronic kidney disease, there might be changes in these cells, but the presence of those markers still points to TAL. Also, the absence of other markers like AQP2 (collecting duct) or SLC12A3 (distal convoluted tubule) helps narrow it down. So putting this together, the cell type is likely the thick ascending limb epithelial cell of the nephron.",
         "The cell exhibits high expression of mitochondrial genes (MT-ND3, MT-CO1, etc.), consistent with high metabolic activity. Key markers include **UMOD** (uromodulin) and **SLC12A1** (NKCC2), both specific to the thick ascending limb (TAL) of the nephron. Additional TAL-associated genes like **FXYD2**, **ATP1B1**, and **KNG1** further support this. Chronic kidney disease may alter expression profiles, but the core markers pinpoint a stressed or adapted TAL epithelial cell.\n\nCell type: Thick ascending limb epithelial cell (nephron)",
         "437",
         "458",
         "592"
        ],
        [
         "19",
         "15",
         "53765774",
         "endothelial cell",
         "You are an expert in single-cell biology.\n\nBelow is metadata for one cell, followed by a list of its genes in descending expression:\nTissue: lung\nDisease: normal\nDevelopment stage: 75-year-old human stage\nGenes: MT2A TMSB10 B2M TMSB4X MT1M DEPP1 HLA-B FTH1 IFITM3 TM4SF1 IFI27 MT1E RPL34 RPL10 RPS18 RPL41 RPL13 MGP RPS6 RPL32 RPS27 RPLP2 HLA-C GPX3 RPS3 CLDN5 RPLP1 RPL13A RPS27A RPS19 RPL21 IFITM1 S100A6 EEF1A1 HYAL2 RPS14 RPL26 MT1X FTL PTMA RPS3A RPS2 RPL28 RPL9 TPT1 UBC CD9 RPS25 RPS15 RPL23A RPL29 FKBP1A CEBPD RPL35A CAVIN2 RPL3 RPL27A H3-3B RPL15 ARID5A RPS23 CD59 RAMP2 RPL27 RPS12 ACTB RPL39 RPS28 IFITM2 RPS4X RPLP0 RPL35 RNASE1 EDN1 RPS8 SRGN RPS20 RPL37A RPL12 RPL37 RPL10A EPAS1 RPS7 RPS15A RAC1 HLA-E BST2 SPARCL1 RPS29 MYL12A TUBA1B RPS5 FAU RPL7 RPL11 IGFBP7 CTNNB1 RPL22 TOMM7 CLEC14A\n\nPlease identify what cell type this might be, as granular and accurate as possible.\nKeep your response concise and clear.\nAt the end of your response, strictly place the final lines in this format:\n\nCell type: X\n",
         "Okay, let's see. The metadata says the cell is from a normal lung tissue of a 75-year-old human. The genes listed are in descending order of expression. I need to figure out the cell type based on these genes.\n\nFirst, I remember that certain genes are markers for specific cell types. Let me go through some of the top genes. MT2A, MT1E, MT1X are metallothioneins involved in metal ion binding and stress response. They might be expressed in various cells, not sure yet. TMSB10 and TMSB4X are thymosin beta family members, which are involved in actin sequestration. These are often found in cells with high cytoskeletal dynamics, maybe endothelial or immune cells?\n\nB2M is beta-2-microglobulin, part of MHC class I molecules, so present in most nucleated cells. HLA-B and HLA-C are MHC class I genes too, so maybe antigen-presenting cells, but again, many cells have MHC I. FTH1 is ferritin heavy chain, involved in iron storage. IFITM3 and IFI27 are interferon-induced proteins, suggesting response to viral infection or interferon signaling. That could point towards immune cells like macrophages or dendritic cells, but also epithelial cells in the lung might upregulate these when stressed.\n\nLooking further down, there's CLDN5, which is a tight junction protein found in endothelial cells. CD59 is a complement inhibitor, also on endothelial cells. ACTB is beta-actin, ubiquitous but high expression in structural cells. EDN1 is endothelin-1, which is produced by endothelial cells and involved in vasoconstriction. CAVIN2 is part of caveolae in endothelial cells. CLEC14A is a C-type lectin involved in endothelial cell biology. EPAS1 is HIF-2α, which can be expressed in endothelial cells under hypoxia, but also in other cells. SPARCL1 is secreted protein acidic and rich in cysteine-like 1, associated with endothelial cells.\n\nAlso, genes like RPL and RPS are ribosomal proteins, which are highly expressed in cells with active protein synthesis. Endothelial cells might have that, but so do many other cells. However, combining CLDN5, CD59, EDN1, CAVIN2, CLEC14A, and SPARCL1—these are pretty specific to endothelial cells. The presence of HLA genes and interferon response genes could indicate activation due to normal immune surveillance in the lung endothelium.\n\nThe tissue is lung, so likely a pulmonary endothelial cell. Maybe a specific type? There are different endothelial cells in the lung, like alveolar capillary endothelium or vascular. CLDN5 is more associated with continuous endothelium, which lines the blood vessels. SPARCL1 is expressed in vascular endothelial cells. CLEC14A is involved in angiogenesis and endothelial function. Putting this together, it's probably a vascular endothelial cell from the lung. Given the age, 75 years, maybe there's some age-related expression, but the markers still point to endothelial.",
         "The cell shows high expression of endothelial markers (CLDN5, CD59, EDN1, CAVIN2, CLEC14A, SPARCL1) and MHC class I genes (HLA-B, HLA-C), alongside interferon-response genes (IFITM3, IFI27). These features align with lung vascular endothelial cells, which exhibit antigen presentation capacity and basal interferon signaling for immune surveillance. Ribosomal genes (RPL/RPS) reflect active protein synthesis, consistent with endothelial homeostasis. The absence of epithelial (e.g., SFTPB), immune-specific (e.g., CD68), or smooth muscle markers further supports this.\n\nCell type: Lung vascular endothelial cell",
         "420",
         "629",
         "770"
        ],
        [
         "22",
         "18",
         "45007111",
         "B cell",
         "You are an expert in single-cell biology.\n\nBelow is metadata for one cell, followed by a list of its genes in descending expression:\nTissue: blood\nDisease: COVID-19\nDevelopment stage: 55-year-old human stage\nGenes: MTRNR2L12 RPS27 RPL13 RPL41 CD74 RPS8 EEF1A1 RPS27A RPL32 RPLP1 RPL18A RPL37 RPL39 RPS18 RPS3A MT-CO1 RPS23 RPL10 RPS12 RPL30 RPL29 RPL34 RPL11 MT-CO2 RPL21 RPLP2 RPL19 RPS25 RPS19 RPL36 RPS28 RPS24 RPL28 RPL35A RPS29 RPL8 RPS15A B2M TMSB4X RPL7A TMSB10 RPL23A RPS4X RPL18 FAU RPL9 RPS6 RPL37A RPS21 RPL15 RPL26 RPS3 RPS13 MT-CO3 RPL14 RPL12 TPT1 RPL6 RPS9 RPS14 RPS5 RPS15 MT-ATP8 RPL13A HLA-B RPL3 RPSA HLA-DRA MT-CYB MT-ND3 RPS2 RPL27A RPS11 RPL35 RACK1 RPL10A MT-ATP6 FTH1 RPS7 NACA RPL38 FTL RPL24 CD69 CD52 RPLP0 NOP53 RPL5 COX7C RPL22 HLA-DQB1 ACTB CD37 SRSF5 MT-ND2 TXNIP HLA-DPA1 H3-3A RPL23 MBNL1\n\nPlease identify what cell type this might be, as granular and accurate as possible.\nKeep your response concise and clear.\nAt the end of your response, strictly place the final lines in this format:\n\nCell type: X\n",
         "Okay, let's tackle this. The metadata says the cell is from blood tissue of a 55-year-old human with COVID-19. The gene list is key. Scanning through the genes, I notice a lot of ribosomal proteins: RPS and RPL genes. Those are typically involved in protein synthesis. High expression of these might indicate a cell that's actively producing proteins. Also, there's CD74, which is associated with MHC class II molecules. HLA-DRA and HLA-DQB1 are MHC class II genes as well, so that points towards antigen-presenting cells. B2M is beta-2-microglobulin, part of MHC class I.\n\nLooking at other markers: CD52 is found on lymphocytes, including T cells and B cells. CD69 is an early activation marker. FAU and TMSB4X are involved in various processes but not super specific. Then there are mitochondrial genes like MT-CO1, MT-CO2, MT-ATP6. High mitochondrial content could suggest a metabolically active cell, maybe a monocyte or macrophage, but the ribosomal proteins are more prominent. \n\nWait, CD74 is also expressed in B cells and dendritic cells. HLA-DRA and HLA-DPA1 are MHC II, so likely an antigen-presenting cell. But B cells also have MHC II. The presence of B2M (MHC I) is common in many cells. The lack of specific T cell markers like CD3, or myeloid markers like CD14, CD16. Maybe a B cell? But B cells typically have CD19, CD20. Those aren't listed here. Hmm. Wait, there's CD37 and CD52. CD37 is more B-cell associated. \n\nAlternatively, could this be a plasma cell? Plasma cells have high ribosome production for antibody secretion. Plasma cells express CD38, CD138, which aren't here. Maybe not. \n\nAnother angle: COVID-19 might lead to activation. CD69 is an activation marker. If it's an activated B cell, that might fit. Or a memory B cell. Alternatively, given the MHC II and CD74, maybe a dendritic cell? But dendritic cells have other markers like CD11c. \n\nWait, let's check the genes again. RACK1 is involved in various signaling pathways. FTH1 and FTL are ferritin genes, which can be in many cells. TMSB4X is thymosin beta 4, found in many immune cells. \n\nWait, B cells have high MHC II expression. The presence of HLA-DQB1 and HLA-DRA suggests active antigen presentation. But the ribosomal proteins are so dominant. Maybe a plasmablast? They're proliferating and producing antibodies, hence lots of ribosomes. But again, typical markers like CD27 might be missing. \n\nAlternatively, this could be a stressed cell due to COVID-19. Viral infection can induce stress responses, leading to increased ribosomal biogenesis. But the cell type? If it's from blood, maybe a monocyte? But monocytes have CD14. Not listed here. \n\nAlternatively, a memory B cell. Some B cell subsets might upregulate ribosomal proteins when activated. The presence of CD37 and CD52, along with MHC II, but absence of more specific markers. \n\nWait, CD74 is part of the invariant chain of MHC II, so cells that are processing antigens for presentation. B cells, dendritic cells, monocytes. But without more specific markers, maybe a B cell. \n\nAnother thought: the high expression of ribosomal proteins is a hallmark of proliferating cells. Maybe a lymphocyte that's activated and proliferating, like a blast cell. But in COVID-19, maybe a plasmablast? They do have high ribosome counts. \n\nGiven the genes listed, including B2M, CD74, HLA-DRA, and the ribosomal proteins, I'm leaning towards a B cell, possibly an activated or proliferating B cell, which would have high ribosomal activity. Alternatively, given the presence of CD69 (activation), maybe an activated B cell. But without more specific markers like CD19 or CD20, which are common B cell markers. Wait, looking again: HLA-DQB1 is part of MHC II, which B cells express. CD37 is a B cell marker. The presence of CD37 and CD52 (lymphocytes) and MHC II genes, along with ribosomal proteins, suggests a B cell. \n\nSo, the cell type is likely a B cell. But how granular can we get? Given the activation marker CD69, maybe an activated B cell. Or, considering COVID-19, perhaps a plasmablast or memory B cell. But without specific markers like CD27 or CD38, it's safer to say B cell. Alternatively, a memory B cell. \n\nAlternatively, maybe a plasma cell, but plasma cells typically downregulate MHC II, which contradicts the presence of HLA-DRA here. So, activated B cell or memory B cell. Alternatively, given the high ribosomal proteins, maybe a naive B cell in active state. But I'm not sure. \n\nAnother check: The genes include CD74 and HLA-DRA, which are part of MHC II processing. B cells use these for antigen presentation. The absence of T cell markers (like CD3) and myeloid markers (like CD14, CD16) supports B cell. \n\nSo, the most probable cell type here is a B cell. To be more granular, perhaps activated B cell, but given the information, B cell is the main type. Maybe even a memory B cell if there's prior exposure, but without explicit markers, B cell is the safe answer.",
         "The cell exhibits high expression of ribosomal proteins (RPS/RPL), MHC class II-related genes (CD74, HLA-DRA, HLA-DQB1), and B-cell-associated markers (CD37, CD52, B2M). These features, combined with activation markers (CD69) and absence of myeloid/T-cell-specific genes, strongly suggest an activated B cell. The ribosomal upregulation aligns with heightened protein synthesis during antigen response, consistent with COVID-19 infection driving B-cell activation. \n\nCell type: Activated memory B cell",
         "426",
         "1157",
         "1266"
        ],
        [
         "24",
         "20",
         "35895143",
         "naive thymus-derived CD4-positive, alpha-beta T cell",
         "You are an expert in single-cell biology.\n\nBelow is metadata for one cell, followed by a list of its genes in descending expression:\nTissue: blood\nDisease: normal\nDevelopment stage: infant stage\nGenes: RPL10 EEF1A1 RPS12 RPLP1 RPS18 RPL32 RPS23 RPL13 RPS15A RPL30 RPL18A TMSB4X RPS15 RPL11 RPS27A B2M RPS3 RPL12 RPS27 RPS14 RPS19 RPL19 RPS8 RPLP0 RPS9 RPL29 RPL39 RPS13 RPL14 RPL3 RPL28 RPS28 RPL18 RPS25 RPL8 RPL26 RPS3A RPL34 RPS24 RPS7 RPL35A RPL7A RPL5 RPS5 FAU ACTB TMSB10 RACK1 EEF1D PABPC1 RPS6 RPS26 TPT1 RPL35 RPS4X RPL17 RPL37 MT-CO1 RPL41 RPL36 JUN NACA FTH1 RPSA HLA-B BTF3 MT-CO2 PTMA PFDN5 RPL27 PFN1 RPL24 RPS2 NOSIP HNRNPA1 RPL15 RPL6 EEF1B2 RPL9 EIF1 RPL10A SARAF IL7R RPLP2 IFITM1 FTL LTB LEF1 HNRNPA2B1 HSPA8 RPL4 PNRC1 SELL CALM1 MT-ND4 RPL23A HLA-A LDHB CNBP PTPRCAP\n\nPlease identify what cell type this might be, as granular and accurate as possible.\nKeep your response concise and clear.\nAt the end of your response, strictly place the final lines in this format:\n\nCell type: X\n",
         "Okay, let's tackle this question. The user provided a list of genes expressed in a single cell from blood tissue, with normal disease state and infant stage. I need to figure out the cell type as accurately as possible.\n\nFirst, looking at the genes listed. Many ribosomal proteins like RPL and RPS genes are highly expressed. That's common in cells with high protein synthesis, which could be lymphocytes, especially since they're proliferating. But also, other cells like erythroblasts or maybe even some progenitors have high ribosome content. But since this is blood, likely a mature cell type.\n\nTMSB4X and TMSB10 are thymosin beta proteins involved in actin sequestration, which is typical in cells that need dynamic cytoskeleton changes, like T cells or other immune cells. ACTB is beta-actin, also supporting cytoskeleton structure. \n\nHLA-B and HLA-A are MHC class I molecules, present on all nucleated cells, but higher in immune cells. B2M is beta-2-microglobulin, part of MHC class I. So this cell is nucleated, which excludes red blood cells. \n\nIL7R is the interleukin-7 receptor. IL7R is crucial for T cell development and survival. That's a strong hint towards T cells. SELL is CD62L, which is involved in lymphocyte homing, again pointing to T or B cells. \n\nGenes like LEF1 are involved in T cell receptor signaling. LTB (lymphotoxin beta) is associated with B cells and some T cells. But IL7R and SELL are more T cell specific. Also, JUN is a transcription factor involved in various cells but can be part of activation in T cells.\n\nLooking at other markers: CD3 is a T cell marker, but I don't see CD3 genes listed here. Wait, the genes provided don't include CD3D, CD3E, etc. Hmm. That's a problem. Maybe it's a different cell type. Alternatively, maybe it's a naive T cell, which might have lower CD3 expression? Or perhaps a different subset.\n\nCheck for other markers: PTMA is prothymosin alpha, which is involved in cell proliferation. FAU is a ribosomal protein but also part of the ubiquitin-like protein. RACK1 is involved in signaling, present in various cells. EEF1A1 and EEF1D are translation elongation factors, again high protein synthesis.\n\nMT-CO1 and MT-CO2 are mitochondrial genes, which could indicate active metabolism. But many cells have that. \n\nHSPA8 is heat shock protein, common in many cells. CALM1 is calmodulin, involved in signaling. \n\nNow, the absence of CD19, CD20 (MS4A1), CD79A/B would argue against B cells. No CD14, CD16 for monocytes. No CD56 for NK cells. \n\nIL7R and SELL (CD62L) are present, which in blood would be more typical of naive T cells, which express high levels of CD62L and IL7R. However, the lack of CD3 genes is puzzling. Maybe the dataset doesn't include them, or they are expressed at lower levels? Alternatively, maybe it's a hematopoietic stem cell, but those would have different markers like CD34. \n\nWait, the development stage is infant. So maybe it's a developing T cell? But infant blood would have mature T cells as well. \n\nAnother angle: the presence of RPL and RPS genes is very high. Ribosomal proteins are abundant in cells actively translating proteins. T cells, when activated, upregulate protein synthesis. But this is a normal sample, so maybe it's a resting cell. However, naive T cells are in G0 phase, so maybe not. Alternatively, this could be a B cell, but I don't see B cell-specific markers. \n\nLooking again: The gene list includes FAU, which is part of the ubiquitin system. JUN and FOS are AP-1 complex, involved in T cell activation. But again, without CD3, it's hard. \n\nWait, there's LTB (lymphotoxin beta). LTB is more associated with B cells and lymphoid tissue organization. But SELL (CD62L) is on naive T cells. Hmm. \n\nWait, the gene list includes IL7R, SELL, LEF1, TMSB4X, and RPS genes. Maybe a naive T cell. But why no CD3? Could it be that in the dataset, CD3 genes are not detected due to low expression? Maybe the technology used (like 10x Genomics) might not capture all genes if they're low. Alternatively, the cell is a progenitor. \n\nAlternatively, looking at RACK1, which is involved in T cell receptor signaling. The presence of JUN might suggest activation, but without activation markers like CD69 or CD25. \n\nAnother thought: Natural Killer cells. But NK cells typically have CD56 (NCAM1), which isn't listed here. Also, IFITM1 is an interferon-induced protein, present in various leukocytes. \n\nWait, the gene IL7R is also present in some dendritic cells, but that's less likely. \n\nAlternatively, considering the ribosomal proteins, maybe it's a hematopoietic stem cell (HSC) or progenitor. HSCs express CD34, which isn't in the list. Progenitor cells might have high ribosomal content. But again, IL7R is more T cell. \n\nAlternatively, could it be a plasmacytoid dendritic cell? Not sure. \n\nWait, the gene list includes PTPRCAP, which is CD45-AP, part of the CD45 complex. CD45 is a pan-leukocyte marker, so that's consistent with a leukocyte. \n\nSo, putting this together: high ribosomal proteins, IL7R, SELL, LEF1, TMSB4X, ACTB. The most likely candidate is a naive T cell. Even if CD3 isn't in the list, maybe due to technical reasons (dropout in scRNA-seq). Alternatively, a memory T cell, but SELL is higher in naive. \n\nAlternatively, maybe a gamma-delta T cell, but that's more specific. \n\nGiven the information, the best bet is a naive CD4+ T cell. Alternatively, a CD8+ T cell. But without CD4 or CD8 markers listed, it's hard to be certain. But the presence of IL7R and SELL would lean towards naive T cells. \n\nAnother check: The gene LEF1 is involved in T cell receptor signaling. So, combining all this, the cell type is likely a naive T cell. \n\nAlternatively, if IL7R is also present in B cell progenitors, but in blood, more likely mature cells. \n\nSo, the answer would be a naive T cell. But wait, infants have recent thymic emigrants, which might have similar markers. \n\nYes, I think the cell type is a naive T cell, possibly CD4+.",
         "The cell exhibits high expression of ribosomal genes (RPL/RPS), TMSB4X (actin sequestration), and IL7R (critical for T cell survival), alongside SELL (CD62L, homing receptor) and LEF1 (TCR signaling). These markers, combined with the absence of lineage-specific genes for B cells, monocytes, or NK cells, strongly suggest a naive T cell. The presence of HLA class I genes (B2M, HLA-A/B) and pan-leukocyte marker PTPRCAP (CD45-AP) further supports this. The infant stage aligns with naive T cell prevalence in early development.\n\nCell type: naive CD4+ T cell",
         "413",
         "1467",
         "1611"
        ],
        [
         "28",
         "24",
         "17494605",
         "oligodendrocyte",
         "You are an expert in single-cell biology.\n\nBelow is metadata for one cell, followed by a list of its genes in descending expression:\nTissue: cerebral cortex\nDisease: normal\nDevelopment stage: 50-year-old human stage\nGenes: PCDH9 IL1RAPL1 CTNNA3 PLP1 PPP2R2B NRXN3 ST18 DLG2 CADM2 RNF220 MAGI2 NCAM2 SLC24A2 TMTC2 TCF12 ANK2 PTPRD SHTN1 NTM SEPTIN7 ZBTB20 PDE4B FMNL2 UNC5C SLC44A1 MAP7 NKAIN2 MBP EDIL3 PLCL1 DNM3 ANK3 APP NLGN1 CLASP2 FRMD5 PHLPP1 AUTS2 ROBO1 ADD1 ELMO1 TMEM144 CCNH TTLL7 MARCHF1 GRM3 PDE1C SPOCK1 DOCK3 QKI TRIM2 ARAP2 NCAM1 SIK3 DPYD AK5 KIF13A MBNL2 PTPRK ANKIB1 MOBP GNAO1 CNTNAP2 FRYL SASH1 SPOCK3 ATXN1 SH3GL3 FBXL7 SSH2 PEX5L ALCAM BCAS3 WNK1 PTK2 PPP1R12B PRUNE2 USP54 DOCK4 PDE1A PALM2AKAP2 HIP1 CERCAM MAP4K4 AKAP6 ADGRB3 CDC42BPA SCD SLCO3A1 EXOC6B C10orf90 GAB1 DAAM2 CACNA2D1 LSAMP PIP4K2A TMEM184B LPAR1 USP34 PLPPR1\n\nPlease identify what cell type this might be, as granular and accurate as possible.\nKeep your response concise and clear.\nAt the end of your response, strictly place the final lines in this format:\n\nCell type: X\n",
         "Okay, let's see. The task is to identify the cell type based on the given metadata and gene list. The metadata says it's from the cerebral cortex of a 50-year-old human, normal, no disease mentioned. The genes are listed in descending order of expression.\n\nFirst, I need to recall the major cell types in the cerebral cortex. The main ones are neurons (excitatory and inhibitory), astrocytes, oligodendrocytes, microglia, etc. Since the genes are provided, I should look for markers specific to these cell types.\n\nLooking at the top genes: PCDH9, IL1RAPL1, CTNNA3, PLP1, PPP2R2B, NRXN3, ST18, DLG2, CADM2... Hmm. Let me check each gene's association.\n\nPLP1 is a major myelin protein, typically expressed in oligodendrocytes. Oligodendrocytes produce myelin, so that's a strong indicator. But wait, other genes here might complicate things. Let's check others.\n\nMBP (Myelin Basic Protein) is another key myelin-related gene, also found in oligodendrocytes. MOBP (Myelin-associated Oligodendrocyte Basic Protein) is another oligodendrocyte marker. CNTNAP2 is involved in neuron-glia interactions but can be in oligodendrocytes. MAGI2 and QKI are also associated with myelination.\n\nBut wait, some genes like NRXN3 (Neurexin 3) are synaptic and might be neuronal. However, oligodendrocytes do express some cell adhesion molecules involved in axon interaction. Let's cross-reference.\n\nNeuronal markers like SYT1 or SNAP25 aren't in the list. Instead, genes like PLP1, MBP, MOBP, MAG, and QKI are prominent here. These are all strong oligodendrocyte markers. Also, PPP2R2B is involved in signal transduction but not specific. However, the presence of multiple myelin-related genes points towards oligodendrocytes.\n\nBut wait, there's also APP (Amyloid Precursor Protein), which is found in neurons but can be in other cells. However, given the dominance of myelin genes, maybe it's a mature oligodendrocyte. The age is 50 years, which is adult, so mature oligodendrocytes make sense.\n\nPutting this together: High expression of PLP1, MBP, MOBP, MAGI2, QKI, CNTNAP2, and other myelin-related genes strongly suggests this is an oligodendrocyte. Also, since it's the cerebral cortex, oligodendrocytes are abundant there for myelination of axons.",
         "The cell exhibits high expression of myelin-related genes (PLP1, MBP, MOBP, MAGI2, QKI) and oligodendrocyte-associated markers (CNTNAP2, ANK3, CLASP2). These genes are critical for myelination, lipid synthesis, and axon-glial interactions, which align with mature oligodendrocyte function in the adult cerebral cortex.\n\nCell type: Oligodendrocyte",
         "426",
         "547",
         "634"
        ],
        [
         "37",
         "31",
         "35644005",
         "memory B cell",
         "You are an expert in single-cell biology.\n\nBelow is metadata for one cell, followed by a list of its genes in descending expression:\nTissue: nasal cavity\nDisease: COVID-19\nDevelopment stage: 2-5 year-old child stage\nGenes: CD74 RPLP1 RPS12 EEF1A1 RPS8 RPL32 RPL10 RPL41 RPL30 B2M RPL19 RPL34 RPL11 RPS27 RPS14 RPS15 RPS23 RPL18A RPL39 HLA-DRA RPS27A RPL13 RPL29 ACTB RPS18 RPS15A RPL8 RPS3 MT-CO2 RPS19 RPL28 RPS5 RPS13 RPS7 RPL26 RPS4X RPS21 RPL18 RPL12 RPS3A RPS28 RPS2 MT-CO1 RPL37 RPLP0 RPS6 RPL7A RPL21 FTL RPL14 TMSB10 RPL36 RACK1 RPL5 PFDN5 RPL3 HLA-DPA1 MT-CYB HLA-B NACA RPL6 RPLP2 MT-ATP6 FTH1 RPSA HLA-C RPL35A RPS25 RPL24 MT-CO3 RPS16 FAU RPS24 RPS26 BTG1 TMSB4X RPL23A RPL10A RPL4 RPL13A RPL37A EEF1B2 MS4A1 MT-ND4 MT-ND3 CD52 RPS4Y1 ATP5MC2 PTMA CD37 RPL9 CYBA RPS9 RPL15 ZFP36L2 PABPC1 RPL36A HLA-A RNASET2 MT-ND4L\n\nPlease identify what cell type this might be, as granular and accurate as possible.\nKeep your response concise and clear.\nAt the end of your response, strictly place the final lines in this format:\n\nCell type: X\n",
         "Okay, let's try to figure out the cell type here. The metadata says it's from the nasal cavity of a 2-5 year-old child with COVID-19. The genes listed are mostly ribosomal proteins like RPL and RPS genes, which are usually highly expressed in cells active in protein synthesis. But there's also some immune-related genes. Let's look closer.\n\nHLA-DRA, HLA-DPA1, HLA-DRB1 (though not listed here, sometimes other HLAs), B2M (beta-2-microglobulin part of MHC class I), CD74 – these are markers for antigen-presenting cells. CD74 is specifically involved in MHC class II antigen presentation. MS4A1 is CD20, a B cell marker. But wait, the genes here include MS4A1, so maybe B cells? However, other B cell markers like CD19 or CD79a aren't listed. But sometimes in single-cell data, not all markers are present. Alternatively, dendritic cells or macrophages express HLA genes. \n\nLooking at other genes: ACTB (actin), FTL (ferritin light chain), FTH1 (ferritin heavy chain) – these are common in many cells but might indicate metabolic activity. TMSB4X and TMSB10 are thymosin beta proteins, involved in actin sequestration, found in various cells including immune cells. \n\nThe presence of mitochondrial genes like MT-CO1, MT-CO2, MT-ATP6 – could suggest high metabolic activity, which is common in activated immune cells. But high mitochondrial content can also be a quality control issue, but given the context of COVID-19, maybe it's part of the cell's state.\n\nMS4A1 (CD20) is a strong indicator for B cells. But if this is a B cell, why so many HLA genes? Plasma cells downregulate MHC II, but memory B cells might express some. Alternatively, maybe a B cell that's activated and presenting antigen. Also, CD37 and CD52 are present; CD37 is a B cell marker, CD52 is found on lymphocytes including B and T cells. \n\nOther genes: RACK1 is involved in various signaling, PABPC1 is RNA binding, which could be active in B cells producing antibodies. ZFP36L2 is involved in mRNA stability, seen in immune cells. \n\nWait, but the tissue is nasal cavity, so maybe mucosal B cells? Or plasma cells? Plasma cells typically have high immunoglobulin genes, which aren't listed here. The ribosomal proteins might just indicate high protein production, which is true for plasma cells, but again, without Ig genes, maybe not. Alternatively, epithelial cells – but HLA-DRA and CD74 are more immune. \n\nPutting this together: High expression of MHC class II genes (HLA-DRA, HLA-DPA1), CD74, and MS4A1 (CD20) points towards a B cell. The presence of ribosomal proteins might indicate active protein synthesis, which is consistent with B cells, especially if they're activated and producing antibodies. Considering the nasal cavity in a COVID-19 context, this could be a memory B cell or an activated B cell involved in the immune response. Alternatively, maybe a plasmablast, but again, lack of immunoglobulin genes. Another possibility is a dendritic cell, but CD20 is more specific to B cells. \n\nThe cell type is likely a B cell, given CD20 (MS4A1), CD37, HLA-DR expression. So the most granular would be a B cell, possibly activated or memory B cell.",
         "The cell shows high expression of ribosomal proteins (e.g., RPL/RPS genes), MHC class II genes (HLA-DRA, HLA-DPA1), and CD74 (MHC II chaperone), alongside B cell markers (MS4A1/CD20, CD37). This profile, combined with the nasal cavity location and COVID-19 context, indicates an activated B cell engaged in antigen presentation and antibody production. The absence of plasma cell markers (e.g., immunoglobulins) suggests it is not fully differentiated into a plasma cell.\n\nCell type: Activated memory B cell",
         "430",
         "737",
         "858"
        ],
        [
         "46",
         "40",
         "20331652",
         "plasmacytoid dendritic cell",
         "You are an expert in single-cell biology.\n\nBelow is metadata for one cell, followed by a list of its genes in descending expression:\nTissue: bone marrow\nDisease: Down syndrome\nDevelopment stage: 13th week post-fertilization human stage\nGenes: H4C3 CD74 ACTB EEF1A1 MT-CO1 TUBA1B RPLP1 RPL41 PTMA HMGN2 HMGB1 MTRNR2L12 TUBB RPS27 ACTG1 FOS RPS12 STMN1 PFN1 MT-ATP6 RPL10 MT-CO2 HMGB2 MT-CO3 TMSB10 RPS3A HSP90AA1 PLD4 RPL28 RPL32 RPL37 RPS23 RPS3 B2M KLF6 MT-ATP8 RPS28 TPT1 RPLP0 RPS6 FTH1 RPL39 GAPDH PPIA RPS8 RPL30 RPL19 RPS13 RPS21 TMSB4X RPL3 RPS29 RPS7 HNRNPA2B1 RPL13 HNRNPA1 VIM H3-3B MT-ND3 RPS24 EIF1 RPS15 RPS15A MT-ND4 MT-CYB CFL1 CYBA RPS19 RPL11 RPL21 RPL34 RPSA RPL14 RPS2 MT-ND4L RPL6 RPS18 RPS9 H2AZ1 RPS14 HSPA8 RPL8 UBC H3-3A IRF8 RPL15 FAU RPS4X MT-ND5 IER2 RPLP2 HSPA5 JCHAIN RPL26 RPL35A LSP1 RACK1 ID2 RPL29 RPS27A\n\nPlease identify what cell type this might be, as granular and accurate as possible.\nKeep your response concise and clear.\nAt the end of your response, strictly place the final lines in this format:\n\nCell type: X\n",
         "Okay, let's tackle this cell type identification problem. The metadata says the tissue is bone marrow, the disease is Down syndrome, and the development stage is 13th week post-fertilization human. The genes listed are in descending order of expression.\n\nFirst, bone marrow cell types. At 13 weeks, human fetal bone marrow is developing, so maybe hematopoietic cells? Down syndrome is associated with transient abnormal myelopoiesis, so could be a hematopoietic progenitor.\n\nLooking at the genes. High expression of ribosomal proteins (RPL and RPS genes), which are common in cells with high protein synthesis, like actively proliferating cells. Also, mitochondrial genes (MT-CO1, MT-ATP6), which might indicate high energy use. ACTB, TUBA1B, TUBB are cytoskeletal, involved in cell structure. VIM (vimentin) is a mesenchymal marker but also found in some hematopoietic cells. CD74 is involved in antigen presentation, seen in B cells and dendritic cells. B2M is beta-2-microglobulin, part of MHC class I, present in many cells. HMGB1 and HMGB2 are chromatin-associated proteins. FOS is an immediate early gene, involved in proliferation/differentiation.\n\nHSP90AA1 and HSPA8 are heat shock proteins, stress response, but also general in many cells. IRF8 is a transcription factor important in myeloid cells, like monocytes/dendritic cells. PLD4 is associated with plasmacytoid dendritic cells. JCHAIN is part of immunoglobulins, typically in plasma cells, but PLD4 and JCHAIN together might suggest pDCs. However, other markers like CD123 (IL3RA) or CLEC4C (BDCA-2) aren't listed here. Wait, but PLD4 is a marker for pDCs. Also, LSP1 is expressed in lymphocytes and myeloid cells.\n\nWait, IRF8 and PLD4 combination. IRF8 is critical for myeloid and lymphoid development. PLD4 is a marker for pDCs. JCHAIN might indicate early B cells or plasma cells, but if PLD4 is present, maybe pDC. However, pDCs typically express other markers like CLEC4C. But maybe in early development, the markers are different. Also, Down syndrome is associated with transient myeloproliferative disorder, which involves megakaryocyte precursors, but those would have markers like CD41, CD61. Not seeing those here.\n\nAlternatively, given ribosomal proteins and mitochondrial genes, maybe a progenitor cell with high proliferation. But IRF8 and PLD4 could hint towards dendritic lineage. Alternatively, maybe a erythroid progenitor? But then you might see GYPA or other globin genes. Not here. HBA1/HBB not listed. \n\nAnother angle: CD74 and B2M are part of MHC II and I respectively. B cells and dendritic cells express MHC II. But PLD4 is more specific for pDCs. However, JCHAIN is part of immunoglobulin J chain, which is in plasma cells and pDCs. So maybe a plasmacytoid dendritic cell? But in bone marrow, pDCs are present. Alternatively, pre-B cells? But JCHAIN is more plasma cell. Hmm.\n\nLooking up PLD4: yes, PLD4 is a marker for plasmacytoid dendritic cells. IRF8 is also involved in pDC development. JCHAIN can be expressed in pDCs as they can produce some immunoglobulins. So combining PLD4, IRF8, JCHAIN, maybe this is a pDC. Also, LSP1 is expressed in pDCs. Additionally, HMGB1, HMGN2 are chromatin proteins, which might be involved in the pDC's role in nucleic acid sensing.\n\nBut other markers: TPT1 (TCTP), which is involved in growth, and RACK1, which is a signaling scaffold. The presence of ribosomal proteins suggests high translation activity, which is consistent with pDCs as they produce cytokines like type I interferons upon activation. However, fetal pDCs at 13 weeks might have different gene expression profiles.\n\nAlternatively, could this be a hematopoietic stem cell or progenitor? But HSCs usually have different markers like CD34, which isn't listed here. The absence of CD34 might argue against that.\n\nAnother thought: Down syndrome is associated with GATA1 mutations in transient leukemia, but the genes here don't include GATA1. But the presence of IRF8 and PLD4 may still point towards a dendritic cell lineage.\n\nGiven the combination of PLD4, IRF8, JCHAIN, and LSP1, along with the context of bone marrow and developmental stage, the most likely cell type is a plasmacytoid dendritic cell (pDC). These cells are part of the immune system and present in bone marrow. The high ribosomal and mitochondrial genes align with their active state, even in development. The Down syndrome context might relate to immune dysregulation, but the markers point to pDC.",
         "The cell exhibits high expression of ribosomal (RPL/RPS) and mitochondrial (MT-) genes, indicative of active proliferation and protein synthesis. Key markers include **PLD4** and **IRF8** (specific to plasmacytoid dendritic cells, pDCs), **JCHAIN** (linked to immunoglobulin processing), **CD74** (antigen presentation), and **LSP1** (leukocyte signaling). These markers, combined with the bone marrow context and developmental stage, strongly suggest an early immune progenitor with pDC characteristics. Down syndrome may influence aberrant immune cell profiles, but the gene signature aligns most closely with a differentiating plasmacytoid dendritic cell.\n\nCell type: Plasmacytoid dendritic cell precursor",
         "431",
         "1045",
         "1194"
        ],
        [
         "51",
         "492",
         "45166837",
         "CD14-positive, CD16-negative classical monocyte",
         "You are an expert in single-cell biology.\n\nBelow is metadata for one cell, followed by a list of its genes in descending expression:\nTissue: blood\nDisease: COVID-19\nDevelopment stage: 60-year-old human stage\nGenes: S100A9 S100A8 FTL ACTB S100A6 EEF1A1 FTH1 B2M TMSB4X LYZ MT-CO1 TMSB10 MT-CO2 CST3 MT-CO3 RPL28 TPT1 S100A4 RPL37 MTRNR2L12 RPLP1 RPL6 RPL11 RPL13 HLA-B RPS24 MT-CYB RPS19 RPL32 RPS14 RPL30 RPL19 RPS12 SH3BGRL3 RPL10 RPL41 RPS28 RPL39 GAPDH RPS3 IFITM3 RPS13 S100A11 RPS23 RPS9 RPL34 RPS15 RPS8 RPL36 RPL15 RPL7A RPL35A MT-ND3 PFN1 RACK1 RPL8 RPS27 RPS18 RPL18A RPL29 ARID5B MT-ND1 RPL23A RPL18 FAU RPL12 TYROBP RPS27A FCN1 H3-3A MYL6 VIM TSPO RPS15A PTMA RPL26 RPS21 RPS25 LGALS1 RPL13A RPLP2 MTRNR2L1 RPS7 SERF2 HLA-A RPS3A HLA-C GSTP1 ATP5F1A PFDN5 OAZ1 CLIC1 ZNF688 RPS6 RPL5 RPL3 PPIA MT2A RPL9 SRGN\n\nPlease identify what cell type this might be, as granular and accurate as possible.\nKeep your response concise and clear.\nAt the end of your response, strictly place the final lines in this format:\n\nCell type: X\n",
         "Okay, let's see. The metadata says the cell is from blood tissue in a 60-year-old human with COVID-19. The genes listed are in descending order of expression. I need to figure out the cell type based on these genes.\n\nStarting with the top genes: S100A9 and S100A8 are highly expressed. These are markers often associated with myeloid cells, specifically neutrophils or monocytes. FTL and FTH1 are involved in iron metabolism, common in macrophages. ACTB and EEF1A1 are housekeeping genes, so maybe not cell-specific. B2M is part of MHC class I, present in most cells. LYZ (lysozyme) is another myeloid marker, found in monocytes and neutrophils. MT-CO1, MT-CO2, MT-CO3 are mitochondrial genes, which might indicate high metabolic activity. \n\nLooking further down, TMSB4X and TMSB10 are thymosin beta proteins, involved in actin regulation, often seen in immune cells. CST3 is cathepsin C, found in lysosomes of myeloid cells. IFITM3 is an interferon-induced protein, which makes sense in the context of viral infection like COVID-19. HLA genes (HLA-B, HLA-A, HLA-C) are part of antigen presentation, so maybe antigen-presenting cells like monocytes or dendritic cells. \n\nFCN1 is a gene expressed in classical monocytes. VIM is vimentin, a marker for mesenchymal cells, but can be expressed in activated immune cells. TYROBP is a signaling molecule in NK cells and myeloid cells. \n\nThe presence of ribosomal proteins (RPL and RPS genes) is common in cells with high protein synthesis, which could be activated immune cells. However, some cell types like plasmacytoid dendritic cells or plasma cells have high ribosome content, but the myeloid markers here point more towards monocytes or neutrophils. \n\nWait, S100A8/S100A9 (calprotectin) are highly expressed in neutrophils, but also in monocytes during inflammation. However, FCN1 is more specific to monocytes. LYZ is in both, but maybe higher in monocytes. Also, COVID-19 often leads to a myeloid cell response. In severe cases, there's an increase in inflammatory monocytes. IFITM3 is involved in viral response, which fits. So putting it together: high S100A8/A9, FCN1, LYZ, HLA genes, IFITM3. This looks like a monocyte, possibly a classical monocyte. Alternatively, a neutrophil, but FCN1 and HLA might lean more towards monocyte. Also, in COVID-19, there's activation of monocytes. The cell type could be a CD14+ classical monocyte, which expresses FCN1 and S100A genes. Alternatively, maybe a macrophage, but the tissue is blood, so more likely a monocyte. Another point: TYROBP is part of the DAP12 signaling complex in myeloid cells, including monocytes and macrophages. \n\nSo the cell type is likely a classical monocyte (FCN1+, S100A8/9 high) from the blood of a COVID-19 patient. The high expression of ribosomal proteins might indicate activation or stress response due to infection. Final answer: classical monocyte.",
         "The cell exhibits high expression of myeloid markers (S100A8, S100A9, LYZ, CST3), interferon-response genes (IFITM3), and HLA class I/II genes, alongside monocyte-specific markers (FCN1). Ribosomal protein genes (RPL/RPS) suggest activation. These features align with an inflammatory monocyte subset, likely **classical CD14+ monocytes**, which are elevated in COVID-19 and exhibit S100A8/A9 upregulation during infection.\n\nCell type: Classical monocyte (CD14+ FCN1+)",
         "429",
         "675",
         "795"
        ],
        [
         "88",
         "78",
         "37417767",
         "CD8-positive, alpha-beta T cell",
         "You are an expert in single-cell biology.\n\nBelow is metadata for one cell, followed by a list of its genes in descending expression:\nTissue: blood\nDisease: COVID-19\nDevelopment stage: 1-year-old human stage\nGenes: B2M ACTB TMSB4X CCL5 MT-CO1 TMSB10 RPL41 GNLY RPL10 RPLP1 MT-CO2 MT-CO3 IL32 NKG7 RPS12 RPS15A RPL28 EEF1A1 GZMA RPS24 HLA-B RPS27 GAPDH SH3BGRL3 RPS15 HLA-C RPL39 MT-CYB VIM RPS3 RPS14 HLA-A RPL13 HMGN2 CFL1 RPS19 PTMA RPS23 RPS3A RPS28 ACTG1 RPS18 RPLP0 RPS7 RPL11 RPS8 RPS27A RPL29 RPL32 RPS13 LGALS1 RPL18A RPL30 CD52 PFN1 RPS4X RPL19 RPL34 RPS26 RPL18 ARHGDIB FTH1 RPSA MT-ATP6 RPL12 RPL7A RPL35A RPL14 RACK1 RPL36 RPL37 RPS25 FAU GZMB MYL6 RPL5 PPIA CD74 ARPC2 RPL6 RPLP2 MYL12A TPT1 RPL24 RPL8 RPS9 CD99 BTF3 RPS21 S100A6 TMA7 COX4I1 RPS6 HMGB1 IFITM1 SERF2 CD3D NACA ATP5MC2 RPL13A\n\nPlease identify what cell type this might be, as granular and accurate as possible.\nKeep your response concise and clear.\nAt the end of your response, strictly place the final lines in this format:\n\nCell type: X\n",
         "Okay, let's see. The task is to determine the cell type based on the given metadata and gene list. The metadata says it's from blood, COVID-19 disease, and a 1-year-old human. The genes are listed in descending expression.\n\nFirst, I need to look at the highly expressed genes. B2M and ACTB are common housekeeping genes, so maybe not too informative. Then there's CCL5, GNLY, GZMA, GZMB, NKG7. These genes are often associated with cytotoxic activity. For example, GNLY (granulysin), GZMA/B (granzymes), and NKG7 are markers for NK cells and cytotoxic T cells. Also, CD3D is present, which is a T cell marker. But wait, CD3D is lower in the list, so maybe not the most dominant. \n\nLooking at other genes: RPL and RPS genes are ribosomal proteins, which are typically in cells with high protein synthesis, but that's common in many cells. HLA genes (HLA-A, B, C) are MHC class I, present in most nucleated cells, but their expression might be upregulated in certain immune cells.\n\nThe presence of IL32 and CCL5 could indicate T cells or NK cells. CCL5 is a chemokine involved in attracting immune cells. GNLY and granzymes are more specific to cytotoxic cells. CD52 is a marker found on lymphocytes. PFN1 is profilin 1, involved in actin polymerization, important in immune cell function.\n\nNow, considering the disease is COVID-19, which often involves T cell responses. But the cell could be a CD8+ T cell or a Natural Killer cell. The high expression of cytotoxic granules (granzymes, granulysin) points towards a cytotoxic lymphocyte. Since CD3D is present, that would suggest a T cell rather than NK cell. However, CD3D is not at the very top. Alternatively, in some activated NK cells, certain T cell markers might be present, but more likely, this is a cytotoxic T cell.\n\nWait, but let me check other markers. CD8+ T cells would typically express CD8, but that's not listed here. The presence of CD3D, even if lower, still supports T cells. Maybe it's a gamma-delta T cell or another subset. Alternatively, NK cells don't express CD3, so if CD3D is present, it's more likely a T cell. But the strong cytotoxic profile with GNLY, GZMs, and NKG7 is characteristic of both activated CD8+ T cells and NK cells. \n\nAnother angle: The ribosomal proteins (RPL, RPS) are highly expressed, which is typical in cells with high metabolic activity, like activated T cells. In COVID-19, there's a lot of T cell activation. So putting it all together: high cytotoxic markers, presence of CD3D, and the context of COVID-19, this is probably a cytotoxic CD8+ T cell. However, sometimes NK cells can have similar markers but lack CD3. Since CD3D is in the list, albeit lower, it's more likely a T cell. But maybe it's a Natural Killer T (NKT) cell? But those are rare. Alternatively, maybe a mucosal-associated invariant T (MAIT) cell? Probably not, as MAIT cells have other specific markers.\n\nWait, another thought: The presence of genes like IL32, which is expressed in T cells, especially CD4+ Th1 cells, but also in CD8+ T cells. CCL5 is also produced by T cells. The combination of CCL5, GNLY, GZMA/B, NKG7, and CD3D points to an activated CD8+ T cell. Also, the ribosomal proteins suggest active protein synthesis, consistent with an activated state. In COVID-19, CD8+ T cells are crucial for antiviral response. So I think the cell type is a CD8+ cytotoxic T cell. But let me check if there are any conflicting markers. No CD8A or CD8B in the gene list. Hmm, that's a problem. CD8+ T cells should express CD8. The absence here might be because the dataset doesn't include it, or maybe it's lower in expression. Alternatively, maybe it's a gamma-delta T cell, which can be CD3+ but CD8-. But gamma-delta T cells are less common in blood. Alternatively, maybe a CD4+ cytotoxic T cell? Some CD4+ T cells can have cytotoxic activity. But CD4 is not listed here either. The absence of CD4 or CD8 markers complicates it. However, the presence of CD3D still indicates T cell lineage. Maybe the cell is a CD8+ T cell, and CD8 genes are just not in the top expressed genes listed here. Since the gene list is in descending order, CD8 might be lower. Alternatively, maybe the cell is an NK cell, but then CD3D shouldn't be present. Hmm. Let me check NK cell markers. NK cells typically have markers like NCAM1 (CD56), KLRD1 (CD94), etc. Those aren't listed here. Instead, the presence of CD3D, even if lower, might still indicate T cell origin. \n\nAnother possibility: In COVID-19, there's activation of cytotoxic T cells with exhaustion markers, but that's more about PD-1, LAG3, etc., which aren't listed here. Alternatively, maybe it's a mucosal-associated invariant T cell, but again, specific markers are missing. \n\nGiven the information, the strongest candidates are CD8+ cytotoxic T cells or NK cells. Since CD3D is present, leaning towards T cell. However, without CD8A/B, perhaps it's a gamma-delta T cell. Alternatively, maybe the dataset's gene list doesn't include CD8 because it's lower in expression. Given that the top genes are ribosomal and housekeeping, followed by cytotoxic markers, and CD3D is present, I think the most accurate call is CD8+ T cell. But I'm not 100% certain. Alternatively, maybe a Natural Killer cell with some T cell genes, but that's less likely. \n\nWait, let's check if any other T cell subsets have these markers. For example, MAIT cells express high levels of cytotoxic molecules, but they also have TCR Vα7.2 and are CD161+. Those markers aren't listed. Gamma-delta T cells can be cytotoxic and express CD3 but not CD4 or CD8. However, they are less common in blood compared to conventional T cells. \n\nGiven the context of COVID-19, which induces strong CD8+ T cell responses, and the presence of cytotoxic genes, the most probable cell type is an activated CD8+ cytotoxic T cell. Even though CD8A/B isn't in the list, the other markers and the context make this the best fit. Alternatively, maybe the cell is an NK cell with some contamination or misannotation, but CD3D should not be there. So I'll go with CD8+ T cell.",
         "The cell exhibits high expression of cytotoxic markers (GNLY, GZMA/B, NKG7), T-cell-associated genes (CD3D, IL32), and ribosomal proteins. These features, combined with the COVID-19 context, suggest an activated cytotoxic T cell. While CD8+ T cells typically express CD8A/B (not listed), the strong cytotoxic profile and CD3D presence support this classification. Alternative possibilities like NK cells are less likely due to CD3D expression.\n\nCell type: Activated CD8+ cytotoxic T cell",
         "414",
         "1488",
         "1599"
        ],
        [
         "98",
         "88",
         "45086023",
         "CD8-positive, alpha-beta T cell",
         "You are an expert in single-cell biology.\n\nBelow is metadata for one cell, followed by a list of its genes in descending expression:\nTissue: blood\nDisease: COVID-19\nDevelopment stage: 48-year-old human stage\nGenes: ACTB MT-ATP6 MT-CO2 B2M MT-ND4 MT-ND3 MT-CO3 MT-CYB MT-CO1 MTRNR2L12 GNLY TMSB4X TPT1 EEF1A1 RPS29 HLA-A HLA-B RPL37A RPS19 RPLP1 NKG7 MT-ND5 RPL41 CCL5 RPL39 TMSB10 ACTG1 RPS24 MT-ND1 RPL32 RPL37 RPS18 JUND DDX5 RPL13 AHNAK PTMA RPS15A RPS27 KLF6 RBM39 RPL28 ATM MBNL1 EIF1 RPL19 RPL10 CALM1 CYBA RPS3 MT-ND2 ITGB2 RPS25 RPL27A ADGRE5 FUS CFL1 MT-ND6 ZFP36L2 A2M ARID1B RPS14 PABPC1 RPS11 RPL34 H1-10 IFITM2 RPL23A RPL26 LPP ETS1 PRKCB RPL18A RPL7A RPS23 LCP1 ARL4C RPS2 RPLP2 TXK MYO1G CCND2 RPL29 CD247 SYNE1 DOCK5 PHF3 CDC42 UBL5 N4BP2L2 MACF1 MT-ND4L GZMB CD44 RPL12 FAU UBA52 GNB1 CDV3 CSNK1A1\n\nPlease identify what cell type this might be, as granular and accurate as possible.\nKeep your response concise and clear.\nAt the end of your response, strictly place the final lines in this format:\n\nCell type: X\n",
         "Okay, let's try to figure out the cell type here. The metadata says the tissue is blood, disease is COVID-19, and the development stage is 48-year-old human. The genes listed are in descending order of expression.\n\nFirst, I'll look for highly expressed genes that are markers for specific immune cells. ACTB and B2M are housekeeping genes, so not specific. Then there's GNLY, CCL5, NKG7, GZMB. These genes are associated with cytotoxic cells, like NK cells or CD8+ T cells. For example, GNLY encodes granulysin, which is found in cytotoxic granules. NKG7 is a marker for NK cells and activated T cells. CCL5 is a chemokine produced by T cells and NK cells. GZMB is granzyme B, also involved in cytotoxicity.\n\nLooking at other genes: CD247 is part of the T-cell receptor complex. CD44 is involved in lymphocyte activation. CDV3 might be associated with T cells. There's also genes like HLA-A and HLA-B, which are MHC class I molecules, present in most nucleated cells but important for antigen presentation to T cells.\n\nThe presence of genes like RPS and RPL (ribosomal proteins) is common in many cells due to protein synthesis, so not as informative. But the combination of cytotoxic markers points towards a T or NK cell. Now, in COVID-19, both CD8+ T cells and NK cells are involved in the immune response. Let me check if there are specific markers that differentiate them. For example, CD8+ T cells express CD8A, but that's not listed here. NK cells typically have markers like NCAM1 (CD56), which isn't in the list. However, GNLY and GZMB are more strongly associated with NK cells, though CD8+ T cells also express them. But there's also CD247 (CD3ζ), which is part of the T cell receptor complex, suggesting T cell lineage.\n\nWait, CD3 is a T cell marker. If CD3 subunits are present, that would indicate T cells. CD247 is the CD3ζ chain. So that's a T cell marker. But NK cells don't have CD3. So the presence of CD247 would suggest this is a T cell. However, some studies show that in activated NK cells, there might be some CD3ζ expression, but it's more specific to T cells.\n\nOther T cell markers: There's also CD44 and ITGB2 (CD18), which are involved in adhesion and activation. ETS1 is a transcription factor in T cells. PRKCB is involved in T cell receptor signaling. So combining CD247 with cytotoxic markers like GNLY, NKG7, CCL5, GZMB, this might be a cytotoxic CD8+ T cell. In COVID-19, CD8+ T cells are crucial for antiviral response. \n\nAdditionally, the presence of genes like LCP1 (L-plastin), which is expressed in lymphocytes. RPL and RPS genes are abundant in many cells, so less specific. HLA genes are expected in immune cells presenting antigens. \n\nSo putting this together: High expression of cytotoxic granules (GNLY, GZMB), T cell receptor component (CD247), and other T cell markers. Therefore, this is likely a cytotoxic CD8+ T cell. Granularity would be to specify it's a cytotoxic T cell, possibly activated given the context of COVID-19.",
         "The cell exhibits high expression of cytotoxic markers (GNLY, NKG7, CCL5, GZMB) and T-cell receptor-associated genes (CD247, CD3 subunits inferred via CD247), alongside ribosomal proteins. These features, combined with the blood tissue origin and COVID-19 context, strongly indicate an activated cytotoxic CD8+ T cell involved in antiviral response. The absence of NK-specific markers (e.g., NCAM1/CD56) further supports T-cell lineage. \n\nCell type: Activated cytotoxic CD8+ T cell",
         "426",
         "722",
         "833"
        ],
        [
         "107",
         "97",
         "44640339",
         "CD14-positive, CD16-negative classical monocyte",
         "You are an expert in single-cell biology.\n\nBelow is metadata for one cell, followed by a list of its genes in descending expression:\nTissue: blood\nDisease: COVID-19\nDevelopment stage: 67-year-old human stage\nGenes: S100A9 S100A8 FTL B2M ACTB IFI27 MT-CO2 S100A4 S100A6 TMSB10 RPL28 TMSB4X RPL13 IFITM3 RPL41 EEF1A1 MT-CO1 S100A12 RPL39 RPS28 FTH1 RPS27 RPL10 RPL18A HLA-C SH3BGRL3 S100A11 TYROBP RPLP1 HLA-A PFN1 MT-ND3 RPL32 RPL37 MYL6 RPS8 H3-3A HLA-B RPS15A SAT1 RPS15 CST3 RPS21 S100A10 RPL34 RPS9 RPS13 MT-ATP6 CLIC1 RPL35A RPL37A RPS24 GAPDH RPL11 SERF2 LY6E AIF1 ACTG1 CFL1 RPL19 RPS19 RPS18 TPT1 MT-CO3 SRGN RPS14 ATP5F1E RPL26 LGALS1 RPS12 LYZ RPLP2 RPL12 FCER1G TYMP FAU RPL18 MT-ND4 VCAN RPL7A OAZ1 RPL30 RPS7 NACA RPS2 IFI6 CALM1 MTRNR2L12 MNDA RACK1 CTSS MT-CYB VIM SPI1 ANXA1 PTMA PFDN5 RPL29 FCN1 RPS3\n\nPlease identify what cell type this might be, as granular and accurate as possible.\nKeep your response concise and clear.\nAt the end of your response, strictly place the final lines in this format:\n\nCell type: X\n",
         "Okay, let's see. I need to figure out the cell type based on the given metadata and gene list. The tissue is blood, disease is COVID-19, and the development stage is a 67-year-old human. The genes listed are in descending order of expression.\n\nFirst, looking at the top genes: S100A9 and S100A8 are highly expressed. These genes are part of the S100 calcium-binding protein family, commonly associated with myeloid cells like neutrophils and monocytes. They play roles in inflammation and immune response. Then there's FTL (ferritin light chain) and B2M (beta-2-microglobulin), which are involved in iron metabolism and MHC class I molecules, respectively. ACTB is actin, a cytoskeletal gene, which is pretty common in many cells but might not be specific.\n\nNext, IFI27 stands out. This gene is induced by interferon, suggesting an antiviral response. Since the disease is COVID-19, this makes sense as the immune cells would be responding to the virus. MT-CO2 and MT-CO1 are mitochondrial genes, part of the electron transport chain. High mitochondrial content can sometimes indicate metabolically active cells, but in immune cells, maybe activated cells or certain myeloid subsets.\n\nLooking further down, there are ribosomal proteins like RPL28, RPL13, RPS28, etc. High ribosomal protein expression is typical in cells with active protein synthesis, which could be the case in activated immune cells producing cytokines or other proteins. HLA genes like HLA-C, HLA-A, HLA-B are MHC class I molecules, present in most nucleated cells, but their expression might be upregulated in antigen-presenting cells.\n\nGenes like CST3 (cystatin C) and LYZ (lysozyme) are markers of monocytes or macrophages. IFITM3 is involved in antiviral defense, again pointing to immune cells responding to infection. TYROBP is a signaling molecule in myeloid cells. AIF1 and CD68 (though not listed) are sometimes monocyte/macrophage markers, but AIF1 is present here.\n\nFCER1G is part of the Fc epsilon receptor, involved in IgE responses, found in myeloid cells like monocytes, macrophages, and dendritic cells. SPI1 is a transcription factor crucial for myeloid cell development. VIM (vimentin) is a cytoskeletal protein found in various cells, including macrophages.\n\nThe presence of S100A family genes, along with monocyte-associated markers (LYZ, CST3, AIF1, FCER1G, SPI1) and interferon-stimulated genes (IFI27, IFITM3) suggests that this cell is likely a monocyte-derived cell. Given the context of COVID-19, which often induces a strong myeloid response, and the age of the patient (elderly), the cell could be an activated monocyte or a macrophage. However, the high expression of S100A8/S100A9 (calprotectin) is very characteristic of neutrophils as well. But neutrophils typically have shorter lifespans and may have different ribosomal content. Monocytes might have higher MHC expression. Alternatively, it could be a myeloid-derived suppressor cell (MDSC), which are activated in chronic inflammation and infections. But MDSCs are a heterogeneous group.\n\nWait, but let me check the markers again. S100A8/A9 are also expressed in monocytes, especially under inflammatory conditions. In COVID-19, there's known monocyte activation. The presence of genes like HLA and CST3, which are more monocyte/macrophage, versus neutrophil markers like MPO (not listed here) which aren't present. The lack of specific neutrophil elastase (ELANE) or defensins (DEFA1, DEFA3) suggests it's not a neutrophil. So, more likely a monocyte. But which subtype? Classical (CD14+), intermediate (CD14+CD16+), or non-classical (CD16+). However, without surface protein markers, it's hard. But gene expression: IFITM3 is in monocytes. TYROBP (TYRO protein tyrosine kinase binding protein) is involved in immune receptor signaling in myeloid cells. FCN1 is a marker for classical monocytes. Wait, FCN1 is in the gene list. FCN1 (Ficolin-1) is highly expressed in classical monocytes. So, FCN1 is present in the genes. That's a strong indicator for classical monocytes. Additionally, CST3 and LYZ support monocyte lineage. SPI1 (PU.1) is a key transcription factor for monocytes.\n\nSo putting this together: High S100A8/A9, FCN1, LYZ, CST3, HLA class I genes, interferon-stimulated genes, and TYROBP. This points towards a classical monocyte, which are CD14+ CD16- and express FCN1. In COVID-19, these monocytes are known to be activated and contribute to the inflammatory response. Therefore, the cell type is most likely a classical monocyte.",
         "The cell exhibits high expression of S100A8/S100A9 (calprotectin), indicative of myeloid inflammation, alongside monocyte-associated markers (FCN1, CST3, LYZ, AIF1, SPI1) and interferon-stimulated genes (IFI27, IFITM3). These features, combined with ribosomal protein genes reflecting activation, align with a classical monocyte subset (CD14+ CD16−) in an inflammatory state, consistent with COVID-19 immune responses.  \n\nCell type: Classical monocyte (CD14+ FCGR3A−)",
         "422",
         "1033",
         "1152"
        ],
        [
         "112",
         "101",
         "5736610",
         "luminal epithelial cell of mammary gland",
         "You are an expert in single-cell biology.\n\nBelow is metadata for one cell, followed by a list of its genes in descending expression:\nTissue: breast\nDisease: normal\nDevelopment stage: 28-year-old human stage\nGenes: AREG IER3 SERPINA3 CLDN4 RPL41 S100A6 RPLP1 SERPINA1 SAT1 JUND RPL13 EEF1A1 MGP RPS18 RPS12 RPS23 TMSB10 RPL30 RPS27A RPS8 RPS28 RPS19 RPL36 RPL32 RPS27 RPS15A RPL10 EIF1 UBC RPS3A RPL19 RPL39 RPL7A RPL12 RPL15 TPT1 FTH1 RPL11 KCNMA1 RPL26 JUN RPL35A S100A11 RPL24 C15orf48 RPS9 TACSTD2 RPS3 RPS4X BTG1 RPL3 MT2A RPS15 H3-3B RPL34 CCL2 RPL9 RPL29 RPS24 NFKBIA TM4SF1 RHOB RPL37 MGST1 PTMA FTL CEBPD CD63 RPS7 MIF IER2 RPS2 RPL28 RPL18A RPS13 NACA HSP90AA1 HSP90AB1 S100A10 CRYAB CD59 WFDC2 RPS25 RPL35 RPL27 RPS21 H1-2 RPL36A RPL8 CCN2 RGS16 RPS29 BBC3 S100A14 MT-CO1 RPL10A RPL21 B2M GADD45B FAU\n\nPlease identify what cell type this might be, as granular and accurate as possible.\nKeep your response concise and clear.\nAt the end of your response, strictly place the final lines in this format:\n\nCell type: X\n",
         "Okay, let's see. The cell is from breast tissue, normal, from a 28-year-old. The genes listed are in descending order of expression. I need to figure out the cell type based on these genes.\n\nFirst, I'll look at the top genes. AREG is amphiregulin, which I remember is associated with epithelial cells and can be involved in growth regulation. Then IER3, SERPINA3, CLDN4. CLDN4 is claudin-4, a tight junction protein, which is typically found in epithelial cells, especially luminal cells in the breast. SERPINA3 is Serpin Family A Member 3, which might be involved in protease inhibition, also seen in epithelial cells.\n\nLooking further down, there are a lot of ribosomal proteins like RPL and RPS genes. High ribosomal protein expression can indicate cells with high protein synthesis, which might be secretory cells. Breast epithelial cells, especially luminal cells that produce milk proteins, might have high ribosomal activity.\n\nGenes like MGP (matrix Gla protein) and S100A6/S100A11 are calcium-binding proteins. S100 proteins are often in epithelial cells. MGP is involved in extracellular matrix, maybe in myoepithelial cells? Wait, but myoepithelial usually express ACTA2 (alpha smooth muscle actin), which isn't listed here. So maybe not myoepithelial.\n\nAlso, TACSTD2 is Trop-2, a cell surface marker expressed in luminal epithelial cells. CD59 and WFDC2 (also known as HE4) are markers for certain epithelial cells. WFDC2 is expressed in some glandular epithelial cells, including breast.\n\nLooking for other markers: KCNMA1 is a potassium channel, which might be in secretory cells. CCL2 is chemokine ligand 2, sometimes associated with macrophages, but if the cell is epithelial, maybe it's part of an inflammatory response? But the disease is normal, so probably not. Alternatively, CCL2 can be produced by epithelial cells under certain conditions.\n\nNo immune cell markers like CD45, CD3, CD19 here. Also, lack of ERBB2 (Her2) or ESR1 (estrogen receptor) might not be helpful since this is a normal cell. However, the presence of RPL and RPS genes is very prominent. Maybe a basal or luminal epithelial cell?\n\nLuminal epithelial cells typically express keratins like KRT18/KRT19, which aren't in the top genes here. But maybe they are further down. Wait, the list starts from highest expression, so if those keratins aren't listed, maybe it's a different type. However, sometimes single-cell data can vary in gene detection. Alternatively, maybe it's a specific subtype.\n\nWait, the presence of TACSTD2 (TROP2) is a strong indicator. TROP2 is a marker for luminal epithelial cells in the breast. Also, CD24 is another luminal marker, but it's not listed here. However, other genes like MUC1 might be absent. But given the high expression of CLDN4 and TACSTD2, this points towards a luminal epithelial cell.\n\nAdditionally, genes like S100A6 and S100A11 are part of the S100 family, which are often expressed in epithelial cells. RPL and RPS genes suggest active protein synthesis, consistent with secretory functions. Luminal cells in the breast are responsible for milk production, so high ribosomal activity makes sense.\n\nAlso, genes like MGP (matrix Gla protein) might be involved in extracellular matrix regulation, which could be part of the luminal cell's environment. However, other stromal or myoepithelial markers like ACTA2 or VIM (vimentin) are not present here, making stromal or myoepithelial less likely.\n\nSo putting it all together: the cell expresses markers of epithelial origin (CLDN4, TACSTD2, SERPINA3), lacks myoepithelial/stromal markers, has high ribosomal protein genes, and is from normal breast tissue. Therefore, the most likely cell type is a luminal epithelial cell. But could it be more specific? Maybe a luminal progenitor or mature luminal cell? Since it's from a normal adult, mature luminal epithelial cell seems plausible.",
         "The cell exhibits high expression of luminal epithelial markers (CLDN4, TACSTD2, SERPINA3) and secretory-associated ribosomal genes (RPL/RPS), alongside S100 calcium-binding proteins (S100A6, S100A11). These features, combined with the absence of myoepithelial (e.g., ACTA2) or stromal markers, strongly indicate a secretory luminal epithelial cell. The presence of WFDC2 (HE4) further supports a mature, hormone-responsive luminal phenotype in normal breast tissue.\n\nCell type: Luminal epithelial cell (mature, secretory)",
         "415",
         "894",
         "1021"
        ],
        [
         "116",
         "105",
         "6683173",
         "oligodendrocyte",
         "You are an expert in single-cell biology.\n\nBelow is metadata for one cell, followed by a list of its genes in descending expression:\nTissue: middle temporal gyrus\nDisease: normal\nDevelopment stage: 80 year-old and over human stage\nGenes: IL1RAPL1 PCDH9 SLC44A1 CADM2 CTNNA3 DLG2 SLC24A2 PPP2R2B FRMD5 PDE8A GPM6B CNTNAP2 PHLPP1 EDIL3 PIP4K2A ERBIN ST18 NKAIN2 PTPRD NRXN3 PLCL1 ELMO1 PLXDC2 DIP2B DOCK10 MBP QKI MAGI2 NPAS3 NCAM1 MAP7 PLP1 SIK3 SLCO3A1 PTPRK PDE4B KIF6 TMEM165 ADGRB3 ANK2 PRUNE2 CLMN KIRREL3 APBB2 PXK TSPAN5 ERBB4 KLHL32 TCF12 MOBP LIFR ANK3 DNM3 WDPCP DPYD MAN2A1 TTLL7 CDK19 PICALM ALCAM ZBTB20 BBS9 CDH20 PEX5L FNIP1 TJP1 DOCK5 PALM2AKAP2 SH3GL3 ENOX1 WWOX KLHL4 CLASP2 PRKN RAPGEF5 AGAP1 FMNL2 HIP1 TMEM144 ROBO1 AUTS2 FRYL CERCAM PLPPR1 ADD3 DAAM2 NCAM2 KCNH8 NCKAP5 DOCK9 MBNL2 DST TRIM2 SLAIN1 L3MBTL4 BIRC6 PTK2 ZSWIM6 NFASC DLG1\n\nPlease identify what cell type this might be, as granular and accurate as possible.\nKeep your response concise and clear.\nAt the end of your response, strictly place the final lines in this format:\n\nCell type: X\n",
         "Okay, let me try to figure out the cell type here. The metadata says the tissue is middle temporal gyrus, which is part of the brain's cortex. The disease is normal, and the development stage is 80+ years old. So, it's a healthy, aged brain cell.\n\nLooking at the list of genes, I need to pick out the ones that are markers for specific cell types. Let's start with some key genes. MBP, PLP1, and MOBP are all myelin-related genes. MBP (myelin basic protein) and PLP1 (proteolipid protein) are classic markers for oligodendrocytes, which produce myelin. MOBP (myelin-associated oligodendrocyte basic protein) is also specific to oligodendrocytes. \n\nOther genes like QKI (quaking homolog) are involved in myelination and are expressed in oligodendrocytes. MAG (myelin-associated glycoprotein) is another myelin gene, but it's not in the list. However, MAGI2 is present, but I'm not sure about its relevance here.\n\nThere's also CNTNAP2, which is associated with neurons, but since this is a single cell, maybe it's not a neuron. The presence of multiple myelin genes suggests oligodendrocyte rather than neuron or astrocyte. Astrocytes would have markers like GFAP, which isn't listed here. Microglia markers like AIF1 (IBA1) are also absent.\n\nAdditionally, genes like ERBB4 and SLC44A1 might be expressed in other glial cells, but the strong presence of myelin genes points more towards oligodendrocytes. Since the person is older, maybe it's a mature oligodendrocyte. Some genes like PTPR (protein tyrosine phosphatase receptor) could be in oligodendrocyte precursor cells (OPCs), but OPCs usually express markers like PDGFRA or CSPG4, which aren't listed here. \n\nSo, putting it all together: the high expression of myelin-related genes (MBP, PLP1, MOBP, QKI) in a cell from the middle temporal gyrus of an elderly individual suggests this is an oligodendrocyte. Given the specific markers, it's likely a mature oligodendrocyte involved in maintaining myelin sheaths around neuronal axons in the cortex.",
         "The cell exhibits high expression of myelin-related genes (MBP, PLP1, MOBP, QKI) and oligodendrocyte-associated genes (PDE4B, MAGI2, NFASC, CNTNAP2), while lacking neuronal (e.g., SYN1) or microglial (e.g., CX3CR1) markers. These features, combined with its location in the aged human cortex, strongly indicate a mature oligodendrocyte involved in myelination maintenance.\n\nCell type: Mature oligodendrocyte",
         "433",
         "476",
         "585"
        ],
        [
         "118",
         "107",
         "14363102",
         "oligodendrocyte",
         "You are an expert in single-cell biology.\n\nBelow is metadata for one cell, followed by a list of its genes in descending expression:\nTissue: cerebral cortex\nDisease: normal\nDevelopment stage: 50-year-old human stage\nGenes: PPP2R2B PDE4B CADM2 IL1RAPL1 NRXN3 SIK3 PCDH9 FRMD5 PLP1 SLC24A2 ANK3 TTLL7 ST18 DLG2 CTNNA3 ANK2 RNF220 MAGI2 MBP PEX5L FCHSD2 EDIL3 TMEFF2 QKI TMTC2 SLC44A1 AKAP6 ELMO1 NCAM2 DOCK4 TRIM2 APP NLGN1 NKAIN2 GNAO1 C10orf90 PTPRD PPFIA2 MOBP LRP1B BCAS1 ZBTB20 CLASP2 BAZ2B FMNL2 DST NPAS3 AUTS2 SCD5 SGK1 GPM6B LRRTM4 AK5 TJP1 SHTN1 TCF12 RTN4 ZNF638 ERBB4 APBB2 MAP7 MARCHF1 PDE1C CTNND2 DOCK10 SEMA6A DOCK9 KCNH8 DNAJC6 ENOX1 SSH2 CREB5 SLAIN1 CCNH ADGRL3 ATL1 EXOC6B PTBP2 SEPTIN7 GAB1 HHIP EPN2 CDH20 UNC5C COL4A5 ROBO1 PHIP TMEM144 CDC42BPA PDE1A PHACTR3 KIF13A DIP2B TNRC6B LSAMP MYO6 ATP8A1 DOCK1 ARHGAP21 OSBPL9\n\nPlease identify what cell type this might be, as granular and accurate as possible.\nKeep your response concise and clear.\nAt the end of your response, strictly place the final lines in this format:\n\nCell type: X\n",
         "Okay, let's try to figure out the cell type here. The metadata says it's from the cerebral cortex of a 50-year-old human, normal. The genes listed are in descending order of expression. \n\nStarting with the top genes. PPP2R2B is a phosphatase subunit, involved in various signaling pathways. Not sure if that's specific. PDE4B is related to cAMP signaling, found in neurons and glia. CADM2 is a cell adhesion molecule, associated with synaptic function. IL1RAPL1 is linked to X-linked intellectual disability and involved in synapse formation. NRXN3 is a neurexin, which are presynaptic cell adhesion molecules. These all sound neuronal.\n\nLooking further down, PLP1 is a major myelin protein, typically in oligodendrocytes. But PLP1 can also be expressed in some neurons during development, though in a 50-year-old, maybe more likely oligodendrocyte. But wait, MBP and MOBP are also present here. MBP is definitely a myelin protein, so oligodendrocyte marker. MOBP is another myelin-associated gene in oligodendrocytes. So this cell might be an oligodendrocyte.\n\nBut wait, there are also genes like SLC24A2 (solute carrier family 24 member 2), which is involved in ion transport. ANK3 encodes ankyrin-G, which is important for axon initial segment and nodes of Ranvier in neurons. DLG2 is discs large homolog 2, part of postsynaptic density proteins. NRXN3 and NLGN1 (neuroligin) are synaptic. So some neuronal genes here. Hmm, maybe a neuronal cell? But the presence of PLP1, MBP, MOBP is strong for oligodendrocyte.\n\nWait, maybe it's an oligodendrocyte. Oligodendrocytes are responsible for myelination in the CNS. Their markers include PLP1, MBP, MOBP, MAG, CNP, etc. MAG is listed here as MAGI2, but MAGI2 is a membrane-associated guanylate kinase, not the same as MAG (myelin-associated glycoprotein). Wait, MAG is a different gene. Let me check: MAG is also called GMA or myelin-associated glycoprotein, gene name MAG. Not sure if MAGI2 is related. The presence of PLP1, MBP, MOBP is more convincing. Other genes like QKI (quaking homolog) are important for myelination and expressed in oligodendrocytes. ERBB4 is a receptor tyrosine kinase, involved in glial development. \n\nBut then there's also ANK3, which is neuronal. Maybe this cell is an oligodendrocyte, but some neuronal genes might be expressed at lower levels, or perhaps there's some overlap. Alternatively, could it be a specific type of neuron with some myelin-related genes? That's less likely. Oligodendrocytes have their specific markers. Let me cross-reference the genes.\n\nPLP1, MBP, MOBP, QKI, MAGI2 (maybe not MAG), SLC44A1 (solute carrier, might be involved in choline transport, which could be in oligodendrocytes). Also, CLASP2 is involved in microtubule dynamics, possibly in glia. \n\nAnother angle: looking for markers that distinguish between neurons and glia. Neuronal markers like SYT1, SNAP25, etc., aren't listed here. Instead, the presence of multiple myelin-related genes points to oligodendrocyte. The top genes like NRXN3 and IL1RAPL1 could be part of the cell's interaction with neurons, but the strong expression of PLP1 and MBP is more definitive. \n\nSo the cell type is likely an oligodendrocyte. But wait, there's also OLIG1/OLIG2 as transcription factors for oligodendrocytes, but those genes aren't listed here. However, not all markers need to be present. The combination of PLP1, MBP, MOBP, and QKI supports oligodendrocyte. Therefore, the answer should be oligodendrocyte.",
         "The cell exhibits strong expression of myelin-related genes (PLP1, MBP, MOBP, QKI) and oligodendrocyte-associated markers (ANK3, ERBB4, SLC44A1), while lacking neuronal synaptic vesicle markers. These features, combined with its cerebral cortex origin, strongly indicate a mature oligodendrocyte involved in myelination.\n\nCell type: Oligodendrocyte",
         "429",
         "845",
         "927"
        ],
        [
         "129",
         "118",
         "37597135",
         "natural killer cell",
         "You are an expert in single-cell biology.\n\nBelow is metadata for one cell, followed by a list of its genes in descending expression:\nTissue: blood\nDisease: COVID-19\nDevelopment stage: 4-year-old human stage\nGenes: B2M ACTB TMSB4X RPS27 RPL30 RPL41 MT-CO1 RPL28 EEF1A1 HLA-B RPL29 RPS14 RPS15A NKG7 RPLP1 RPS12 RPL32 RPL11 RPS27A HLA-C MT-CO2 TMSB10 RPS8 RPS26 RPS3 RPL19 RPS24 GNLY RPL13 RPL7A RPL10 RPS13 RPL34 RPS28 RPL8 RPL14 RPL12 S100A4 GZMB HLA-A TPT1 RPL6 FAU RPS23 RPL39 IFITM1 H3-3B RPLP2 RPS7 SH3BGRL3 RPS3A RPL35A RPL37 RPS21 RPL18 CCL5 PTMA RPS4X RPS19 RPS6 RPL37A RPL18A CTSW PPIA EEF1D CD7 TXNIP CORO1A FTL GAPDH GZMA RPL27 RPS15 NACA RPS29 VIM RPL21 MYL12A CST7 RPS11 RPL15 ACTG1 RPL23A RACK1 RPS18 MT-CO3 RPSA RPS25 SRGN RPL31 RPL35 IFITM2 RPL22 TYROBP TAGLN2 CLIC1 PSME1 PABPC1 MT-CYB RPL26\n\nPlease identify what cell type this might be, as granular and accurate as possible.\nKeep your response concise and clear.\nAt the end of your response, strictly place the final lines in this format:\n\nCell type: X\n",
         "Okay, let's try to figure out what cell type this is. The metadata says it's from blood, COVID-19, and a 4-year-old human. The genes listed are in descending expression order.\n\nFirst, I'll look for immune cell markers. Blood cells are typically myeloid or lymphoid. Let's check the genes. High expression of B2M and ACTB are common housekeeping genes, so not specific. Then there's TMSB4X, which is involved in actin regulation, found in various cells. \n\nLooking further, RPS and RPL genes are ribosomal proteins, present in most cells, but maybe not helpful here. Then NKG7 stands out—it's associated with cytotoxic cells like NK cells and CD8+ T cells. GNLY (granulysin) and GZMB (granzyme B) are also cytotoxic markers. CCL5 is a chemokine produced by T cells and NK cells. CST7 (cystatin F) is another marker for cytotoxic lymphocytes. \n\nHLA genes (HLA-B, HLA-C, HLA-A) are MHC class I, expressed in most nucleated cells but might indicate antigen presentation, though cytotoxic cells have them. CD7 is a T-cell and NK cell marker. GZMA is another granzyme, supporting cytotoxic function. \n\nThere's also FAU, which I'm less familiar with, but maybe not critical. S100A4 is seen in some T cells and monocytes. VIM is a mesenchymal marker but can be in activated lymphocytes. \n\nNo CD3 markers listed, but CD8 isn't mentioned either. However, NK cells don't require CD3. The presence of NKG7, GNLY, GZMB, CST7, and CCL5 points towards a cytotoxic cell. Since CD7 is present, which is on both T and NK cells, but the lack of CD3 (assuming it's not in the list) might lean towards NK cells. \n\nAlso, the disease is COVID-19. Studies show that NK cells are involved in the response. The high expression of ribosomal genes might indicate active protein synthesis, typical in immune cells responding to infection. \n\nSo putting it all together: cytotoxic genes, NK and T cell markers, but absence of T-cell receptor genes (like CD3 subunits). More likely an NK cell. Granularity—maybe a mature, activated NK cell in the context of COVID-19.",
         "The cell exhibits high expression of cytotoxic markers (GNLY, GZMB, NKG7, CST7), ribosomal proteins (RPS/RPL genes), and MHC class I genes (HLA-A/B/C), alongside CD7 and CCL5. These features are characteristic of cytotoxic lymphocytes, particularly natural killer (NK) cells, which are activated during viral infections like COVID-19. The absence of T-cell receptor-associated genes (e.g., CD3) further supports an NK cell identity.  \n\nCell type: Activated natural killer (NK) cell",
         "416",
         "495",
         "609"
        ],
        [
         "130",
         "119",
         "3605316",
         "CD14-positive monocyte",
         "You are an expert in single-cell biology.\n\nBelow is metadata for one cell, followed by a list of its genes in descending expression:\nTissue: blood\nDisease: normal\nDevelopment stage: 58-year-old human stage\nGenes: S100A8 FTH1 FOS FTL ACTB S100A9 B2M JUN RPLP1 LYZ MT-CO1 H3-3B SAT1 KLF6 DUSP1 S100A4 CST3 TMSB4X CD74 CEBPD TMSB10 RPL10 S100A6 IFI30 TYROBP VIM PSAP FCN1 RPS13 MT-CO2 UBC RPL11 IFITM3 CTSS FAU RPS12 OAZ1 RPL28 RPL30 RPS24 HLA-C JUNB RPL26 C12orf57 RPL32 S100A12 RPL41 SH3BGRL3 RPL14 GABARAP RPS28 RPL19 RGS2 IER2 CD14 RPS14 HLA-B LSP1 SRGN ATP5F1E FOSB DUSP6 RPL39 STXBP2 S100A11 TPT1 SERF2 RPL34 PLAUR ITM2B EIF1 RPL29 MNDA GAPDH RPS23 RPS15A RPL13 RPL18A RPS21 RPS27A FCER1G RPL7A NACA MCL1 ANXA1 FPR1 RPS3A AIF1 RPS15 HLA-DRA PABPC1 RPL6 RPS8 PPP1R15A NCF1 RHOB SERPINA1 IFITM2 RPS3 MYL6\n\nPlease identify what cell type this might be, as granular and accurate as possible.\nKeep your response concise and clear.\nAt the end of your response, strictly place the final lines in this format:\n\nCell type: X\n",
         "Okay, let's try to figure out the cell type here. The metadata says it's from blood, normal, and a 58-year-old human. The genes listed are in descending order of expression.\n\nStarting with the top genes: S100A8 and S100A9 are highly expressed. I remember these are markers for myeloid cells, especially neutrophils and monocytes. Then FTH1 and FTL are involved in iron storage, common in cells that handle iron metabolism, which again points to myeloid lineage. ACTB is a cytoskeletal gene, pretty common in many cells but not specific.\n\nLooking further down, genes like LYZ (lysozyme) are typical for monocytes and macrophages. CST3 (cystatin C) is also associated with monocytes. CD74 and HLA genes (HLA-C, HLA-B, HLA-DRA) suggest antigen presentation, which is a feature of monocytes, dendritic cells, or macrophages. TYROBP is involved in immune receptor signaling, often in myeloid cells.\n\nThere's also FCER1G, which is part of the Fc receptor complex, found in monocytes and dendritic cells. Genes like IFITM3 and AIF1 are associated with immune response in myeloid cells. ANXA1 and FPR1 might indicate neutrophils, but the presence of CD14 (a monocyte marker) leans more towards monocytes.\n\nOther markers like S100A12, which is also in the S100 family, are expressed in neutrophils and monocytes. The absence of specific T-cell or B-cell markers (like CD3 or CD19) in the top genes makes me think it's not a lymphocyte. \n\nPutting this together, the high expression of S100A8/S100A9, CD14, CST3, LYZ, and HLA genes points towards a monocyte. However, some genes like LYZ can be in macrophages too. But since this is from blood, it's more likely a monocyte rather than a tissue macrophage. Maybe a classical monocyte subset? Or considering CD14 and FCER1G, perhaps a CD14+ monocyte. The presence of HLA-DRA might hint at some antigen-presenting function, which monocytes do. Also, the absence of dendritic cell-specific markers like CD1c or CD141. \n\nSo the most granular would be a classical monocyte, CD14+ CD16- perhaps, given the markers. Alternatively, just a monocyte in general, but given the specific genes, CD14+ is prominent.",
         "The cell exhibits high expression of myeloid markers (S100A8, S100A9, LYZ, CST3, CD14), lysosomal/antigen presentation genes (CTSS, HLA-C, HLA-B, HLA-DRA), and lacks lymphoid-specific markers. The S100A8/S100A9 pair and CD14 strongly indicate a monocyte origin, while elevated ribosomal genes (RPL/RPS) suggest active protein synthesis typical of monocytes. The absence of dendritic cell-specific markers (e.g., CD1c, CLEC9A) or neutrophil-specific effectors (e.g., MPO) narrows it to a classical monocyte subset.\n\nCell type: CD14+ classical monocyte",
         "416",
         "504",
         "650"
        ],
        [
         "153",
         "140",
         "42503598",
         "luminal epithelial cell of mammary gland",
         "You are an expert in single-cell biology.\n\nBelow is metadata for one cell, followed by a list of its genes in descending expression:\nTissue: mammary gland\nDisease: normal\nDevelopment stage: 38-year-old human stage\nGenes: FTH1 MT-CO1 AZGP1 MT-CO3 MT-ATP6 RPLP1 MT-CO2 MT-ND4 RPS4X XBP1 RPL3 EEF1A1 TPT1 RPL41 RPL13 RPS6 RPL10 RPS27A RPS3 PTMA RPL7A MT-CYB RPL15 MGP RPS2 RPS3A GAPDH B2M RPL14 RPS12 RPL8 RPL13A RPL5 SOX4 RPL29 TRPS1 RPL19 RPS8 RPS9 RPL26 RPS14 FTL RPS18 KRT19 RPL32 RPL18A RPS24 RPL12 RPL9 NACA RPS19 MT-ND3 RPL18 RPL11 IER3 RACK1 RPS15 RPS7 RPL30 S100A6 TBX3 RPL28 MT2A RPS5 H3-3B RPL7 RPL6 FAU RPS11 RPL35A SRP14 PGK1 CCNI RPL21 NPM1 TMC5 RPS27 RPS16 RPL24 BTF3 RPL10A RPL23A RPLP2 S100A11 H3-3A RPS23 RPS10 KRT18 UBC RPL37 CD63 TMEM165 SERF2 RPLP0 RPL37A SELENOM VAPA GNAS SUMO2 HSP90AB1\n\nPlease identify what cell type this might be, as granular and accurate as possible.\nKeep your response concise and clear.\nAt the end of your response, strictly place the final lines in this format:\n\nCell type: X\n",
         "Okay, let's see. The metadata says this cell is from the mammary gland of a 38-year-old human, and it's normal, not diseased. The gene list is quite long, so I need to pick out the key markers.\n\nStarting with the top genes: FTH1 is highly expressed. I remember that FTH1 encodes ferritin heavy chain, which is involved in iron storage. It's often found in various cells, maybe more in epithelial cells? Then MT-CO1, MT-CO3, MT-ATP6—those are mitochondrial genes, part of the electron transport chain. High mitochondrial activity might suggest a metabolically active cell, like secretory cells which need lots of energy.\n\nLooking further down, AZGP1 stands out. AZGP1 (Alpha-2-glycoprotein 1, zinc-binding) is known to be expressed in mammary epithelial cells, particularly in luminal cells. Also, KRT18 and KRT19 are keratins associated with luminal epithelial cells in the mammary gland. XBP1 is involved in the unfolded protein response, which is important in secretory cells, like those producing milk.\n\nThere are a lot of ribosomal proteins (RPL and RPS genes), which are typical in cells with high protein synthesis activity. Since mammary gland epithelial cells, especially those involved in milk production, would need to produce a lot of proteins, this fits. Also, genes like EEF1A1 and GAPDH are housekeeping genes but still support active metabolism.\n\nLooking for other markers: MGP (Matrix Gla Protein) is expressed in some epithelial cells. SOX4 might be involved in cell differentiation. B2M is part of MHC class I, common in many cells. The presence of genes like FTL (Ferritin light chain) alongside FTH1 reinforces iron metabolism, which could relate to lactating cells needing to manage iron for milk.\n\nNo strong immune markers here, so unlikely to be an immune cell. Also, stromal or fibroblast markers like VIM or ACTA2 aren't prominent. The combination of AZGP1, KRT18/19, XBP1, and high ribosomal/mitochondrial genes points towards a luminal epithelial cell, possibly a milk-secreting cell. Since the age is 38, which is post-puberty and possibly in a non-lactating state (since the disease is normal), maybe a luminal epithelial cell that's differentiated but not actively lactating. Alternatively, basal cells usually express KRT5 or KRT14, which aren't listed here. So luminal epithelial cell makes sense.",
         "The cell exhibits high expression of mitochondrial (MT-CO1/CO2/CO3, MT-ATP6) and ribosomal genes (RPL/RPS families), indicative of active metabolism. Key markers include AZGP1 (luminal epithelial marker), KRT18/KRT19 (luminal keratins), and XBP1 (secretory/unfolded protein response), which collectively align with secretory epithelial function. Absence of basal (e.g., KRT5/14) or immune markers supports a luminal identity. The profile matches a differentiated, non-proliferative luminal epithelial cell in the adult mammary gland, likely involved in protein synthesis and secretion.\n\nCell type: Luminal epithelial cell (mammary gland)",
         "417",
         "529",
         "680"
        ],
        [
         "165",
         "152",
         "53762469",
         "alveolar macrophage",
         "You are an expert in single-cell biology.\n\nBelow is metadata for one cell, followed by a list of its genes in descending expression:\nTissue: lung\nDisease: normal\nDevelopment stage: 75-year-old human stage\nGenes: FTL FTH1 TMSB4X B2M MT2A CRIP1 CD74 S100A6 LYZ S100A4 TMSB10 HLA-DRA S100A11 FABP4 C1QB EEF1A1 C1QA TYROBP TPT1 RPL41 RPL21 RPL10 RPLP1 RPS27 S100A10 ACTB CST3 RPLP2 RPS18 HLA-DRB1 CYBA HLA-B SH3BGRL3 APOC1 RPL39 SAT1 RPL34 RPL28 RPS27A MYL6 PFN1 SERF2 GLUL OAZ1 RPL13 RPL26 RPS28 LGALS1 RPS23 RPS19 FCER1G CTSD H3-3B CD52 RPS3A IFI30 RPS14 C1QC RPL9 LGALS3 RPS13 HLA-DRB5 HLA-DPA1 VIM RPL32 RPS12 RPL35 RPL13A GAPDH YBX1 C1orf162 GPX4 RGCC CSTB RPS20 VAMP8 ALDOA RPS29 MT1X RPL15 CD63 RPS15 LST1 SERPINA1 RPS25 RPS8 RPL18A RPS6 ALDH2 PSAP GRN RPS9 RPL12 RPL27A GABARAP RPL11 SFTPC AIF1 RPS3 RPLP0\n\nPlease identify what cell type this might be, as granular and accurate as possible.\nKeep your response concise and clear.\nAt the end of your response, strictly place the final lines in this format:\n\nCell type: X\n",
         "Okay, let's tackle this problem. The user provided a list of genes expressed in a lung cell from a 75-year-old human with normal disease status. The task is to determine the cell type as accurately as possible based on the gene markers.\n\nFirst, I'll start by recalling common cell types in the lung. The main ones include epithelial cells (like alveolar type I and II), immune cells (macrophages, dendritic cells, lymphocytes), fibroblasts, endothelial cells, etc. Since the genes listed are from a single cell, I need to look for markers specific to certain cell types.\n\nLooking at the top genes: FTL and FTH1 are involved in iron metabolism. These are often expressed in macrophages, which handle iron storage. Then there's TMSB4X and B2M. B2M is part of MHC class I, which is present in most cells but highly expressed in immune cells. CD74 and HLA-DRA are related to MHC class II, which is typical for antigen-presenting cells like macrophages or dendritic cells.\n\nOther genes like LYZ (lysozyme) and CST3 (cystatin C) are also macrophage markers. AIF1 is another gene associated with macrophages. Genes like C1QB, C1QA, and C1QC are part of the complement system, which macrophages use for pathogen clearance. FCER1G is involved in immune response, again pointing towards immune cells. TYROBP is a signaling molecule in myeloid cells.\n\nAdditionally, some genes like S100A family members (S100A6, S100A4, S100A10, etc.) are expressed in macrophages. CD63 and CD68 (though CD68 isn't listed) are also macrophage markers. The presence of APOC1 and CST3 further supports this. Genes like FABP4 might be a bit confusing, but some macrophages express this, especially in specific contexts.\n\nLooking for other possibilities: Alveolar type II cells have markers like SFTPC, which is present here. However, SFTPC is lower in the list, and the other dominant markers point more towards macrophages. The high expression of lysosomal genes (CTSD) also fits with macrophage phagocytic activity.\n\nPutting this all together: The combination of MHC class II genes (HLA-DRA, HLA-DRB1), lysosomal enzymes (LYZ, CTSD), complement components, and other macrophage markers (AIF1, CST3, CD74) strongly indicates a myeloid lineage cell. Given the tissue is lung, alveolar macrophages are the resident macrophages here. The presence of some ribosomal proteins (RPL, RPS genes) is common in many cells but doesn't contradict macrophage identity.\n\nSo, the cell type is most likely an alveolar macrophage. The SFTPC might be a red herring, possibly due to contamination or a subpopulation, but the majority of markers align with macrophages.",
         "The cell exhibits high expression of genes associated with lysosomal activity (CTSD, CST3), antigen presentation (CD74, HLA-DRA, HLA-DRB1), myeloid/macrophage markers (LYZ, AIF1, CST3, C1QB/C1QA/C1QC), and iron metabolism (FTL, FTH1). These features, combined with lung tissue origin, strongly align with a **macrophage** identity. The presence of SFTPC (a type II alveolar epithelial marker) is atypical but may reflect low-level contamination, macrophage phagocytic activity, or a rare hybrid state. Dominant myeloid markers and functional signatures outweigh this outlier.\n\nCell type: Alveolar macrophage",
         "413",
         "591",
         "737"
        ],
        [
         "166",
         "930",
         "30340997",
         "CD14-positive monocyte",
         "You are an expert in single-cell biology.\n\nBelow is metadata for one cell, followed by a list of its genes in descending expression:\nTissue: blood\nDisease: normal\nDevelopment stage: unknown\nGenes: LYZ S100A9 FTL TMSB4X S100A8 MT-CO3 MT-CO1 B2M ACTB TPT1 RPL13 RPL41 RPLP1 MT-ATP6 FTH1 MT-ND1 MT-ND3 S100A6 RPL37 TMSB10 RPS24 RPL34 RPL28 RPL26 RPL11 RPL39 FOS SH3BGRL3 RPS14 S100A4 CTSS SAT1 MT-CO2 RPS16 EEF1A1 RPL10 RPL9 RPS18 RPS27 RPL30 RPS28 RPS3A RPS13 RPL36 RPS19 RPLP2 TYROBP JUNB HLA-A RPL19 FAU G0S2 RPL21 RPL32 PTMA MT-ND2 CST3 RPS12 S100A11 MT-ND4 RPS23 FCN1 RPS2 TXNIP MT-CYB NFKBIA RPS15A RPL18A RPL6 RPS9 RPL27A OAZ1 NACA JUN H3-3A CYBA RPL35 RPS29 RPL8 HLA-B THBS1 RPL15 HLA-DRA PSAP CYP1B1 RPL18 AIF1 RPS4X RPS27A SERF2 EMP3 RPS8 RPL13A RPS15 ARPC3 DDX5 DUSP1 MNDA EVI2B UBA52\n\nPlease identify what cell type this might be, as granular and accurate as possible.\nKeep your response concise and clear.\nAt the end of your response, strictly place the final lines in this format:\n\nCell type: X\n",
         "Okay, let's see. The metadata says the cell is from blood, disease is normal, development stage unknown. The genes listed are in descending order of expression.\n\nFirst, I'll look at the top genes. LYZ is lysozyme, which is often found in myeloid cells like monocytes or neutrophils. S100A9 and S100A8 are part of the S100 family proteins, which are also highly expressed in neutrophils and monocytes. FTL is ferritin light chain, involved in iron storage, common in many cells but maybe not specific. TMSB4X is thymosin beta-4, which is involved in actin regulation and is found in various immune cells.\n\nLooking further down, MT-CO3, MT-CO1, MT-ATP6, MT-ND1, etc., are mitochondrial genes. High mitochondrial content can indicate cells with high energy needs, like monocytes or macrophages. B2M and ACTB are housekeeping genes, so they might not be as informative.\n\nRPL and RPS genes are ribosomal proteins, which are generally involved in protein synthesis. Their presence is common in many cell types, but sometimes certain immune cells have higher expression. However, the combination with the other genes might be more telling.\n\nFOS and JUNB are immediate-early genes involved in cell activation. Their presence might suggest a cell that is activated or responding to stimuli. However, in normal blood, monocytes might express these under certain conditions.\n\nLooking at other markers: TYROBP is a signaling molecule in myeloid cells. CST3 is cystatin C, expressed in monocytes. AIF1 is allograft inflammatory factor 1, associated with macrophages and monocytes. HLA-DRA is part of MHC class II, which is expressed in antigen-presenting cells like monocytes, dendritic cells, but not in neutrophils (since neutrophils typically don't present antigen). However, the presence of FCN1 (Ficolin-1) is a marker for a subset of monocytes, specifically classical monocytes (CD14++ CD16-). \n\nPutting this together: High expression of LYZ, S100A8/9, CST3, TYROBP, FCN1, and HLA-DRA points towards a monocyte. The presence of FCN1 suggests it's a classical monocyte. Also, the lack of markers like CD3 (T-cells) or CD19 (B-cells) supports this. The ribosomal proteins might be due to active protein synthesis in monocytes. Mitochondrial genes could indicate a metabolically active state, which monocytes are. So, the cell type is likely a classical monocyte.",
         "The cell exhibits high expression of myeloid markers (LYZ, S100A8/9, CST3, TYROBP), mitochondrial genes (MT-CO1/2/3, MT-ND), and ribosomal proteins. FCN1 and HLA-DRA suggest monocyte lineage, while S100A family genes and absence of lymphoid-specific markers further exclude neutrophils or lymphocytes. FCN1 specifically marks classical monocytes (CD14++ CD16-).\n\nCell type: Classical monocyte (CD14++ CD16-)",
         "413",
         "531",
         "637"
        ],
        [
         "167",
         "153",
         "7542355",
         "T cell",
         "You are an expert in single-cell biology.\n\nBelow is metadata for one cell, followed by a list of its genes in descending expression:\nTissue: small intestine\nDisease: normal\nDevelopment stage: 20th week post-fertilization human stage\nGenes: RPLP1 EEF1A1 RPS12 MT-CO1 RPL13 RPL10 MT-CO3 RPS2 RPS15A RPS18 TMSB4X RPL41 MT-CO2 RPL11 FTL TPT1 RPS3A RPS14 RPL32 RPL39 RPS19 MT-ATP6 RPS27 RPL37 RPL28 RPL13A RPS24 RPL3 RPS29 GAPDH RPL37A RPL34 RPS3 RPL12 RPL9 RPL18A RPL21 RPS6 RPL30 RPLP2 B2M RPSA RPL10A MT-ND4 FTH1 RPLP0 RPL26 RPS8 RPL15 RPS7 RPS28 RPL23A RPS16 RPL19 RPS9 RPS27A RPS4X RPS13 RPL7A RPL8 RPL27A RPS5 RPS23 IL7R RPL35A RPS25 RPL18 NACA RPL35 RPL29 RPS15 RPL36 RPL14 RPL24 RPS11 RACK1 RPL27 MT-ND1 RPL6 RPL5 EEF1B2 MT-ND3 H3-3A RPS21 FAU RPL22 MT-CYB RPL23 HLA-A RPL7 ATP5F1E TMSB10 RPS20 UBB RPL4 ACTB UBA52 HLA-C MT-ND2 RNF213\n\nPlease identify what cell type this might be, as granular and accurate as possible.\nKeep your response concise and clear.\nAt the end of your response, strictly place the final lines in this format:\n\nCell type: X\n",
         "Okay, let's try to figure out the cell type here. The metadata says it's from the small intestine, normal, at 20 weeks post-fertilization. The gene list is a lot, so I need to look for key markers.\n\nFirst, I notice many ribosomal proteins like RPL and RPS genes. These are often in cells with high protein synthesis, like epithelial cells or rapidly dividing cells. Then there's MT-CO1, MT-CO2, MT-ATP6 which are mitochondrial genes, indicating high energy production. GAPDH and ACTB are housekeeping genes, so maybe not specific.\n\nLooking for cell-specific markers. TMSB4X and TMSB10 are thymosin beta proteins, associated with actin sequestration, common in immune cells or certain epithelial cells. IL7R catches my eye—IL7 receptor is important in lymphocytes, especially T cells. B2M is beta-2-microglobulin, part of MHC class I, present in most cells but maybe higher in immune cells. HLA-A and HLA-C are MHC class I genes as well.\n\nWait, the tissue is small intestine. So possible cell types: epithelial (enterocytes, goblet, enteroendocrine), immune cells (like T cells, B cells), stromal cells. Enterocytes have high ribosomal activity due to absorption and secretion. But IL7R is more immune. Maybe intraepithelial lymphocytes? They are T cells residing in the epithelium.\n\nCheck if other genes support this. RPL and RPS are abundant in many cells, but IL7R is a stronger indicator for T cells. Also, there's no obvious markers for enterocytes like MUC2 (goblet) or digestive enzymes. B2M and HLA genes are present in most nucleated cells but could be consistent with immune cells. Thymosin beta proteins are in lymphocytes too. \n\nSo combining tissue location (small intestine), presence of IL7R, and ribosomal genes indicating active protein synthesis, this might be a T cell, specifically an intraepithelial lymphocyte. At 20 weeks, the gut is developing, and immune cells are present. The high ribosomal proteins could be due to the cell's activation state or proliferation.",
         "The cell exhibits high expression of ribosomal (RPL/RPS) and mitochondrial (MT-*) genes, consistent with active protein synthesis and metabolism. The presence of **IL7R** (a T-cell marker), **B2M** (β-2-microglobulin), and **HLA-A/C** (MHC class I) suggests an immune lineage. **TMSB4X/TMSB10** (actin-binding proteins) and lack of epithelial/secretory markers (e.g., MUC2, LYZ) further support an immune identity. Within the small intestine, IL7R+ T cells are typically intraepithelial lymphocytes (IELs), which reside in the epithelial layer and play roles in mucosal immunity.  \n\nCell type: Intraepithelial T lymphocyte",
         "429",
         "447",
         "607"
        ],
        [
         "171",
         "157",
         "30449502",
         "CD14-positive monocyte",
         "You are an expert in single-cell biology.\n\nBelow is metadata for one cell, followed by a list of its genes in descending expression:\nTissue: blood\nDisease: normal\nDevelopment stage: unknown\nGenes: FTH1 LYZ FTL MT-CO1 S100A9 B2M CXCL8 MT-CO3 MT-ATP6 MT-ND3 RPLP1 IL1B S100A8 MT-CO2 SRGN TMSB4X EEF1A1 NFKBIA CTSS SAT1 EIF1 RPL10 MT-ND1 VIM FCN1 RPL13 HLA-B RPL28 MT-CYB MT-ND2 MT-ND4 MARCKS RPL39 RPL41 RPS27 TPT1 RPS27A G0S2 RPS24 RPS14 RPS9 H3-3A RPLP2 C15orf48 PNRC1 RPL37 RPS28 RPL32 CXCL2 RPL30 RPS8 RPS12 RPL13A RPL34 RPS26 RPL18A RPL29 RPS18 S100A6 TMSB10 UBA52 NAMPT RPS15A RPS4X RPL11 RPL26 VCAN RPL14 TNFAIP2 TYROBP RPS13 ACTB RPL37A RPL23 NACA RPS11 RPL19 S100A4 HLA-A RPS2 RPS3A RPL12 PTMA S100A12 RPL21 OAZ1 PTPRC ANXA1 RPL9 RPL8 RPS23 S100A11 TKT BCL2A1 RPL18 ARPC3 FAU ACTG1 RPS3 SH3BGRL3\n\nPlease identify what cell type this might be, as granular and accurate as possible.\nKeep your response concise and clear.\nAt the end of your response, strictly place the final lines in this format:\n\nCell type: X\n",
         "Okay, let's try to figure out what cell type this is based on the given metadata and gene expression. The tissue is blood, disease is normal, and development stage is unknown. The genes are listed in descending order of expression.\n\nFirst, I'll look for highly expressed genes that are markers for specific blood cells. FTH1 and FTL are involved in iron storage, often seen in cells that handle iron, like erythrocytes or macrophages. But LYZ (lysozyme) is a marker for myeloid cells, especially monocytes and neutrophils. S100A9 and S100A8 are part of the S100 calcium-binding proteins, commonly expressed in neutrophils and monocytes. CXCL8 is a chemokine produced by macrophages and neutrophils. \n\nMT-CO1, MT-CO2, MT-CO3, MT-ATP6, MT-ND genes are mitochondrial genes. High mitochondrial content can indicate cells with high energy needs, like activated immune cells. But some cells like red blood cells (mature erythrocytes) lose mitochondria, so maybe these are immature cells? But the tissue is blood, not bone marrow. Alternatively, maybe monocytes or neutrophils, which are active in the immune response and have mitochondria.\n\nLooking at other genes: B2M is part of MHC class I, present in all nucleated cells. IL1B and CTSS are involved in inflammatory responses, pointing towards immune cells like macrophages or dendritic cells. VIM (vimentin) is a cytoskeletal protein found in many cells, including monocytes. HLA-B and HLA-A are MHC class I genes, which again are present in nucleated cells.\n\nGenes like RPL and RPS are ribosomal proteins, so high ribosome production, which is common in cells actively synthesizing proteins. Inflammatory cells might be producing lots of proteins. \n\nS100A6 and S100A12 are also part of the S100 family, again pointing towards myeloid lineage. TYROBP is involved in immune receptor signaling, found in NK cells, monocytes. ANXA1 is associated with neutrophil function. PTPRC is CD45, a leukocyte common antigen, present in all white blood cells. \n\nPutting this together: High expression of LYZ, S100A8/S100A9, CXCL8, IL1B, CTSS, and other inflammatory genes. These markers are strongly indicative of myeloid cells. Among myeloid cells, neutrophils have high S100A8/A9, lysozyme, but monocytes/macrophages also express these, along with genes like FTH1, FTL. However, the presence of MT- genes (mitochondrial) might suggest that these are monocytes rather than neutrophils, as neutrophils have lower mitochondrial content when mature. Alternatively, could be a subtype like classical monocytes. \n\nWait, but some studies show that certain monocyte subsets have higher mitochondrial activity. Also, genes like VCAN (versican) are associated with monocyte subsets. HLA genes are present, so nucleated cells. The combination of S100 proteins, lysozyme, and inflammatory cytokines would lean towards a monocyte, perhaps a classical monocyte (CD14+ CD16-). Alternatively, a macrophage, but since it's blood, more likely a monocyte. Also, FCN1 is a marker for classical monocytes. \n\nSo, considering the markers: FTH1, LYZ, FTL, S100A9/A8, CXCL8, IL1B, CTSS, VIM, FCN1. FCN1 is specifically expressed in classical monocytes. High expression of ribosomal proteins might indicate activated state or a particular subset. \n\nCell type is likely a classical monocyte (CD14+ CD16-), as FCN1 is a marker for them. Alternatively, a neutrophil, but S100A8/A9 and LYZ are in both. But neutrophils might have higher defensins, which aren't listed here. The presence of FCN1 tips it towards monocytes. Additionally, VCAN is another marker for classical monocytes. \n\nSo the conclusion is that this is a classical monocyte.",
         "The cell exhibits markers of myeloid lineage (LYZ, S100A9/S100A8, FCN1) with high ribosomal protein expression and mitochondrial genes, indicative of an active metabolic state. Key monocyte markers (FCN1, VCAN, S100A12) and absence of neutrophil-specific markers (e.g., DEFA1/3) point to a classical monocyte subset. \n\nCell type: Classical monocyte (CD14+ CD16-)",
         "417",
         "831",
         "928"
        ],
        [
         "183",
         "167",
         "1004188",
         "T cell",
         "You are an expert in single-cell biology.\n\nBelow is metadata for one cell, followed by a list of its genes in descending expression:\nTissue: liver\nDisease: normal\nDevelopment stage: 66-year-old human stage\nGenes: B2M MT-CO1 MT-CYB MT-ATP6 MT-CO3 MT-CO2 RPL41 GNLY RPS27A RPS27 MT-ND1 EEF1A1 RPL10 MT-ND3 RPS14 TMSB10 RPS12 RPL13 RPS3 TMSB4X RPL3 RPL34 RPS15A RPL28 RPL19 MT-ND2 RPS24 RPS23 RPL30 RPS15 RPS2 HLA-A RPLP2 RPS3A MT-ND4 RPL32 RPL23A RPS28 RPL39 RPL8 RPL11 RPS7 HLA-C RPL21 RPL26 HLA-B RPS19 RPS8 RPS21 TPT1 RPL18A NKG7 RPL7A RPL14 RPS26 RPL36 RPS29 IL7R RPL9 RPS4X RPS6 RPL29 RPS25 RPL12 RPS18 RPL7 RPL36AL IL32 BTG1 SH3BGRL3 RPL10A FAU VIM S100A4 FTH1 RPL37 RPS9 MT-ND5 RPL27 RPL18 RPL37A PPP2R5C NACA RPL35A RPS20 EEF1B2 RPL5 RPS13 RPL22 RPS5 RPLP1 GZMH RPL15 HLA-E RPL13A FTL ACTG1 EEF1D CD52 RPL6\n\nPlease identify what cell type this might be, as granular and accurate as possible.\nKeep your response concise and clear.\nAt the end of your response, strictly place the final lines in this format:\n\nCell type: X\n",
         "Okay, let's see. I need to figure out the cell type based on the given metadata and gene list. The tissue is liver, disease is normal, and the development stage is a 66-year-old human. So, it's an adult liver cell.\n\nLooking at the genes listed, a lot of them are ribosomal proteins (RPL and RPS genes) and mitochondrial genes (MT- prefixes). Those are pretty common in most cells because they're involved in basic functions like protein synthesis and energy production. But there are some other genes here that might be more specific.\n\nNoticing genes like GNLY, NKG7, GZMH, and IL7R. Wait, those are associated with immune cells. GNLY (granulysin) and GZMH (granzyme H) are cytotoxic granules found in NK cells and T cells. NKG7 is a marker for natural killer cells and cytotoxic T cells. IL7R is the interleukin-7 receptor, which is found on T cells, especially memory T cells. \n\nHLA genes are also present here: HLA-A, HLA-B, HLA-C, HLA-E. HLA class I molecules are expressed on all nucleated cells, but higher expression might indicate an immune cell. But since this is liver, maybe liver-resident immune cells?\n\nThe liver has various immune cells like Kupffer cells (macrophages), T cells, NK cells. But Kupffer cells would have markers like CD68, which isn't listed here. The presence of cytotoxic granules suggests a cytotoxic lymphocyte. So NK cells or CD8+ T cells.\n\nLooking at the genes again: GNLY, NKG7, GZMH, IL7R. NK cells typically have GNLY, NKG7, GZMB (but GZMH is a variant). IL7R is more common in T cells. However, some overlap exists. Also, there's EEF1A1, which is involved in protein synthesis, maybe not cell-type specific. \n\nVIM and S100A4 are sometimes associated with fibroblasts or some immune cells, but not sure. FAU is a ribosomal protein. Maybe the combination of cytotoxic markers and HLA genes points towards a resident memory T cell or NK cell in the liver.\n\nAnother angle: Liver-specific cell types like hepatocytes, cholangiocytes, stellate cells, or endothelial cells. But those usually have different markers. Hepatocytes express albumin, CYP enzymes, which aren't here. The genes here are heavy on ribosomal and immune-related. So probably an immune cell within the liver.\n\nGiven the markers, maybe a hepatic cytotoxic T cell or NK cell. NK cells in liver are called pit cells. Alternatively, a resident memory CD8+ T cell. But IL7R is present, which is on T cells. NK cells usually don't express IL7R. So maybe a CD8+ T cell. But need to check which markers are more specific.\n\nGNLY can be in both NK and T cells. NKG7 is more specific for NK and CD8+ T cells. GZMH is in cytotoxic cells. IL7R is more T cell. HLA genes are present, but that's general.\n\nPutting it all together, the cell is likely a cytotoxic T lymphocyte (CD8+ T cell) or an NK cell. Since IL7R is present, maybe a memory CD8+ T cell residing in the liver. Alternatively, an NK cell. The absence of CD3 markers might lean towards NK, but the gene list doesn't include CD3 genes. Wait, the genes listed don't have CD3D, CD3E, which are T cell markers. So maybe NK cell?\n\nAlternatively, maybe a gamma-delta T cell? Not sure. The key is the combination of GNLY, NKG7, GZMH, IL7R. If CD3 genes are missing, but they might not be in the top expressed genes here. However, the metadata is only the top genes. The presence of IL7R and cytotoxic markers, along with ribosomal genes (which could be due to high protein synthesis in active cells), maybe it's a tissue-resident memory CD8+ T cell in the liver. These cells are known to reside in the liver and have cytotoxic functions.\n\nSo the answer would be a CD8+ resident memory T cell. Alternatively, an NK cell. But without CD56 (NCAM1) or CD16 (FCGR3A) in the gene list, which are NK markers, maybe T cell is more likely. But the genes listed here don't include T cell receptor genes. Hmm.\n\nWait, maybe the presence of genes like HLA-E, which interacts with NKG2 receptors on NK cells. But then again, HLA-E is expressed in many cells. Maybe the combination of IL7R and cytotoxic genes points more to T cells. Alternatively, since the tissue is liver, and there are liver-resident NK cells which have different markers. But without more specific markers, it's tricky.\n\nAlternatively, looking at genes like FAU, VIM, S100A4. S100A4 is associated with some T cell subsets and fibroblasts. VIM is a mesenchymal marker, but can be expressed in activated lymphocytes.\n\nAnother thought: The high expression of ribosomal genes might indicate a highly proliferative cell, but the person is 66, so maybe not. Alternatively, cells with high metabolic activity.\n\nPutting it all together, the most likely cell type is a liver-resident cytotoxic T cell, possibly a CD8+ resident memory T cell. Alternatively, a natural killer cell. Given the presence of IL7R, which is more T cell, and the absence of classic NK markers like NCAM1 or FCGR3A, I'll lean towards CD8+ T cell.",
         "The cell exhibits high expression of cytotoxic markers (GNLY, NKG7, GZMH), IL7R (associated with T cell survival), and HLA class I genes, alongside ribosomal proteins. These features align with a liver-resident cytotoxic lymphocyte. The presence of IL7R and absence of NK-specific markers like FCGR3A (CD16) or NCAM1 (CD56) favor a tissue-resident memory CD8+ T cell over an NK cell. \n\nCell type: CD8+ resident memory T cell",
         "423",
         "1183",
         "1292"
        ],
        [
         "184",
         "168",
         "44247302",
         "CD14-positive, CD16-negative classical monocyte",
         "You are an expert in single-cell biology.\n\nBelow is metadata for one cell, followed by a list of its genes in descending expression:\nTissue: blood\nDisease: COVID-19\nDevelopment stage: 55-year-old human stage\nGenes: S100A9 S100A8 B2M FTL IFI27 ACTB TMSB4X IFITM3 FTH1 S100A6 CD74 S100A4 TMSB10 LYZ FOS RPL28 HLA-A FCN1 MTRNR2L12 IFI6 HLA-B GAPDH PSAP TYROBP EEF1A1 MT-CO1 IFITM1 LY6E CTSS HLA-C RPL41 SH3BGRL3 MT-CO2 PFN1 CST3 TPT1 S100A10 RPS12 SERF2 RPS18 DUSP1 JUN AIF1 RPL10 CD14 RPS13 RPL11 SRGN RPL19 RPS9 ITGB2 OAZ1 RPL13 GRN RPL30 RPS14 RPS19 JUNB RPL29 ACTG1 CYBA HLA-DRA RPLP1 RPS3 FAU MNDA UBC RPL39 RPS24 RPS15 CFL1 ARHGDIB PTMA RPL35A S100A11 RPLP2 RPL15 RPS28 EIF1 HLA-DRB1 LGALS1 FCER1G S100A12 RPL34 RPS15A WDR74 SAMHD1 RPL32 APOBEC3A RPS3A TYMP RPL18 RPS8 MT-ATP6 SAT1 RPL7A RPS25 ATP5F1E NACA RPS23\n\nPlease identify what cell type this might be, as granular and accurate as possible.\nKeep your response concise and clear.\nAt the end of your response, strictly place the final lines in this format:\n\nCell type: X\n",
         "Okay, let's tackle this question. The user provided a list of genes expressed in a cell from a 55-year-old human with COVID-19, and we need to determine the cell type. Let me start by recalling the key markers for different blood cells.\n\nFirst, looking at the top genes: S100A9 and S100A8. These are calprotectin subunits, commonly associated with neutrophils and monocytes. Then there's B2M (beta-2-microglobulin), which is part of MHC class I molecules, present in most nucleated cells. FTL (ferritin light chain) is involved in iron storage, often seen in macrophages. IFI27 is an interferon-inducible protein, which makes sense in viral infections like COVID-19. ACTB is actin, a cytoskeletal gene, so probably not specific.\n\nNext, genes like CD14 and CD74 are interesting. CD14 is a marker for monocytes and macrophages. CD74 is involved in antigen presentation, linking to MHC class II, which is found in antigen-presenting cells like dendritic cells, B cells, and monocytes. Then there's HLA-DRA and HLA-DRB1, which are MHC class II genes, reinforcing the idea of antigen-presenting cells.\n\nLooking at other markers: LYZ (lysozyme) is present in monocytes and neutrophils. FCN1 is a monocyte marker. CST3 (cystatin C) is expressed in monocytes. AIF1 (allograft inflammatory factor 1) is associated with activated macrophages. TYROBP is a signaling molecule in myeloid cells. FCER1G is part of the Fc epsilon receptor, found in various immune cells including monocytes and macrophages.\n\nThe presence of genes like IFITM3, IFI6, and IFITM1 suggests interferon response, which is common in viral infections and seen in monocytes/macrophages responding to pathogens. Also, genes such as MTRNR2L12 and MT-CO1 are mitochondrial genes, which might indicate activated cells with high metabolic activity.\n\nPutting this together, the high expression of S100A8/S100A9, CD14, CD74, HLA-DR genes, and monocyte markers like FCN1 and CST3 points towards a monocyte-derived cell. Given the disease context (COVID-19), there might be an activated or inflammatory state. In COVID-19, monocytes, particularly inflammatory monocytes, are known to be involved in the immune response. Some studies show that severe COVID-19 is associated with an increase in non-classical monocytes or macrophage activation. However, the markers here don't specify subsets like classical vs. non-classical. The presence of HLA-DR suggests they might be mature monocytes or macrophages. Alternatively, could they be dendritic cells? But dendritic cells typically have higher CD1c or CD141, which aren't listed here.\n\nAdditionally, the absence of neutrophil-specific markers like ELANE or MPO makes me lean away from neutrophils, even though S100A8/9 are present there too. But monocytes also express those. Also, the presence of genes like AIF1 and TYROBP aligns more with macrophages or activated monocytes.\n\nConsidering the tissue is blood, it's more likely a monocyte rather than a tissue macrophage. However, in COVID-19, monocytes can differentiate into macrophages in the lungs, but since the tissue here is blood, perhaps it's an activated monocyte. Alternatively, maybe a monocyte-derived dendritic cell, but again, without specific DC markers. Another possibility is a myeloid-derived suppressor cell (MDSC), but those usually have other markers.\n\nWait, looking again: CD14 is present, which is a monocyte marker. FCN1 is another monocyte marker. HLA-DR is present, which is MHC II. So this is likely a classical monocyte. But in COVID-19, there's also reports of CD16+ (FCGR3A) monocytes being involved. However, I don't see FCGR3A in the gene list. The genes listed here are more consistent with classical monocytes (CD14++ CD16-). Alternatively, it could be an intermediate monocyte subset, but without CD16. \n\nAlternatively, could it be a macrophage? If the cell is in blood, but macrophages are usually in tissues. Unless it's a monocyte-derived macrophage in circulation, which might be possible in severe infection. But the tissue is listed as blood, so more likely a monocyte. Additionally, genes like MNDA and CST3 are monocyte markers. AIF1 is also in monocytes/macrophages.\n\nTherefore, the cell type is most likely a classical monocyte. However, given the activation markers (interferon-stimulated genes like IFITM3, IFI6), perhaps it's an activated monocyte. But the question asks for the most granular and accurate. Another angle: CD14+ HLA-DR+ monocytes are often referred to as conventional monocytes. In some contexts, during inflammation, monocytes can downregulate HLA-DR, but here HLA-DRA and HLA-DRB1 are present, so they might still be expressing it. \n\nAlternatively, considering the high expression of S100A8/S100A9, which are also markers for myeloid-derived suppressor cells (MDSCs), but MDSCs usually have other markers like ARG1 or STAT3. Not sure if those are present here. The genes listed don't include those, so maybe not MDSC.\n\nPutting it all together, the cell is most likely a classical monocyte (CD14+), possibly in an activated state due to COVID-19 infection. The gene expression profile strongly supports monocyte identity with interferon response and antigen presentation components.",
         "The cell exhibits high expression of monocyte-associated genes (S100A8, S100A9, FCN1, CD14, CST3, AIF1) and interferon-response genes (IFI27, IFITM3, IFI6), consistent with an activated monocyte population during viral infection. MHC class II genes (HLA-DRA, HLA-DRB1) and lysosomal markers (LYZ, CTSS) further support a role in antigen presentation and inflammatory response. The absence of neutrophil-specific markers (e.g., ELANE, MPO) or dendritic cell markers (e.g., CD1C, CLEC9A) narrows the identity to monocytes. Elevated S100A8/S100A9 and TYROBP suggest a pro-inflammatory state, typical of classical monocytes in COVID-19.\n\nCell type: Classical monocyte (CD14+ HLA-DR+)",
         "417",
         "1165",
         "1350"
        ],
        [
         "185",
         "169",
         "11874016",
         "T cell",
         "You are an expert in single-cell biology.\n\nBelow is metadata for one cell, followed by a list of its genes in descending expression:\nTissue: alveolus of lung\nDisease: pulmonary emphysema\nDevelopment stage: 65-year-old human stage\nGenes: CCL4 MT-CO1 MT-CO3 MT-ATP6 HSP90AA1 MT-CO2 MT-ND4 B2M MT-CYB RPS27 RPS27A H3-3B RPLP1 RPS14 RPS3 MT-ND3 RPL41 MT-ND2 RPL10 RPS19 MT-ND1 RPL13 EEF1A1 RPL19 TPT1 RPS12 RPS15A RPL35A EIF1 RPS2 RPS4X GNLY JUN RPL32 KLF2 RPL39 TXNIP UBC TMSB4X RPL18 HLA-B RPL30 TMSB10 RPS21 RPLP2 DUSP2 PTMA RPS3A RPL18A RPL11 JUND RPL14 SRGN NKG7 HSPA8 RPL37 RPL28 RPS15 RPL23A RPL3 BTG1 RPS13 RPL13A RPS24 UBA52 FTL RPS26 RPL7A CCL5 RPS18 RPL27 RPS8 RPS7 DNAJB1 HSP90AB1 RPL9 RPS6 RPL34 FTH1 PNRC1 MT-ND5 RPS29 NR4A2 RPL26 CALM1 CD69 DDX5 RPS28 RPS23 NCL HLA-A H1-3 PIK3R1 HSPA1A RPL35 RPL21 RPL12 RPS5 HLA-E SERF2\n\nPlease identify what cell type this might be, as granular and accurate as possible.\nKeep your response concise and clear.\nAt the end of your response, strictly place the final lines in this format:\n\nCell type: X\n",
         "Okay, let me try to figure this out. The cell is from the alveolus of a lung with pulmonary emphysema in a 65-year-old human. The genes listed are in descending order of expression.\n\nFirst, I need to look at the most highly expressed genes. The top ones include CCL4, MT-CO1, MT-CO3, MT-ATP6, HSP90AA1, MT-CO2, MT-ND4, B2M, MT-CYB, RPS27, RPS27A, H3-3B, etc. The MT- genes are mitochondrial genes, which are often highly expressed in cells with high energy demands. But in the context of lung cells, maybe immune cells? Alveolar macrophages are known to be active in the lungs and have high metabolic activity. Also, CCL4 is a chemokine involved in immune responses, which macrophages produce.\n\nLooking further down the list, genes like GNLY, NKG7, and CD69 catch my eye. GNLY (granulysin) and NKG7 are associated with cytotoxic cells, like NK cells or T cells. However, the presence of B2M (beta-2-microglobulin) is part of MHC class I, which is present in most cells, but some immune cells might have higher expression. Also, HLA genes like HLA-B and HLA-A are present, which are involved in antigen presentation. Alveolar macrophages do present antigens, so that fits. But cytotoxic cells also have these markers.\n\nWait, but the tissue is alveolus. Pulmonary emphysema involves destruction of alveolar walls, and macrophages are implicated in the pathogenesis. Alveolar macrophages would have lysosomal genes, maybe some proteases, but the genes here include ribosomal proteins (RPS, RPL genes), which are common in many cells but especially in cells with high protein synthesis. Macrophages might have that due to their secretory functions.\n\nThere's also HSP90AA1 and HSP90AB1, heat shock proteins, which are involved in stress responses. Macrophages under stress (like in emphysema) might upregulate these.\n\nAnother angle: GNLY and NKG7 are more typical of cytotoxic T cells or NK cells. But if this is a single cell, could it be a resident memory T cell in the lung? But the tissue is alveolus, where T cells are less common compared to macrophages. Alternatively, maybe a type of lymphocyte infiltrating due to disease. But in emphysema, macrophages are more prominent.\n\nWait, but looking again: the top gene is CCL4, which is produced by macrophages, T cells, NK cells. The mitochondrial genes suggest high energy use. Alveolar macrophages are phagocytic and active, so they need lots of energy. The ribosomal proteins are also part of the protein synthesis machinery, which again fits macrophages producing cytokines and enzymes.\n\nHowever, GNLY and NKG7 are more specific. Could this be a mixed profile? Or maybe a macrophage with some cytotoxic features? Alternatively, maybe a NK cell resident in the alveolus. But in the context of emphysema, which is chronic, maybe chronic inflammation with cytotoxic cells present.\n\nWait, but the disease is pulmonary emphysema. In emphysema, there's an increase in macrophages and CD8+ T cells in the alveoli. CD8+ T cells express cytotoxic markers like GNLY and NKG7. So maybe this is a CD8+ T cell. Let me check the genes again.\n\nCD8+ T cells would express CD8, but that's not listed here. However, they do express CD3, which isn't in the list. The presence of B2M, HLA genes, and ribosomal proteins could still fit. The mitochondrial genes might be due to activated T cells, which have increased metabolic activity. JUN and JUND are transcription factors involved in activation. DUSP2 is involved in T cell receptor signaling. CD69 is an early activation marker. So maybe an activated CD8+ T cell.\n\nAlternatively, NK cells also express GNLY, NKG7, and CD69. But NK cells would have markers like NCAM1 (CD56), which isn't listed here. The absence of CD3 and CD56 might make it hard, but single-cell data sometimes doesn't capture all markers.\n\nBut the tissue is alveolus. In emphysema, both macrophages and T cells are present. However, the high expression of mitochondrial genes (MT-) might suggest a cell with high metabolic activity. T cells when activated upregulate mitochondrial biogenesis. Alternatively, macrophages also have high mitochondrial content.\n\nAnother angle: The presence of FTL and FTH1 (ferritin light and heavy chains) which are involved in iron storage. Macrophages, especially alveolar macrophages, handle iron from phagocytosed red blood cells, so this might support macrophage identity.\n\nBut then the cytotoxic genes (GNLY, NKG7) are confusing. Unless there's a subtype of macrophage that expresses these? Alternatively, maybe a misannotation, but I need to consider the combination.\n\nWait, there's also genes like HLA-B, HLA-A, which are MHC class I. All nucleated cells express MHC I, but antigen-presenting cells like macrophages have higher levels. But T cells also have MHC I.\n\nPutting it all together: High ribosomal and mitochondrial genes, CCL4, HLA genes, ferritin, and some cytotoxic markers. Maybe a macrophage with some activation markers, or a T cell. But given the tissue and disease, alveolar macrophage is a strong candidate. However, the presence of GNLY and NKG7 is more T/NK. Maybe a tissue-resident memory CD8+ T cell? Those can be found in lungs and express cytotoxic granules. CD69 is a marker of tissue-resident T cells. So, combining CD69, GNLY, NKG7, JUN, DUSP2, that might point to a resident memory CD8+ T cell.\n\nAlternatively, in some contexts, macrophages can express low levels of GNLY, but I think that's less common. Let me check some cell markers: Alveolar macrophages are typically marked by CD68, MARCO, etc., which aren't listed here. But the genes provided might not include those. The absence of classic macrophage markers doesn't rule it out if the data is limited. Alternatively, the high expression of MT genes and ribosomal proteins could be due to the cell's activation state.\n\nAlternatively, considering the patient's age and disease, maybe senescent cells? Senescent cells often have high ribosomal and mitochondrial gene expression. But that's a state, not a cell type.\n\nAnother thought: B2M is part of MHC I, so if this cell has high MHC I expression, but also cytotoxic genes, maybe a cytotoxic T cell. CD8+ T cells in the lung could be involved in emphysema pathogenesis. They express cytotoxic molecules when activated.\n\nSo, weighing the genes: The combination of cytotoxic markers (GNLY, NKG7, CD69) and activation markers (JUN, DUSP2), along with MHC I and ribosomal proteins, points towards an activated CD8+ T cell, possibly a tissue-resident memory T cell in the alveolus. However, the high mitochondrial genes could fit either T cells or macrophages. But without classic macrophage markers, maybe leaning towards T cell.\n\nBut wait, another possibility: Natural Killer cells. NK cells express GNLY, NKG7, and CD69. They also express genes like KLF2, which is in the list. However, typical NK markers like NCAM1 (CD56) or KLRD1 (CD94) aren't listed. But absence doesn't rule it out if they weren't detected. However, in the lung, NK cells are present but maybe less so in alveolus compared to T cells or macrophages.\n\nAlternatively, Gamma delta T cells, which have cytotoxic functions and might express similar markers.\n\nBut given the context, the most likely is a CD8+ resident memory T cell. Alternatively, given the disease, maybe a cytotoxic T cell infiltrating the alveolus in emphysema.\n\nAlternatively, another approach: Check for cell type markers in the list. RPL and RPS genes are housekeeping, not cell type specific. CCL4 is produced by both macrophages and T cells. MT genes are high in many cells with energy needs. B2M is ubiquitous. So the distinguishing genes are GNLY, NKG7, CD69, which are more T/NK.\n\nSo, considering all, the cell type is likely a CD8+ T cell, specifically a tissue-resident memory T cell, or a cytotoxic T lymphocyte. In the context of pulmonary emphysema, CD8+ T cells are known to contribute to the pathogenesis. So final answer: CD8+ cytotoxic T cell.",
         "The cell exhibits high expression of mitochondrial genes (MT-CO1, MT-CO3, MT-ATP6) and ribosomal proteins (RPS/RPL), consistent with high metabolic activity. Cytotoxic markers (GNLY, NKG7), activation genes (CD69, JUN, DUSP2), and MHC class I components (B2M, HLA-A/B) suggest an immune cell with effector functions. The absence of classical macrophage markers (e.g., CD68) and presence of tissue-resident memory T cell markers (CD69, cytotoxic molecules) align with an activated cytotoxic T cell. Pulmonary emphysema involves CD8+ T cell infiltration, supporting this identity.  \n\nCell type: CD8+ cytotoxic T cell (tissue-resident memory subset)",
         "426",
         "1816",
         "1974"
        ],
        [
         "187",
         "170",
         "29005838",
         "lymphocyte",
         "You are an expert in single-cell biology.\n\nBelow is metadata for one cell, followed by a list of its genes in descending expression:\nTissue: heart right ventricle\nDisease: dilated cardiomyopathy\nDevelopment stage: fifth decade human stage\nGenes: CCL4 CD247 GNG2 CELF2 PRKCH RAPGEF1 ADGRE5 ZBTB16 HAVCR2 STK10 SAMSN1 PITPNC1 FNDC3B ATP8B1 AAK1 RIPOR2 STK17B ARHGEF3 TMEM131 SOS1 RNF213 ARHGAP15 RAP1GAP2 PPM1L ZEB2 SRPK2 SMYD3 STK4 SSH2 BCL2 LITAF IFI16 KLF2 PARP14 SND1 ELMO1 CHSY3 GFPT1 STX18 PREX1 SIL1 EEA1 SAMD3 SYTL3 PLAC8 PTPRC ZNF207 EML4 EPS15L1 TGFBR1 KDM6A TCF12 MYO1F PDE8A ATP2B4 RAB8B CD53 BTBD9 SMCHD1 UBP1 RICTOR SLCO3A1 FBXO33 UBR5 CAPZB NCALD TMEM181 RASGRP1 CADM1 SYNJ2 LSM14A HLCS DNAJC10 ST8SIA4 SMG1 XYLT1 SETX DYRK1A SPATA5 ETS1 NCOR1 GSK3B FAM172A WAC PHACTR4 TMED8 CTBP2 DDR2 EXOC6B MTDH GATAD2A LARP4B RBM6 INPP4A ENOX2 MINDY3 EZR AFF1 RSU1 CHST11\n\nPlease identify what cell type this might be, as granular and accurate as possible.\nKeep your response concise and clear.\nAt the end of your response, strictly place the final lines in this format:\n\nCell type: X\n",
         "Okay, let's see. The metadata says the tissue is heart right ventricle, disease is dilated cardiomyopathy, development stage is fifth decade human. The genes listed are in descending order of expression. I need to figure out the cell type.\n\nFirst, the tissue is right ventricle, so we're looking at cardiac cells. Dilated cardiomyopathy affects the heart muscle, leading to enlargement and reduced pumping ability. Common cell types in the heart include cardiomyocytes, fibroblasts, endothelial cells, and immune cells like macrophages or T-cells.\n\nLooking at the genes: CD247 is part of the T-cell receptor complex, which is involved in T-cell activation. HAVCR2 (TIM-3) is a marker for exhausted T-cells or certain T-cell subsets. PTPRC is CD45, a leukocyte common antigen, so that's immune cells. CCL4 is a chemokine produced by lymphocytes and macrophages. CD53 is another immune cell marker, associated with lymphocytes.\n\nOther genes like ZBTB16 (PLZF) are involved in T-cell development. SAMSN1 is found in activated lymphocytes. TGFBR1 is involved in T-cell regulation. KDM6A is a histone demethylase, which might relate to immune cell function. RICTOR is part of mTORC2, which is important in T-cell signaling. RAB8B and EXOC6B are involved in vesicle trafficking, maybe in immune cells.\n\nBut wait, there are also genes like ATP2B4 (a calcium transporter) which is in cardiomyocytes. But the presence of multiple immune-related genes might suggest that this is an immune cell infiltrating the heart tissue. Dilated cardiomyopathy often has immune infiltration. So maybe a T-cell subtype?\n\nLooking at specific markers: HAVCR2 (TIM-3) and CD247 (TCR). TIM-3 is a checkpoint molecule, often on exhausted CD8+ T-cells or Th1 cells. Also, LAG3 is another checkpoint, but not listed here. The combination of CD247, PTPRC, CD53, HAVCR2, and other T-cell genes points towards T-cells. Since it's in the heart with dilated cardiomyopathy, it's likely a tissue-resident or infiltrating T-cell.\n\nBut which subtype? The presence of ZBTB16 might indicate a mucosal-associated invariant T (MAIT) cell or a specific T subset. However, ZBTB16 is also known in innate-like T-cells. The gene GNG2 is part of G-protein signaling, which is common in T-cells. Additionally, genes like PARP14 are associated with Th2 cells and macrophage activation. However, without more specific markers like CD4 or CD8, it's hard to tell. But given the context, maybe a cytotoxic CD8+ T-cell with exhaustion markers (HAVCR2) in the setting of chronic disease.\n\nAlternatively, considering the presence of PTPRC (CD45) and CD53, which are pan-leukocyte, but the other markers lean towards T-cells. Also, CD247 is part of the TCR complex, so this is likely a T-cell. Granularly, maybe a tissue-resident memory T-cell or an exhausted CD8+ T-cell in the context of chronic cardiomyopathy.\n\nOther possibilities: Fibroblasts or endothelial cells usually express different markers (like COL1A1, VWF). Cardiomyocytes have markers like TNNT2, MYH6. But those genes aren't in the list. The high expression of immune-related genes supports an immune cell type. So, T-cell is most likely. \n\nTo specify further, HAVCR2 (TIM3) and LAG3 are often co-expressed in exhausted T-cells. Since HAVCR2 is present but not LAG3, maybe a subset. Also, CD8+ T-cells in chronic conditions express these markers. In dilated cardiomyopathy, there's known T-cell infiltration. So, the cell type is likely a CD8+ T-cell, possibly exhausted or activated, infiltrating the heart in dilated cardiomyopathy.\n\nAnother check: TGFBR1 is part of TGF-beta signaling, which can modulate T-cell function. KDM6A (UTX) is involved in T-cell differentiation. RICTOR in mTOR signaling for T-cell activation. So all these support T-cell identity.\n\nConclusion: This is a CD8+ T-cell, possibly exhausted, infiltrating the right ventricle in dilated cardiomyopathy.",
         "The cell exhibits markers of immune activation (CD247, HAVCR2, PTPRC) and T-cell-associated signaling (ZBTB16, SAMSN1, TGFBR1, RICTOR), alongside genes linked to chronic immune responses (PARP14, KDM6A). These features, combined with the context of dilated cardiomyopathy (often involving T-cell infiltration), suggest an activated or exhausted CD8+ T-cell infiltrating the heart tissue. Absence of cardiomyocyte/fibroblast-specific markers further supports this.\n\nCell type: CD8+ tissue-infiltrating T-cell (exhausted phenotype)",
         "428",
         "902",
         "1031"
        ],
        [
         "190",
         "173",
         "15073125",
         "oligodendrocyte",
         "You are an expert in single-cell biology.\n\nBelow is metadata for one cell, followed by a list of its genes in descending expression:\nTissue: cerebral nuclei\nDisease: normal\nDevelopment stage: 42-year-old human stage\nGenes: PCDH9 IL1RAPL1 PTGDS PTPRD PPP2R2B EDIL3 NRXN3 SIK3 NCKAP5 CTNNA3 CADM2 QKI PLP1 NCAM2 SLC24A2 ADGRL3 NKAIN2 APP MAGI2 ANK3 PEX5L DLG1 DLG2 FRMD5 ENPP2 TMEM144 NLGN1 ROBO1 TJP1 MBP WWOX FTH1 NPAS3 ST18 TCF4 UNC5C SEPTIN7 PLCL1 MAN2A1 PDE1C SPOCK3 ZBTB20 PHLPP1 SPOCK1 AUTS2 RYBP ANK2 TRAPPC8 PDE4B SRPK2 UBE2E2 CTNNA2 PLD5 ERBIN RALGAPA1 RALY SLC44A1 PTK2 LCOR DENND5A FOXJ3 LSAMP ZNF536 TCF12 SSH2 GAB1 TTLL7 CCNY DST LPAR1 NTM NEO1 SCARB2 APBB1 PRKN MAP7 KMT2C PPP1R12B AK3 SLC38A9 SLC5A11 GPM6B FAM107B PIK3R1 SEMA6A ELMO1 FNIP2 ZFYVE16 ZNF654 CADM1 ANKS1B ATP8A1 ARID2 DBNDD2 HHIP DSCAML1 PPP3CA ZNF595 PPM1B SIPA1L1\n\nPlease identify what cell type this might be, as granular and accurate as possible.\nKeep your response concise and clear.\nAt the end of your response, strictly place the final lines in this format:\n\nCell type: X\n",
         "Okay, let's tackle this. The metadata says the cell is from the cerebral nuclei, which are part of the basal ganglia. The disease is normal, and it's from a 42-year-old human. The genes listed are in descending order of expression.\n\nLooking at the genes, some key ones stand out. PLP1 is highly expressed in oligodendrocytes, which produce myelin. MBP is another myelin-related gene, also pointing towards oligodendrocytes. Then there's QKI, which is involved in mRNA processing in oligodendrocytes. Other genes like MAG, CNP, and MOBP are typical oligodendrocyte markers, but they aren't listed here. Wait, but PLP1 and MBP are definitely strong indicators.\n\nAlso, genes like PCDH9 and CNTNAP2 are involved in cell adhesion and neuronal function, but maybe these are expressed in oligodendrocytes too. Let me check. PTGDS is expressed in oligodendrocytes and involved in lipid metabolism. DLG1 and DLG2 are part of the discs large family, which are scaffolding proteins, found in various cells including neurons and glia. \n\nBut the presence of NCAM2 (neural cell adhesion molecule 2) might suggest a neuronal cell type. Wait, but some glial cells also express NCAMs. Hmm. Let me cross-verify. Oligodendrocyte markers are PLP1, MBP, QKI, MAG. Are these present? PLP1 and MBP are here, QKI is listed as well. MAG isn't in the gene list, but maybe other markers are present.\n\nOther genes like ERBB3 or SOX10 are more specific, but they're not listed here. However, the combination of PLP1, MBP, QKI, and PTGDS strongly suggests oligodendrocyte lineage. Also, WWOX is involved in brain development and may be expressed in glial cells. ANK3 is ankyrin-G, found in neurons, but maybe also in some glia? Not sure. \n\nWait, there's SLC44A1, which is a choline transporter, maybe involved in myelination. The presence of myelin basic protein (MBP) and proteolipid protein (PLP1) is really strong evidence. Also, PTPRD is a receptor-type tyrosine phosphatase, which can be involved in cell adhesion and signaling in glial cells.\n\nConsidering all this, the most likely cell type is an oligodendrocyte. They are responsible for myelination in the central nervous system, and the markers here align with that. The cerebral nuclei (basal ganglia) do contain oligodendrocytes as part of the white matter tracts and supporting cells. The age being 42 doesn't conflict since oligodendrocytes are present throughout adulthood.",
         "The cell originates from the cerebral nuclei (basal ganglia) and exhibits high expression of oligodendrocyte-associated genes like **PLP1**, **MBP**, **QKI**, and **PTGDS**, which are critical for myelination and lipid metabolism. Other genes (e.g., **DLG1/2**, **NCAM2**) suggest roles in glial-neuronal interactions. The absence of mature neuronal markers (e.g., **SYT1**, **SNAP25**) and astrocyte-specific markers (e.g., **GFAP**, **AQP4**) further supports oligodendrocyte identity. The expression profile aligns with a mature, myelinating oligodendrocyte.\n\nCell type: Oligodendrocyte",
         "432",
         "572",
         "719"
        ],
        [
         "213",
         "195",
         "34578862",
         "natural killer cell",
         "You are an expert in single-cell biology.\n\nBelow is metadata for one cell, followed by a list of its genes in descending expression:\nTissue: blood\nDisease: normal\nDevelopment stage: 71-year-old human stage\nGenes: B2M RPL41 MT-CO1 RPL10 TMSB4X GNLY EEF1A1 RPLP2 RPLP1 RPL13 RPS27A RPS27 RPS14 NKG7 RPL13A RPS12 KLRB1 RPS17 RPL11 RPL26 TMSB10 RPS15A RPL23A PFN1 MT-CO3 RPL28 SH3BGRL3 RPL32 RPS18 HLA-B IFITM2 HLA-C ACTB RPS29 RPS3A EIF1 RPS15 RPL7 RPL37 CCL4 CCL3 RPL14 TPT1 RPSA RPL7A RPL3 RPS4X UBA52 RPL15 RPS6 RPS13 RPL37A GZMB SERF2 HLA-E RPS11 RPL39 RPS2 RPL31 RPL34 RPL17 RPL27 JUN PTMA RPL21 RPL18 DDX5 MT-ND1 RPL36 RPL30 RPL10A H3-3B MT-CO2 RPS3 MT-ATP6 RPS7 MT-ND2 IFITM1 CYBA UBB S100A4 RPS20 RPS25 RPL19 RPL9 RPL27A RPS24 RPL35A RPS28 MYL6 RPS26 RPL36A RPL29 RPL4 CMC1 RBM3 RACK1 RPL18A ARL4C RPL12\n\nPlease identify what cell type this might be, as granular and accurate as possible.\nKeep your response concise and clear.\nAt the end of your response, strictly place the final lines in this format:\n\nCell type: X\n",
         "Okay, let's try to figure out the cell type here. The metadata says it's from blood, normal, and a 71-year-old human. The genes listed are in descending expression. Let's start by looking for highly expressed genes that are markers for specific blood cells.\n\nFirst, I notice a lot of ribosomal proteins like RPL and RPS genes. These are usually involved in protein synthesis and are common in cells that are actively producing proteins. But many cell types have these, so maybe not the most specific.\n\nLooking for immune-related genes. There's GNLY, which is Granulysin, typically found in cytotoxic T cells and NK cells. Then there's NKG7, which is a marker for NK cells and cytotoxic T cells. KLRB1 encodes CD161, associated with NK cells and some T cell subsets. GZMB is Granzyme B, again pointing towards cytotoxic cells, either CD8+ T cells or NK cells.\n\nCCL4 and CCL3 are chemokines produced by T cells and NK cells during inflammation. PFN1 is Profilin 1, involved in actin dynamics, which is important in immune cell function. HLA genes like HLA-B, HLA-C, and HLA-E are MHC class I molecules, present on all nucleated cells, but their expression might be upregulated in certain immune cells.\n\nTMSB4X and TMSB10 are thymosin beta proteins, involved in actin sequestration, which is common in cells that need to be motile, like immune cells. ACTB is beta-actin, a cytoskeletal protein, ubiquitous but necessary for cell structure and movement.\n\nNow, considering the combination of GNLY, NKG7, GZMB, KLRB1, and the chemokines CCL3/4, this strongly suggests a cytotoxic lymphocyte. The presence of these markers together is typical for either NK cells or CD8+ T cells. However, NK cells usually have higher expression of genes like NCAM1 (CD56), which isn't listed here. But sometimes in single-cell data, not all markers are present. Alternatively, KLRB1 (CD161) can be expressed on a subset of T cells, like mucosal-associated invariant T (MAIT) cells or some γδ T cells, but more commonly NK cells.\n\nLooking at other genes: IFITM2 and IFITM1 are interferon-induced transmembrane proteins, which are involved in immune responses. Their presence supports an immune cell type. Also, MT-CO1, MT-CO2, MT-CO3 are mitochondrial genes, which might indicate active cells with high metabolic activity, like activated T or NK cells.\n\nThe absence of CD3 genes (like CD3D, CD3E) might be a point against T cells, but sometimes in single-cell data, not all markers are detected. Alternatively, if the cell is an NK cell, CD3 wouldn't be present. So if there's no CD3, but presence of NKG7, GNLY, GZMB, and KLRB1, more likely NK cell.\n\nAnother check: RPL and RPS genes are high, which are in many cells, but maybe higher in NK cells? Not sure. Also, genes like EEF1A1 and ACTB are common in many cells.\n\nPutting it all together: The markers point towards a cytotoxic lymphocyte. Given the combination of NKG7, GNLY, GZMB, KLRB1, and absence of T cell receptor genes (like TRAC, TRBC1/2) or CD3, this is more likely a natural killer (NK) cell. However, sometimes CD8+ T cells can express some of these markers, especially in activated states. But the presence of CCL3 and CCL4 is also common in NK cells. Also, KLRB1 (CD161) is a marker for NK cells and some T cell subsets. Since the tissue is blood, NK cells are expected.\n\nSo the most probable cell type here is a natural killer cell.",
         "The cell exhibits high expression of cytotoxic markers (GNLY, NKG7, GZMB), chemokines (CCL3, CCL4), and NK/T cell-associated genes (KLRB1, PFN1). Ribosomal and mitochondrial genes reflect active protein synthesis and metabolism. The absence of T cell receptor genes (e.g., CD3 subunits) and strong NK-associated markers (NKG7, GNLY) favor an NK cell identity over cytotoxic T cells.\n\nCell type: Natural Killer (NK) cell",
         "424",
         "822",
         "930"
        ],
        [
         "220",
         "199",
         "25137652",
         "natural killer cell",
         "You are an expert in single-cell biology.\n\nBelow is metadata for one cell, followed by a list of its genes in descending expression:\nTissue: lung\nDisease: squamous cell lung carcinoma\nDevelopment stage: 69-year-old human stage\nGenes: B2M TMSB4X CCL4 CCL3 ZFP36 RPL41 RPS27 HLA-B RPL10 RPLP2 RPS27A RPS7 RPS15A NKG7 RPS15 RPS29 RPL34 JUNB FTL RPS18 PTMA RPL32 RPL26 RPL13 RPL37A EIF1 BTG1 EEF1A1 RPLP1 RPS10 TSC22D3 RPL18A RPL39 RPS28 RPL28 CCL5 TMSB10 RPS2 RPL13A ACTB CFL1 RPS3A KLRB1 SRGN RPL27A RPS19 RPS12 RPS13 JUN HLA-C COMMD6 RPL23A FTH1 RPS3 RPS14 HSPE1 KLRD1 PNRC1 ATP5MG FAU RPL29 ITGB2 RACK1 RPS21 GNLY PFN1 RPL31 OST4 RPL21 IFNG HLA-A RPL35A RPL18 PRF1 RPL5 RPL11 SERF2 RPS20 JUND PLAC8 RPS25 RPS6 HSPA1A RPL3 GSTP1 RPL12 PRKRIP1 HSPG2 RPL8 GZMA CTSW GAPDH SH2D1A RPL35 BANF1 RPL7 NAP1L1 RPS16 PFDN5 LYAR\n\nPlease identify what cell type this might be, as granular and accurate as possible.\nKeep your response concise and clear.\nAt the end of your response, strictly place the final lines in this format:\n\nCell type: X\n",
         "Okay, let's tackle this. The cell is from a lung with squamous cell carcinoma. The gene list is pretty long, so I need to pick out the key markers.\n\nFirst, squamous cell carcinoma (SCC) of the lung is an epithelial cancer, but the genes here might reflect the tumor cells themselves or immune infiltrates. Let's check the genes.\n\nLooking for immune-related genes. There's CCL3, CCL4, CCL5 – these are chemokines associated with T cells and NK cells. Also, NKG7, GNLY, PRF1, GZMA. NKG7 is a marker for cytotoxic cells like NK and CD8+ T cells. GNLY (granulysin), PRF1 (perforin), and GZMA (granzyme A) are all involved in cytotoxic activity. KLRB1 (CD161) and KLRD1 (CD94) are also NK cell markers. HLA genes (HLA-A, B, C) are present, but those are expressed in many cells, though maybe higher in immune cells.\n\nThen there's IFNG (interferon gamma), which is produced by activated T cells and NK cells. T-cell markers like CD3 aren't listed here, but maybe the RPL and RPS genes are ribosomal proteins, which are housekeeping but sometimes vary. However, the presence of cytotoxic granules and chemokines points towards an immune cell type.\n\nLooking at the combination: cytotoxic granules (GNLY, PRF1, GZMA), chemokines (CCL3-5), NK markers (NKG7, KLRB1, KLRD1). These are strong indicators of natural killer (NK) cells or cytotoxic T lymphocytes (CTLs). However, GNLY and PRF1 are more characteristic of NK cells. Also, the absence of CD8 (though maybe not in the list) or CD4. The presence of genes like NKG7 and KLRD1, which are part of the NK cell receptor complex, leans more towards NK cells. Additionally, genes like FCGR3A (CD16) aren't listed here, but maybe they're not expressed. \n\nAnother angle: Tissue is lung, and in tumor microenvironments, NK cells are present as part of the immune response. Squamous cell carcinoma often has immune infiltration. The genes don't show markers for B cells (like CD19, CD20) or macrophages (CD68, etc.), so likely not those. \n\nPutting it all together, the high expression of cytotoxic molecules and NK-specific markers suggests this is a natural killer cell. The granularity would be to specify it's a tumor-infiltrating NK cell in the context of lung squamous cell carcinoma.",
         "The cell exhibits high expression of cytotoxic markers (GNLY, PRF1, GZMA, NKG7), chemokines (CCL3-5), and NK-associated receptors (KLRB1, KLRD1), alongside ribosomal proteins. These features are characteristic of natural killer (NK) cells, specifically activated or tumor-infiltrating NK cells, which are common in squamous cell carcinoma microenvironments. The absence of T-cell-specific markers (e.g., CD3) and presence of IFNG further support this. \n\nCell type: Tumor-infiltrating natural killer cell",
         "416",
         "563",
         "686"
        ],
        [
         "226",
         "205",
         "27054257",
         "microglial cell",
         "You are an expert in single-cell biology.\n\nBelow is metadata for one cell, followed by a list of its genes in descending expression:\nTissue: brain\nDisease: glioblastoma\nDevelopment stage: unknown\nGenes: FTL FOS SAT1 HSPA1A TMSB4X MT-ND3 CCL4 MT-CO3 MT-ATP6 FTH1 RPL41 CD74 TPT1 MT-CO1 HSP90AA1 RPLP1 HLA-DRA B2M RPS19 IER3 EGR1 MT-CO2 RPS27 MT-CYB IL1B DUSP1 RPL10 G0S2 RPL34 HSP90AB1 EEF1A1 RPS14 MT-ND4 RPS2 RPL28 RPS8 MT-ND1 KLF6 RPS23 TMSB10 HSPH1 RPL13 C1QB RPL39 EIF1 MT-ND2 RPL13A RPL32 SRGN RPS28 RPS6 RPL26 RPS12 RPLP2 JUN RPS29 RPL37 RPL37A SPP1 IER5 APOE SOD2 RPL11 RPS21 RPS27A ACTB RPL17 DNAJB1 RPL18A RPL3 RPL21 RPL7A RPL27A PTMA KLF2 RPL15 RGS1 RPS13 RPS9 RPL6 RPL38 RPL35 RPS15A RPL30 RPS16 JUNB SGK1 RPL19 RPS24 C1QA RPS4X OLR1 DDX5 ITM2B RPL18 RPL12 HSPD1 RPL23A CST3 FAU\n\nPlease identify what cell type this might be, as granular and accurate as possible.\nKeep your response concise and clear.\nAt the end of your response, strictly place the final lines in this format:\n\nCell type: X\n",
         "Okay, let's try to figure out the cell type here. The metadata says the tissue is brain and the disease is glioblastoma. So, we're probably looking at a tumor cell from glioblastoma. Let me think about the genes listed.\n\nGlioblastoma is a type of glioma, which are tumors arising from glial cells. The main types of glial cells are astrocytes, oligodendrocytes, and microglia. Now, looking at the genes expressed here. There's a lot of mitochondrial genes like MT-CO1, MT-CO2, MT-ATP6, which are part of the electron transport chain. High mitochondrial activity might indicate active metabolism, common in cancer cells.\n\nThen there's FOS and JUN, which are immediate early genes involved in cell proliferation and stress responses. These are often upregulated in cancer. HSP genes like HSPA1A and HSP90AA1 are heat shock proteins, which help in protein folding and stress response—again, common in stressed or cancerous cells.\n\nLooking at immune-related genes: CCL4 is a chemokine, and CD74, HLA-DRA, B2M are involved in antigen presentation. That makes me think of antigen-presenting cells, but in glioblastoma, the tumor cells themselves can sometimes express these, or maybe there's infiltration of immune cells like microglia or macrophages. But the tissue is brain, and the disease is glioblastoma, so it's more likely the tumor cells or tumor-associated macrophages/microglia.\n\nWait, there's also C1QA and C1QB, which are part of the complement system. These are typically expressed by microglia in the brain. But in glioblastoma, tumor-associated macrophages/microglia (TAMs) are abundant. However, the presence of genes like GFAP (not listed here) would point more towards astrocytes. Since GFAP isn't in the gene list, maybe it's not an astrocyte. Alternatively, the tumor cells might have a different expression profile.\n\nLooking at ribosomal proteins: RPL and RPS genes are highly expressed. High ribosome production is common in rapidly dividing cells, like cancer cells. So this could support the idea of a tumor cell. But microglia or macrophages also have active protein synthesis.\n\nOther genes: EGR1 and IER3 are involved in stress responses and cell growth regulation. SOD2 is involved in oxidative stress, which is typical in cancer. SPP1 (osteopontin) is associated with tumor progression and macrophage activity. APOE is produced by astrocytes and macrophages. But again, the primary cell type here is glioblastoma, which originates from astrocytes. However, the lack of GFAP is confusing. Maybe it's a specific subtype or the sample has downregulated GFAP.\n\nAlternatively, considering the high expression of CD74 and HLA-DRA, which are part of MHC class II, these are usually in antigen-presenting cells. In the brain, that's microglia. But glioblastoma cells can sometimes express these as well, especially under inflammatory conditions. However, tumor-associated macrophages/microglia would be more likely. But the main cell type in glioblastoma is the malignant astrocytic cell. However, without GFAP, maybe it's a macrophage/microglia infiltrating the tumor.\n\nWait, the genes also include FTL and FTH1, which are involved in iron metabolism, commonly expressed in microglia and macrophages. SAT1 is involved in polyamine metabolism, which can be upregulated in macrophages. CCL4 is a chemokine secreted by macrophages. So combining these with CD74, HLA-DRA, B2M, C1QA, C1QB, this might actually be a tumor-associated macrophage or microglia. But the tissue is listed as brain and disease as glioblastoma. So it's possible that this cell is a tumor-infiltrating immune cell rather than the tumor cell itself.\n\nBut how to distinguish? Malignant glioblastoma cells might express genes like EGFR, VEGF, etc., but those aren't listed here. The presence of ribosomal proteins and mitochondrial genes is non-specific. The combination of MHC class II genes and complement proteins leans towards microglia/macrophages. So maybe the cell type is a tumor-associated macrophage or microglia.\n\nBut wait, glioblastoma cells can have a mesenchymal subtype which might express some of these immune-related genes. Alternatively, the cell could be a myeloid-derived suppressor cell (MDSC) or a macrophage. Given the high expression of CD74, HLA-DRA, and complement genes, I think the cell type is more likely a tumor-associated macrophage or microglia. However, in the context of glioblastoma, these are often referred to as glioma-associated microglia/macrophages (GAMs). But the answer needs to be as granular as possible.\n\nAlternatively, considering the absence of specific markers like PTPRC (CD45) which is a leukocyte marker, but it's not in the list. However, the presence of CD74 and HLA-DRA might still suggest that.\n\nAlternatively, the cell could be a malignant cell with an aberrant expression profile. But without GFAP or other astrocytic markers, it's hard. Another angle: some studies show that glioblastoma cells can express macrophage markers, a phenomenon called tumor mimicry. So maybe the cell is a glioblastoma cell with a macrophage-like expression profile.\n\nAlternatively, given the metadata says the development stage is unknown, but in glioblastoma, the tumor cells are the main component. However, the gene list here doesn't have classic glioma markers like GFAP, SOX9, etc., but maybe they are not expressed or not in the top genes. The top genes here are FTL, FOS, SAT1, etc.\n\nFTL (ferritin light chain) is highly expressed in microglia. FOS is an immediate early gene, which can be active in many cells. SAT1 is involved in polyamine catabolism and is induced in macrophages. HSPA1A is a heat shock protein. TMSB4X is thymosin beta 4, involved in actin regulation, expressed in many cells. The mitochondrial genes suggest high metabolic activity.\n\nPutting this all together, the presence of MHC class II genes (HLA-DRA, CD74), complement genes (C1QA, C1QB), and macrophage/microglia markers (FTL, FTH1, CCL4) suggests that this cell is a tumor-associated macrophage/microglia. Given that it's from glioblastoma, these are often referred to as glioma-associated microglia/macrophages (GAMs). However, in terms of cell type, if it's a macrophage, it's a brain-resident microglia or infiltrating macrophage. But given the context, the most accurate and granular type would be tumor-associated macrophage (TAM), possibly of the myeloid lineage.\n\nAlternatively, since microglia are the resident macrophages of the brain, and in glioblastoma, both resident microglia and infiltrating macrophages contribute to TAMs. However, without specific markers distinguishing them (like TMEM119 for microglia), it's hard to say. But the combination of C1QA/B and APOE might lean towards microglia. However, APOE is also expressed by astrocytes.\n\nAlternatively, maybe the cell is a myeloid-derived suppressor cell (MDSC), but that's more common in peripheral tumors. Given the information, the most likely cell type is a tumor-associated microglia/macrophage. But the problem states to be as granular as possible. In some classifications, these are considered as microglia-derived or macrophage-derived TAMs. However, in practice, without specific markers, it's often referred to as TAMs. But since the question is about cell type, not origin, perhaps \"myeloid cell\" or \"macrophage/microglia\".\n\nWait, but the genes also include IL1B and DUSP1, which are involved in inflammatory responses, supporting the myeloid lineage. JUN and FOS are also involved in AP-1 transcription factor, which is active in macrophages.\n\nSo putting it all together, the cell type is likely a tumor-associated macrophage/microglia. Since microglia are brain-resident macrophages, but in glioblastoma, there's a mix of resident microglia and infiltrating macrophages. However, given the metadata, the most accurate answer would be macrophage/microglia within the glioblastoma tumor. But the exact distinction between microglia and macrophage might not be possible without specific markers. Therefore, the cell type is a tumor-associated macrophage (TAM) or microglia. But perhaps the answer expects a more specific type.\n\nAlternatively, looking at the genes again: CD74, HLA-DRA, C1QA/B are markers of antigen-presenting cells. In the context of glioblastoma, these are likely glioma-associated microglia/macrophages (GAMs). However, in terms of cell type classification, the answer might be \"tumor-associated macrophage\" or \"microglia\". But since microglia are a type of macrophage in the brain, perhaps the answer is \"microglia\" or \"brain macrophage\". However, given the context of glioblastoma, the standard term is \"glioma-associated microglia/macrophage\", but if that's too specific, maybe just \"macrophage\" or \"microglia\".\n\nAlternatively, looking for markers: CD74 is part of the MHC class II complex. Microglia in their resting state have low MHC II, but when activated (as in tumors), they upregulate it. Infiltrating macrophages also express MHC II. However, other genes like P2RY12 or TMEM119 are microglia-specific, but they are not in the list. So, without those, we can't definitively say microglia vs macrophage. Therefore, the safest answer is \"tumor-associated macrophage/microglia\". But the question asks for as granular as possible, so maybe \"myeloid cell\" but that's not specific enough.\n\nWait, the presence of C1QA and C1QB is more indicative of microglia, as they are part of the complement system produced by microglia. Also, APOE is highly expressed by microglia. So combining these, perhaps it's a microglial cell. But again, without specific markers, it's a bit uncertain. Alternatively, since the disease is glioblastoma, and the cell is from brain tissue, the cell type is likely a glioma-associated microglial cell. However, \"microglial cell\" would be the cell type. Alternatively, if it's a macrophage, then \"macrophage\". But given the brain context, \"microglia\" is more accurate. But the genes might support that.\n\nAlternatively, considering that the cell has high expression of FTL (ferritin light chain), which is a marker for microglia activation. FTH1 is ferritin heavy chain. So microglia often express these. SAT1 is also involved in the immune response in microglia. HSPA1A is stress response. So putting this together, the cell is likely an activated microglial cell within the glioblastoma tumor. Therefore, the cell type is microglia. But in the context of a tumor, they are often referred to as tumor-associated microglia. But if the answer needs to be as per standard cell types, \"microglia\" might suffice. However, the question is in the context of glioblastoma, so maybe \"tumor-associated microglia/macrophage\".\n\nBut I need to check if there's another cell type. Are there any other brain cell types that express these genes? For example, if it's a macrophage that's infiltrated the brain, then it's a macrophage. But microglia are the resident macrophages. Alternatively, the cell could be a monocyte-derived macrophage. But without specific markers, it's hard to distinguish. \n\nIn conclusion, given the information and the gene list, the cell is most likely a tumor-associated macrophage/microglia. But since the answer needs to be as granular as possible, the cell type is likely a microglial cell, given the brain context and the presence of complement genes. However, another angle: glioblastoma cells can express macrophage markers, so maybe the cell is a neoplastic astrocyte with macrophage-like features. But without astrocytic markers like GFAP, that's uncertain. \n\nAlternatively, since glioblastoma stem cells can have different phenotypes, maybe this is a mesenchymal subtype glioblastoma cell, which is known to have a more inflammatory signature, resembling macrophages. The mesenchymal subtype is characterized by expression of genes like CD74, HLA-DRA, and other immune-related genes. In that case, the cell type would be a mesenchymal glioblastoma cell. But the problem is that GFAP is a common marker for astrocytes and glioblastoma, but it's not in the gene list here. However, the absence might not be conclusive as the list is the top expressed genes. If the cell is a glioblastoma cell with mesenchymal features, then the answer would be glioblastoma cell (mesenchymal subtype). But how to confirm?\n\nComparing the genes: Mesenchymal subtype markers include CD44, MET, STAT3, etc., which are not listed here. The genes present here include many ribosomal proteins and mitochondrial genes, which are more related to general metabolism. The MHC class II genes could be part of the mesenchymal signature. For example, some studies show that mesenchymal glioblastoma cells exhibit upregulation of genes like CD74, HLA-DRA, and CCL4. So this might be a mesenchymal glioblastoma cell. \n\nIf that's the case, then the cell type is glioblastoma cell, mesenchymal subtype. However, the question is to identify the cell type, not the tumor subtype. But if the tumor cell itself is adopting a macrophage-like phenotype, it's still a neoplastic cell. However, given that the genes include many typical macrophage/microglia markers, but also the disease is glioblastoma, it's a bit conflicting. \n\nAlternatively, the answer expects \"tumor-associated macrophage\" as the cell type. But the metadata says the tissue is brain and disease is glioblastoma, which can have both tumor cells and infiltrating immune cells. So if this is an immune cell within the tumor, then it's a macrophage/microglia. If it's a tumor cell, then it's a glioblastoma cell with macrophage-like features. \n\nGiven the ambiguity, but considering that the top genes include FTL, FOS, SAT1, and the immune-related genes, I think the cell is more likely a tumor-associated macrophage/microglia. Therefore, the cell type would be microglia or macrophage. Since the tissue is brain, microglia are the resident macrophages, so \"microglia\" is more precise. Hence, the answer is likely microglia, but I need to confirm. \n\nWait, looking up some markers: CD74 and HLA-DRA are expressed in antigen-presenting cells. In the brain, that's microglia. C1QA and C1QB are part of the complement system produced by microglia. APOE is also produced by microglia. So combining these, the cell is a microglial cell. Therefore, the answer is microglia. However, in the context of a tumor, they are tumor-associated microglia. But as per standard cell types, the answer is \"microglia\".",
         "The cell exhibits high expression of genes associated with myeloid lineage and antigen presentation (e.g., **CD74**, **HLA-DRA**, **C1QA/B**, **FTL**, **FTH1**, **APOE**), alongside stress-response (e.g., **FOS**, **HSPA1A**) and ribosomal proteins. These markers align with activated microglia or infiltrating macrophages, which are prominent in glioblastoma as tumor-associated macrophages/microglia (TAMs). The absence of astrocytic markers (e.g., GFAP) and the presence of complement/immune-related genes suggest a myeloid identity rather than neoplastic glioma cells. Given the brain tissue context, the cell is most likely a **microglia** population within the glioblastoma microenvironment.\n\nCell type: microglia",
         "411",
         "3125",
         "3289"
        ],
        [
         "229",
         "208",
         "3968085",
         "CD14-low, CD16-positive monocyte",
         "You are an expert in single-cell biology.\n\nBelow is metadata for one cell, followed by a list of its genes in descending expression:\nTissue: blood\nDisease: normal\nDevelopment stage: 45-year-old human stage\nGenes: FTL CD74 ACTB B2M MT-CO1 FTH1 TMSB4X MT-CO2 FOS RPL10 EEF1A1 TMSB10 RPL41 HLA-DPA1 TYROBP RPS27 RPS19 HLA-DRA RPL34 HLA-B RPL28 RPS24 TPT1 RPL19 RPL30 MT-CO3 MT-CYB RPL32 MT-ND1 HLA-C RPS3A RPS18 DUSP1 HLA-DPB1 RPS15A RPS8 RPL11 RPS28 COTL1 RPLP1 HLA-DRB5 SAT1 AIF1 RPS12 HLA-A MT-ND3 RPS13 PFN1 RPS2 RPS15 FAU RPS27A RPL29 RPS23 RPL26 RPL37 RPL8 RPS4X JUNB RPL18A MT-ATP6 RPL39 RPL18 RPS14 SH3BGRL3 LST1 MT-ATP8 CTSS RPL13 MYL6 S100A11 CYBA IER2 RPS6 CST3 RPS9 RPL14 ATP5F1E RPL12 IFI30 MT-ND5 RPL17 UBC HLA-DRB1 PTMA RPS21 RPS3 RNASEK RPLP0 MT-ND2 MT2A MT-ND4 RPLP2 TXNIP IFITM3 MT-ND4L RPL6 H3-3B RPL24 RPL36\n\nPlease identify what cell type this might be, as granular and accurate as possible.\nKeep your response concise and clear.\nAt the end of your response, strictly place the final lines in this format:\n\nCell type: X\n",
         "Okay, let's see. The metadata says this cell is from blood, normal, and a 45-year-old human. The genes listed are in descending order of expression. I need to figure out the cell type based on the high-expression genes.\n\nFirst, looking at the top genes: FTL, CD74, ACTB, B2M, MT-CO1, FTH1, TMSB4X. FTL and FTH1 are involved in iron metabolism, which makes me think of cells that handle iron storage, like macrophages or monocytes. CD74 is associated with MHC class II molecules, so maybe antigen-presenting cells. B2M is part of MHC class I, which is more ubiquitous, but CD74's presence might indicate MHC II activity. ACTB is a cytoskeletal gene, common in many cells.\n\nThen there's MT-CO1, which is mitochondrial. High mitochondrial genes can indicate cells with active metabolism, but in blood cells, maybe activated cells or certain immune cells. TMSB4X is thymosin beta-4, involved in actin sequestration, seen in immune cells.\n\nLooking further down, genes like HLA-DPA1, HLA-DRA, HLA-DRB1 are all MHC class II genes. These are strongly expressed in antigen-presenting cells like dendritic cells, B cells, or monocytes/macrophages. Also, TYROBP is a signaling molecule in myeloid cells. CST3 is cathepsin C, found in lysosomes, again pointing towards myeloid lineage.\n\nRPL and RPS genes are ribosomal proteins, which are usually highly expressed in cells with active protein synthesis. But since many cells have these, maybe not too specific. However, combined with the MHC II and lysosomal genes, it leans towards a professional antigen-presenting cell.\n\nLooking for markers specific to certain cells: AIF1 (allograft inflammatory factor 1) is expressed in macrophages and monocytes. CTSS (cathepsin S) is also in antigen-presenting cells. S100A11 is a calcium-binding protein found in monocytes/macrophages.\n\nPutting this together: High MHC class II (HLA-D genes), lysosomal enzymes (CTSS, CST3), iron-related genes (FTL, FTH1), and markers like AIF1 and CD74. This combination is characteristic of monocytes or macrophages. Since it's from blood, more likely a monocyte. But could it be a dendritic cell? Dendritic cells also have high MHC II, but they might express other markers like CD1c or CD141, which aren't listed here. Monocytes often express CD14 or CD16, but gene markers here don't show those. However, the presence of CD74, TYROBP, and AIF1 points towards classical monocytes. Alternatively, maybe a dendritic cell subset that's in blood. But given the common markers here, the most probable is a monocyte. Wait, some of the genes like FTL and FTH1 are also highly expressed in macrophages, but since it's blood, it's more likely a monocyte. Alternatively, could it be a myeloid dendritic cell?\n\nWait, another angle: CD74 is part of the invariant chain of MHC II, so cells that are actively producing MHC II, like dendritic cells, B cells, or monocytes. B cells would have CD19, CD20, which aren't here. Monocytes in blood can express CD14, but maybe the genes here don't include CD14. But the presence of genes like HLA-DPA1, DRA, DRB1, and TYROBP (which is part of the DAP12 signaling complex in myeloid cells) supports monocyte lineage. Also, CST3 (cystatin C) is expressed in monocytes.\n\nSo putting it all together: High expression of MHC class II genes, lysosomal proteins, monocyte/macrophage markers (AIF1, CST3, CD74, TYROBP), and iron metabolism genes. This cell is most likely a classical monocyte. Alternatively, a macrophage, but since the tissue is blood, it's more likely a monocyte. However, in some contexts, macrophages can be present in blood, but typically monocytes are the circulating precursors. So the answer is probably a classical monocyte.",
         "This cell exhibits high expression of genes associated with antigen presentation (CD74, HLA-DPA1, HLA-DRA, HLA-DRB1), lysosomal activity (CTSS, CST3), and myeloid lineage markers (TYROBP, AIF1). These features, combined with elevated ribosomal (RPL/RPS) and mitochondrial (MT-CO1, MT-ND1) genes, align with a metabolically active myeloid cell. The prominence of MHC class II machinery and monocyte/macrophage markers (FTL, FTH1, S100A11) suggests a classical monocyte, which circulates in blood and maintains antigen-processing functions.\n\nCell type: Classical Monocyte (CD14++ CD16- human monocyte)",
         "422",
         "874",
         "1026"
        ],
        [
         "233",
         "212",
         "38937500",
         "CD14-positive monocyte",
         "You are an expert in single-cell biology.\n\nBelow is metadata for one cell, followed by a list of its genes in descending expression:\nTissue: blood\nDisease: COVID-19\nDevelopment stage: fifth decade human stage\nGenes: FTL FTH1 B2M ACTB TMSB10 CD74 HLA-B IFITM3 IFI30 S100A4 TMSB4X FOS S100A9 NFKBIA EEF1A1 S100A6 RPL28 CST3 S100A8 TYROBP RPL10 LYZ PSAP HLA-DRB1 SRGN SH3BGRL3 FCN1 HLA-C HLA-DRA LGALS1 RPLP1 RPS15 GAPDH HLA-A RPS13 JUNB RPS8 TPT1 RPL18A RPL19 RPL30 HLA-DRB5 RPL8 RPL13 RPS19 CD52 RPS3 FAU GABARAP PFN1 RPS12 SERPINA1 RPS18 AIF1 CFL1 RPL11 GADD45B RPL26 S100A10 DUSP1 EMP3 APOBEC3A FCER1G ZFP36 RPL14 SAT1 IFITM2 RPL32 HLA-DQB1 ACTG1 RPS15A RPS28 EIF1 RPS23 UBC HLA-DPA1 ID2 MT-CO1 RPL29 KLF6 VIM CTSS MYL6 YBX1 RPS9 RPL7A RACK1 RPL12 RPS24 TIMP1 PFDN5 SERF2 PTMA NPC2 LST1 RPS26 RPS4X ATP5F1E RPS3A OAZ1\n\nPlease identify what cell type this might be, as granular and accurate as possible.\nKeep your response concise and clear.\nAt the end of your response, strictly place the final lines in this format:\n\nCell type: X\n",
         "Okay, let's try to figure out the cell type here. The metadata says it's from blood, COVID-19, and a fifth decade human. The genes listed are in descending expression. First, I'll look for markers that are commonly associated with specific immune cells.\n\nStarting with the top genes: FTL and FTH1 are involved in iron metabolism. High expression might indicate cells that handle iron, like macrophages or monocytes. B2M is part of MHC class I, present in all nucleated cells, so not too specific. ACTB is actin, a structural protein, so again, not cell-specific.\n\nCD74 and HLA genes (HLA-B, HLA-DRB1, HLA-C, HLA-DRA, etc.) are MHC class II markers, which are typically found in antigen-presenting cells like monocytes, dendritic cells, or B cells. IFITM3 and IFI30 are interferon-induced proteins, which makes sense in the context of COVID-19, as viral infections trigger interferon responses. This could point towards myeloid cells like monocytes or macrophages responding to infection.\n\nLooking at S100A4, S100A6, S100A8, S100A9, S100A10: these S100 proteins are often found in neutrophils and monocytes. However, some S100s are also in dendritic cells. CST3 (cystatin C) is expressed in monocytes and macrophages. LYZ (lysozyme) is a marker for myeloid cells as well—monocytes, macrophages, neutrophils.\n\nLooking further down, genes like FCER1G and TYROBP are involved in signaling in myeloid cells. CST3, LYZ, and HLA-DR genes suggest antigen-presenting function. CD52 is present in lymphocytes and monocytes, but combined with other markers, monocytes seem more likely.\n\nIn COVID-19, there's often an expansion of inflammatory monocytes. The presence of genes like FCN1 (Ficolin-1) is a strong marker for classical monocytes. Let me check that. Yes, FCN1 is a specific marker for classical monocytes (CD14++ CD16-). Other markers like AIF1 (Iba1) are also expressed in monocytes/macrophages.\n\nAlso, genes like RPL and RPS are ribosomal proteins, which are highly expressed in many cells, so not specific. But combining with the other markers, it's pointing towards a monocyte. The presence of HLA-DRB1, HLA-DRA (MHC II) supports that they are antigen-presenting, which monocytes do. \n\nSo putting this together: high expression of FCN1, HLA-DR genes, S100 proteins, LYZ, CST3, CD74, IFITM3. All these are indicative of classical monocytes, especially with FCN1. In COVID-19, monocytes are known to be activated and contribute to the immune response. Therefore, the cell type is likely a classical monocyte.",
         "The cell exhibits markers of myeloid lineage (LYZ, CST3, FCER1G) with high MHC class II activity (CD74, HLA-DRB1, HLA-DRA) and interferon response genes (IFITM3, IFI30), consistent with antigen-presenting function. FCN1 and S100A family genes strongly indicate a classical monocyte subset. COVID-19 context aligns with inflammatory monocyte activation. Ribosomal proteins (RPL/RPS) reflect high translational activity typical of activated immune cells.\n\nCell type: Classical monocyte (FCN1+ CD14++ CD16-)",
         "414",
         "598",
         "723"
        ],
        [
         "251",
         "229",
         "25484772",
         "CD8-positive, alpha-beta T cell",
         "You are an expert in single-cell biology.\n\nBelow is metadata for one cell, followed by a list of its genes in descending expression:\nTissue: lung\nDisease: lung adenocarcinoma\nDevelopment stage: 68-year-old human stage\nGenes: B2M TMSB4X JUN RPS19 RPLP2 RPL41 RPS27 ACTB TMSB10 RPLP1 RPS23 RPS25 RPS18 SH3BGRL3 CD2 HLA-C RPL13A RPS27A RPL11 HLA-B RPS15A RPL10 RPL39 RPL37 RPS3A RPS28 RPL34 RPL21 RPL35A RPS17 PFN1 RPL36 HLA-A RPS20 RPL13 RPS12 RPL12 S100A4 RPL37A RPL9 RPL23A RPS4X RPS29 RPL27A RPS16 RPL28 RPL17 RPL29 RPS14 RPL7 NACA HLA-F RPL30 RPL19 ARHGDIB CFL1 SAT1 RPS6 FAU RPL3 HSPE1 RPS9 MYL12A CD63 RPL8 RPL18A RPL38 RPL15 RPS8 RPS15 EIF1 HSPB1 KLRB1 EEF1A1 PSMA7 MIF RPS3 ACTG1 RPS4Y1 COMMD6 GIMAP4 RPL32 CKLF PTMA DHRS7 RPL6 OAZ1 PTGES3 MYL6 LTB GZMA CD3D VIM LAPTM5 RPS24 ID2 RPL7A SLC25A6 RPLP0 ALOX5AP\n\nPlease identify what cell type this might be, as granular and accurate as possible.\nKeep your response concise and clear.\nAt the end of your response, strictly place the final lines in this format:\n\nCell type: X\n",
         "Okay, let's tackle this. The cell is from a lung adenocarcinoma patient, a 68-year-old human. The genes listed are mostly ribosomal proteins (RPL, RPS), which are typically high in cells with active protein synthesis, like cancer cells. But I need to find the specific cell type.\n\nLooking at other genes: ACTB and TMSB4X are involved in cytoskeleton, common in many cells. HLA genes (HLA-A, HLA-B, HLA-C) suggest antigen presentation, pointing towards immune cells. CD3D and CD2 are T-cell markers. GZMA is found in cytotoxic T cells and NK cells. KLRB1 is a marker for NK cells and some T cells. \n\nWait, there's also CD63 and VIM, which are more general. But the combination of CD3D (T-cell receptor), GZMA (cytolytic activity), and KLRB1 (NK cell marker) might indicate a cytotoxic T cell or NK cell. However, CD3D is specific for T cells. But in the context of lung adenocarcinoma, tumor-infiltrating lymphocytes (TILs) are common. TILs include T cells, especially CD8+ cytotoxic T cells. \n\nAdditionally, genes like B2M (beta-2-microglobulin) part of MHC class I, which interacts with T cells. So putting this together: high ribosomal proteins (active cells), T cell markers (CD3D), cytotoxic markers (GZMA), MHC class I genes. This points towards a cytotoxic T cell, specifically CD8+ T cells, which are often found infiltrating tumors. The presence of HLA genes also aligns with T cells presenting antigens. \n\nBut wait, some genes like S100A4 and VIM are associated with epithelial cells or fibroblasts, but in this case, the tumor is adenocarcinoma (epithelial origin), but the cell in question is likely a T cell infiltrating the tumor. So the cell type is a tumor-infiltrating cytotoxic CD8+ T cell.",
         "The cell exhibits high ribosomal protein (RPL/RPS) and HLA gene expression, indicative of active protein synthesis and antigen presentation. Key immune markers (CD3D, GZMA, KLRB1) and cytotoxic T-cell-associated genes (GZMA, CD3D) suggest a tumor-infiltrating cytotoxic T lymphocyte. Elevated HLA class I (HLA-A, HLA-B, HLA-C) aligns with T-cell-mediated antitumor activity. The absence of epithelial (e.g., EPCAM) or stromal markers supports an immune lineage.\n\nCell type: Tumor-infiltrating cytotoxic CD8+ T cell",
         "420",
         "417",
         "546"
        ],
        [
         "275",
         "13",
         "34419233",
         "naive thymus-derived CD4-positive, alpha-beta T cell",
         "You are an expert in single-cell biology.\n\nBelow is metadata for one cell, followed by a list of its genes in descending expression:\nTissue: blood\nDisease: normal\nDevelopment stage: 65-year-old human stage\nGenes: RPS27 EEF1A1 RPL13 RPL10 RPL41 RPL13A RPS29 RPS18 RPS12 RPL32 RPL34 RPLP2 B2M RPS6 RPS27A RPS4X RPS15A RPS14 RPLP1 RPS28 RPS2 RPS3 RPL37 RPL27A RPL7 RPL23A RPS23 RPS8 RPL30 RPL11 TMSB4X RPS3A RPL21 RPL19 TPT1 RPL9 RPS17 RPL3 MT-CO1 RPS16 RPS25 RPL28 RPL31 RPS19 RPL18A RPS13 TMSB10 RPL12 RPS15 RPL39 RPL26 FAU RPL6 MT-CO3 RPL17 RPL10A MT-CO2 RPL36 RPL37A RPL35A RPL15 UBA52 RPL18 RPL5 MT-ND2 RPS21 RPL27 RPL8 MT-ND1 RPS20 RPL4 RPS7 RPL14 RPS5 RPL38 RPSA EEF1G RPS9 RPS24 RPL35 RPL36A MT-ND4 RPL29 RACK1 MT-ATP6 RPL7A NACA RPL22 MT-CYB RPL24 RPS11 MT-ND3 RPL23 COX4I1 RPS26 EEF1D LTB EEF1B2 FTL PFDN5\n\nPlease identify what cell type this might be, as granular and accurate as possible.\nKeep your response concise and clear.\nAt the end of your response, strictly place the final lines in this format:\n\nCell type: X\n",
         "Okay, let me try to figure out the cell type here. The metadata says it's from blood, disease is normal, and the development stage is a 65-year-old human. The genes listed are in descending order of expression.\n\nFirst, looking at the genes, a lot of them start with RPS and RPL, which I remember are ribosomal proteins. High expression of ribosomal genes usually suggests a cell that's actively synthesizing proteins. Then there are some mitochondrial genes like MT-CO1, MT-CO2, MT-ND2, etc. Those are part of the electron transport chain, so maybe the cell has high energy demands.\n\nLooking further, I see B2M (beta-2-microglobulin), which is part of MHC class I molecules. That's present on all nucleated cells, so not super specific. There's TMSB4X and TMSB10, which are thymosin beta proteins involved in actin sequestration. These are often found in cells that need to remodel their cytoskeleton, like immune cells. \n\nThen there's EEF1A1, EEF1G, EEF1D, EEF1B2—these are elongation factors for translation, again supporting active protein synthesis. Also, FTL (ferritin light chain) is involved in iron storage. PFDN5 is a prefoldin subunit, which helps in protein folding.\n\nNot seeing markers for specific immune cells like CD3 (T cells), CD19 (B cells), or CD14 (monocytes). The lack of these might suggest a more generic cell type. High ribosomal and mitochondrial genes could point to a progenitor cell or a cell in a highly active state. But considering it's blood and normal, maybe a red blood cell precursor? But RBCs lose their nuclei, so they wouldn't have ribosomal proteins. Platelets also don't have nuclei. \n\nWait, but in the list, there's MT-CO1 and other mitochondrial genes. If the cell is mature RBC, mitochondria are absent. So maybe a reticulocyte? But reticulocytes still have some ribosomes. However, they are enucleated. Alternatively, maybe a nucleated cell type in the blood. \n\nAlternatively, could this be a lymphocyte? They have ribosomes and are nucleated. But then again, specific markers like CD3 or CD19 are missing. Or maybe a myeloid cell like a monocyte or neutrophil. But again, specific markers aren't listed here. \n\nWait, there's LTB (lymphotoxin beta), which is involved in immune response, possibly in B cells or T cells. But I'm not sure. Also, COX4I1 is cytochrome c oxidase subunit, part of the mitochondrial complex. \n\nAnother angle: the presence of ribosomal proteins is so dominant. Maybe this is a hematopoietic stem cell or progenitor cell. But usually, those would have other markers like CD34. Hmm, not mentioned here. \n\nAlternatively, platelets have lots of mitochondria and are involved in clotting, but they are anucleate. However, their precursors, megakaryocytes, do have nuclei. But megakaryocytes are rare in blood. \n\nWait, there's FTL (ferritin light chain), which is involved in iron storage. High in reticulocytes maybe? But reticulocytes are RBC precursors. But again, RBCs lose nuclei. \n\nAlternatively, could this be a stressed cell undergoing lots of protein production? Maybe a plasma cell? Plasma cells are B cells that secrete antibodies, so they have lots of ribosomes and ER. But plasma cells would have markers like CD138 (SDC1) or XBP1. Not seeing those here. \n\nLooking at the list again: RACK1 is involved in various signaling pathways. NACA is a nascent polypeptide-associated complex, which is part of protein synthesis. \n\nHmm, the combination of high ribosomal proteins, mitochondrial genes, and lack of lineage-specific markers might point towards a progenitor cell. But without specific markers, it's tricky. \n\nAlternatively, given that the sample is from blood, perhaps a reticulocyte? But reticulocytes are not nucleated. Wait, reticulocytes do have residual ribosomal RNA, which is why they're called reticulocytes. They still have some ribosomes for hemoglobin synthesis but no nucleus. But then, the presence of nuclear genes (since all the RPS and RPL genes are part of the ribosome, which in eukaryotes are transcribed in the nucleolus) would require a nucleus. So if the cell has a nucleus, it's not a reticulocyte. \n\nSo maybe a nucleated red blood cell? But in humans, normoblasts (erythroblasts) are nucleated precursors in bone marrow, not typically in peripheral blood unless there's some pathology. But the disease here is normal. So that's unlikely. \n\nAlternatively, a lymphocyte. Lymphocytes have nuclei and ribosomes. But again, specific markers are missing. The presence of B2M suggests MHC I, which is on all nucleated cells, so that's not helpful. \n\nWait, TMSB4X is thymosin beta 4 X-linked. Thymosin beta 4 is involved in actin regulation. High in T cells? Or other immune cells. \n\nAlternatively, maybe a platelet, but platelets are not nucleated. So they wouldn't have RPL genes. So not platelets. \n\nAnother thought: maybe this is a sample with high ribosomal protein expression due to technical reasons (like high RNA content), but assuming the data is correct. \n\nAlternatively, the cell type could be a proerythroblast or other erythroid precursor. Those cells are in bone marrow and have high ribosome production for hemoglobin. But again, in blood, unless there's extramedullary hematopoiesis, which isn't the case here. \n\nAlternatively, a stress erythroid population? But in normal blood, not likely. \n\nWait, the user said it's blood. So peripheral blood. The nucleated cells in peripheral blood are leukocytes: lymphocytes, monocytes, neutrophils, eosinophils, basophils. \n\nSo, looking for which of these have high ribosomal and mitochondrial content. Activated lymphocytes, maybe? When T cells are activated, they upregulate protein synthesis. But again, specific markers are missing. \n\nAlternatively, monocytes have more mitochondria compared to lymphocytes. But again, not sure. \n\nLooking for other genes: FAU is a ribosomal protein. LTB is lymphotoxin beta, which is produced by lymphocytes. But I don't see other definitive markers. \n\nMaybe this is a memory T cell or NK cell? Not sure. \n\nAlternatively, given the high expression of ribosomal proteins and mitochondrial genes, perhaps this is a cell with high metabolic activity, like a plasmacytoid dendritic cell or a activated B cell. \n\nAlternatively, the cell type might be a \"ribosome-rich\" cell type. But that's not a standard term. \n\nWait, another angle: in single-cell RNA-seq, high ribosomal protein expression is sometimes seen in certain cell types, but it can also be a sign of stress or a technical artifact. But assuming the data is accurate, perhaps this is a proliferating cell, as ribosome biogenesis is high during cell division. But in peripheral blood, most cells are not proliferating, except maybe some activated lymphocytes. \n\nAlternatively, hematopoietic stem cells (HSCs) in the blood? But HSCs are rare in peripheral blood and typically have different markers. \n\nWait, there's MT- genes (mitochondrial). High mitochondrial content suggests a cell that relies on oxidative phosphorylation, like monocytes or memory T cells, as opposed to glycolytic cells like neutrophils or activated T cells. \n\nPutting this all together: high ribosomal and mitochondrial genes, from blood, normal. Maybe a lymphocyte subset with high protein synthesis. Alternatively, a monocyte. \n\nBut without specific markers, it's hard. But given the data, perhaps the best guess is a naive T cell or a B cell, but not sure. Wait, there's LTB which is part of the TNF family, produced by lymphocytes. But I'm not sure. \n\nAlternatively, given that B2M is present, and other genes, but no other markers, maybe it's a generic nucleated blood cell, but that's too vague. \n\nWait, another approach: looking up some of these genes. RACK1 is involved in translation and is found in many cells. EEF1A1 is a translation elongation factor. High expression of these plus ribosomal proteins suggests active translation. \n\nIn peripheral blood, the cell types with high translation activity could be activated lymphocytes, but again, specific markers are missing. \n\nAlternatively, maybe a platelet precursor, but megakaryocytes are in bone marrow. \n\nAlternatively, considering the age (65 years), maybe some age-related changes, but not sure. \n\nWait, another gene: FTL (ferritin light chain). High in macrophages, which store iron. But macrophages are not typically in blood; monocytes are. \n\nAlternatively, could this be a dendritic cell? Not sure. \n\nHmm. Maybe the answer is a reticulocyte, but they are enucleated. Wait, but the presence of RPL and RPS genes would require nucleus. So perhaps not. \n\nAlternatively, maybe a nucleated cell that's highly active in protein synthesis. Given that, perhaps a plasma cell. But plasma cells are rare in blood, usually found in bone marrow or lymphoid tissues. But they do sometimes circulate. Plasma cells have high ER and ribosomes. However, the genes listed don't include typical plasma cell markers like SDC1 (CD138), PRDM1 (Blimp1), or XBP1. So maybe not. \n\nAlternatively, a memory B cell? Not sure. \n\nAlternatively, the cell type is a \"progenitor cell,\" but without specific markers, it's hard to confirm. \n\nAlternatively, maybe an erythroblast, but they are not typically in peripheral blood. \n\nWait, the presence of mitochondrial genes like MT-CO1, MT-ND2, etc., suggests active oxidative phosphorylation. So maybe a cell type that relies on OXPHOS. Monocytes and memory T cells are known for that. Neutrophils rely more on glycolysis. \n\nSo, if it's a monocyte, they have high mitochondrial content. But monocytes also express CD14, which isn't in the gene list. But maybe the sample doesn't include that gene. Similarly, if it's a CD16+ monocyte subset, but again, not sure. \n\nAlternatively, a dendritic cell. But again, no specific markers. \n\nAlternatively, a NK cell. NK cells have cytotoxic functions and might have high ribosomal content. But again, specific markers like NCAM1 (CD56) aren't listed. \n\nThis is tricky. Without specific lineage markers, but with high ribosome and mitochondria, perhaps the best guess is a monocyte. But I'm not entirely certain. \n\nWait, another angle: platelets are not nucleated, so their RNA is mostly mitochondrial and some residual mRNA. But platelets do have mitochondrial genes. However, they lack nuclear genes. But the gene list here includes RPS/RPL, which are nuclear-encoded. So platelets would have mitochondrial genes but not the nuclear-encoded ribosomal proteins in their transcriptome because they don't have nuclei. Therefore, this cell must be nucleated, so it's a leukocyte. \n\nSo among leukocytes, the ones with high mitochondrial content are monocytes and lymphocytes (some subsets). If the genes don't include monocyte-specific markers (like CD14, S100A8/9) or lymphocyte markers (CD3, CD19), perhaps it's a generic lymphocyte. \n\nBut the question asks for as granular as possible. Maybe the answer is a CD4+ T cell? But without CD3 or CD4, not sure. \n\nAlternatively, given that TMSB4X is highly expressed in T cells, perhaps this is a T cell. TMSB4X (Thymosin beta-4) is involved in actin polymerization, important for T cell motility. \n\nAlso, B2M is part of MHC I, present on all nucleated cells. \n\nSo combining TMSB4X, high ribosomal and mitochondrial genes, maybe a T cell. But again, without CD3, it's uncertain. \n\nAlternatively, given that in some studies, ribosomal protein genes are highly expressed in certain T cell subsets, like naive T cells, which have lower activation but maintain readiness for protein synthesis upon activation. \n\nAlternatively, considering that the person is 65 years old, maybe a memory T cell. \n\nBut I'm not entirely sure. The most parsimonious answer, given the high ribosomal and mitochondrial genes in a nucleated blood cell, might be a T lymphocyte. However, without specific markers, it's a bit of a stretch. \n\nAlternatively, given the lack of specific markers and the high ribosomal proteins, which are often seen in cells with high translational activity, maybe the cell is a hematopoietic stem or progenitor cell. But again, without CD34 or other markers, this is speculative. \n\nWait, another gene: NACA (Nascent polypeptide-associated complex alpha subunit). Involved in protein translocation. Highly expressed in cells with active protein synthesis. \n\nAnother gene: RACK1 is involved in various processes, including translation and cell migration. \n\nPutting all together, maybe a naive T cell, which maintains high ribosomal content for rapid activation. \n\nAlternatively, considering that the genes listed include many ribosomal proteins but no immunoglobulin genes (which would suggest B cells), and no myeloid markers, perhaps a T cell. \n\nIn some references, naive T cells have higher expression of ribosomal proteins compared to memory T cells. \n\nGiven all this, the most likely cell type is a T cell, possibly a naive CD4+ T cell.",
         "The cell exhibits high expression of ribosomal (RPS/RPL) and mitochondrial (MT-) genes, indicative of active protein synthesis and oxidative metabolism. It lacks lineage-specific markers for myeloid, B, or NK cells but expresses thymosin beta proteins (TMSB4X, TMSB10) and B2M (MHC-I), consistent with a lymphoid identity. The absence of activation or differentiation markers, combined with high ribosomal content, points to a quiescent lymphocyte maintaining translational readiness. Among lymphocytes, naive T cells are known to retain high ribosomal RNA for rapid activation, aligning with the observed profile.\n\nCell type: Naive CD4+ T cell",
         "427",
         "2838",
         "2973"
        ],
        [
         "278",
         "254",
         "25463332",
         "macrophage",
         "You are an expert in single-cell biology.\n\nBelow is metadata for one cell, followed by a list of its genes in descending expression:\nTissue: lung\nDisease: lung adenocarcinoma\nDevelopment stage: 68-year-old human stage\nGenes: FTL B2M TMSB4X CD74 ACTB FTH1 C1QB HLA-DRA C1QA HLA-DRB1 TMSB10 C1QC HLA-B CST3 HLA-A CYBA CTSD FCER1G CD63 GAPDH HLA-DPB1 EEF1A1 S100A11 LGALS1 TYROBP RPLP1 RPL10 OAZ1 PSAP ITM2B CTSB PTMA RPL28 TPT1 HLA-DPA1 S100A6 RPS14 LAPTM5 NPC2 RPL13 UBA52 AIF1 HLA-DQA1 RPL27A RPS8 ACTG1 RNASE1 RPS27A S100A4 RPL8 VIM PFN1 FCGRT RPS19 RPL13A HLA-DMA RPS9 MYL6 RPL11 RPS18 RPL18 RPLP2 IFI30 ANXA2 RPL39 ARPC3 UBC CCL2 PFDN5 RPL29 ATP6V0C CAPG MS4A6A TMEM176B SAP18 TYMP SERF2 HSP90AA1 RPS3A ATP6V1F FAU MS4A7 UBB SDCBP PRDX1 RPL10A CALR RPL41 HSPA1A RPL23A HLA-C RPL35 SH3BGRL3 JUN RPS24 RPS15 RPL7A BLOC1S1 GABARAP IFI27\n\nPlease identify what cell type this might be, as granular and accurate as possible.\nKeep your response concise and clear.\nAt the end of your response, strictly place the final lines in this format:\n\nCell type: X\n",
         "Alright, let's tackle this. So, the metadata says the cell is from a lung adenocarcinoma patient, 68 years old. The genes listed are in descending order of expression. Let me start by recalling common cell types in the lung and markers associated with them.\n\nFirst, lung adenocarcinoma is a type of non-small cell lung cancer, often originating from epithelial cells, like alveolar type II cells. But the genes here might indicate immune cells since tumors often have infiltrating immune cells. Let's look at the top genes: FTL, B2M, TMSB4X, CD74, ACTB, FTH1, C1QB, HLA-DRA, C1QA, HLA-DRB1. \n\nFTL (Ferritin Light Chain) and FTH1 (Ferritin Heavy Chain) are involved in iron storage and are expressed in various cells, including macrophages. B2M (Beta-2-microglobulin) is part of MHC class I molecules, present on all nucleated cells, but high expression might be in immune cells. CD74 is a marker for antigen-presenting cells, like macrophages and dendritic cells. HLA-DRA and HLA-DRB1 are part of MHC class II, which is typically expressed in antigen-presenting cells, suggesting this cell is involved in presenting antigens.\n\nLooking at C1QB, C1QA, C1QC—these are components of the complement system, often produced by myeloid cells like macrophages. TYROBP is a signaling molecule in natural killer cells and myeloid cells. CST3 (Cystatin C) is expressed in macrophages. AIF1 (Allograft Inflammatory Factor 1) is associated with macrophages/microglia. FCER1G is part of the Fc epsilon receptor, found in macrophages, monocytes, dendritic cells. LAPTM5 is linked to lysosomal function in macrophages. MS4A6A and MS4A7 are MS4A family members, often in monocytes/macrophages.\n\nOther genes like HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DMA are MHC class II genes, reinforcing antigen-presenting function. There's also VIM (Vimentin), which is a mesenchymal marker but can be found in macrophages. CD63 is a lysosomal marker, common in macrophages. CCL2 is a chemokine produced by macrophages. \n\nSo putting this together: High expression of MHC class II genes, complement components, CD74, lysosomal proteins, and other macrophage markers. The cell is likely a tumor-associated macrophage. In lung adenocarcinoma, macrophages can be a major component of the tumor microenvironment. The presence of these specific markers points towards a myeloid lineage, specifically a macrophage subtype. Since it's within a tumor, it might be a tumor-associated macrophage (TAM), which are often M2 polarized. The markers don't suggest dendritic cells (lack of specific markers like CD1c or CD141), and T cells would have different markers like CD3. The absence of epithelial markers like EPCAM or surfactant proteins (e.g., SFTPC for type II cells) makes epithelial origin less likely.\n\nTherefore, the cell type is most likely a tumor-associated macrophage, possibly of the alveolar macrophage lineage given the lung tissue origin.",
         "The cell exhibits high expression of MHC class II genes (HLA-DRA, HLA-DRB1, HLA-DPA1), lysosomal/endosomal markers (CD74, CST3, CTSD), complement components (C1QA/B/C), and myeloid-associated genes (TYROBP, FCER1G, AIF1, LAPTM5). These features, combined with the absence of epithelial or surfactant-associated markers, strongly align with a myeloid lineage. The prominence of antigen presentation machinery and macrophage-specific markers (e.g., CD74, MS4A6A, C1Q genes) indicates an antigen-presenting myeloid cell within the tumor microenvironment.\n\nCell type: Tumor-associated macrophage (likely alveolar macrophage-derived)",
         "421",
         "664",
         "813"
        ],
        [
         "296",
         "272",
         "44997243",
         "B cell",
         "You are an expert in single-cell biology.\n\nBelow is metadata for one cell, followed by a list of its genes in descending expression:\nTissue: blood\nDisease: COVID-19\nDevelopment stage: 55-year-old human stage\nGenes: RPL41 RPS27 CD74 RPL10 EEF1A1 RPS12 RPS18 RPL13 RPS28 RPS8 RPLP1 RPS3A RPL37 RPL32 RPL30 RPL19 MTRNR2L12 RPL34 RPL18A HLA-DRA RPS23 RPL39 RPS21 RPL8 RPS27A RPL11 RPS19 B2M RPS13 RPS15A RPS3 RPS6 RPLP2 MT-CO2 RACK1 RPL21 RPL10A RPS24 RPS15 RPL18 RPL14 RPL3 RPS16 RPL35A RPS4X RPS7 MT-CO1 RPL28 TMSB4X FAU RPS5 RPL12 RPS25 RPS29 RPL36 RPL13A RPS2 TPT1 RPS14 RPL9 RPL29 RPL26 RPL15 RPS9 RPSA RPLP0 RPL37A RPL35 DUSP1 HLA-DPA1 RPL7A MT-CO3 MT-ATP8 RPL23A RPS11 RPL22 FTL CD52 RPL4 NACA RPS20 MT-ND4L MT-CYB HLA-B MT-ND3 RPL7 ACTB TMSB10 CD37 UBA52 EEF1B2 EIF1 RPL27 PTMA MT-ATP6 RPL6 HINT1 RPL5 HLA-E RPL24\n\nPlease identify what cell type this might be, as granular and accurate as possible.\nKeep your response concise and clear.\nAt the end of your response, strictly place the final lines in this format:\n\nCell type: X\n",
         "Okay, let's try to figure out the cell type here. The metadata says it's from blood, COVID-19, and a 55-year-old human. The gene list is key. Looking at the genes, I notice a lot of ribosomal proteins like RPL and RPS genes. Those are usually involved in protein synthesis, which is common in many cells, but maybe more so in highly active ones.\n\nAlso, there's CD74 and HLA-DRA, which are MHC class II related. MHC II is typically expressed in antigen-presenting cells like B cells, dendritic cells, or monocytes. But let's check other markers. B2M is beta-2-microglobulin, part of MHC I, so that's present in most nucleated cells. HLA-DPA1 and HLA-DRA again point towards MHC II. Then there's CD52, which is found on lymphocytes, including T and B cells, but also on monocytes. \n\nLooking for more specific markers, CD37 is a B-cell marker. But I don't see CD19 or CD20 here, which are more definitive for B cells. There's FAU, RACK1, which are more general. TMSB4X and TMSB10 are thymosin beta proteins, involved in actin regulation, found in various cells, including T cells. ACTB is actin, ubiquitous. \n\nWhat about monocytes? They have HLA-DR, CD74. CD14 is a monocyte marker, but it's not listed here. Alternatively, dendritic cells? They also express MHC II. But without specific markers like CD11c or CD123, it's hard. \n\nLooking at the ribosomal proteins again. High ribosomal protein expression can indicate activated cells, maybe plasmablasts or plasma cells which are antibody-producing. Plasma cells have CD138, which isn't here. Plasmablasts might express CD38, but not listed. \n\nWait, there's DUSP1. That's involved in stress responses, often upregulated in immune cells under activation. In COVID-19, maybe T cells or monocytes are activated. \n\nHLA-E is present, which is involved in NK cell recognition. But NK cells usually have CD56 or CD16, not listed here. \n\nLooking at the mitochondrial genes: MT-CO1, MT-CO2, MT-CO3, etc. High mitochondrial content might suggest a metabolically active cell. Monocytes or macrophages have higher mitochondrial content compared to lymphocytes. But again, without specific markers. \n\nPutting it all together: High MHC II (HLA-DRA, HLA-DPA1, CD74), some B cell markers (CD37, but not strong), ribosomal proteins. Maybe a B cell, but not enough specific markers. Alternatively, a monocyte-derived cell, like a dendritic cell or activated monocyte. Given the COVID-19 context, perhaps an activated immune cell. \n\nAnother angle: CD52 is present. CD52 is high in T cells, B cells, monocytes. But not specific. However, the combination with MHC II and ribosomal genes might lean towards a B cell. Alternatively, a memory B cell or activated B cell. But again, missing key markers. \n\nAlternatively, given the strong MHC II and CD74, maybe a dendritic cell. But again, without specific markers. \n\nWait, CD24 is not here. Hmm. \n\nAlternatively, considering COVID-19, there's been studies showing certain immune cell types. For example, monocyte-derived dendritic cells or macrophages in severe cases. But this cell is from blood, so more likely circulating. \n\nAlternatively, plasmacytoid dendritic cells? They have HLA-DR, but typically CD123. Not here. \n\nAlternatively, a monocyte. Since monocytes express HLA-DR, CD74, and have higher ribosomal activity. The presence of FTL (ferritin light chain) might also be in monocytes. \n\nBut also, B cells express CD74 as part of the MHC II complex. If CD37 is present (a B cell marker), maybe a B cell. But why no CD19? Maybe the dataset didn't include it, or it's not highly expressed. \n\nHmm. Given the ambiguity, but presence of MHC II and CD74, CD37, and ribosomal genes, perhaps a B cell. However, without more specific markers, it's a bit tricky. Alternatively, a memory B cell. Alternatively, an activated B cell during COVID-19 infection, given the context. \n\nSo, considering all, the most likely cell type is a B cell, possibly activated due to COVID-19, expressing high levels of MHC II and ribosomal proteins indicative of active protein synthesis.",
         "The cell exhibits high expression of ribosomal proteins (e.g., RPL/RPS genes) and MHC class II-related genes (CD74, HLA-DRA, HLA-DPA1), alongside B cell-associated markers (CD37, B2M) and stress-response genes (DUSP1). This profile suggests an activated B cell engaged in antigen presentation and antibody production, consistent with an immune response to COVID-19. The absence of plasma cell markers (e.g., CD138) or monocyte-specific markers (e.g., CD14) supports a B cell identity, likely in a differentiated or activated state.\n\nCell type: Activated memory B cell",
         "423",
         "951",
         "1084"
        ],
        [
         "298",
         "274",
         "16811996",
         "oligodendrocyte",
         "You are an expert in single-cell biology.\n\nBelow is metadata for one cell, followed by a list of its genes in descending expression:\nTissue: pons\nDisease: normal\nDevelopment stage: 29-year-old human stage\nGenes: PCDH9 CADM2 NRXN3 DLG2 PTPRK NKAIN2 QKI NCAM2 IL1RAPL1 PTPRD MAGI2 GAB1 PLP1 PDE4B ALCAM TMTC2 SPOCK3 FRMD5 NLGN1 SIK3 KIRREL3 TCF12 CTNNA3 CREB5 TMEFF2 SLC44A1 AUTS2 ERBB4 RNF220 PHLPP1 MBP PIP4K2A ELMO1 TRIM2 CCDC88A MOBP DEPTOR PDE8A SLCO3A1 DOCK10 SPOCK1 SGCZ ARHGAP21 MAN2A1 GAB2 DLG1 SLC24A2 PDE1C DIP2B FMNL2 LIMCH1 SH3GL3 NTM FUT8 ANK3 CTNND2 ENPP2 SLC12A2 PTK2 NFASC PEX5L TMEM144 HHIP ERBIN AKAP6 NAV2 PLCL1 LRP1B ZEB2 ZBTB20 SUMF1 RTN4 SHTN1 SSH2 LRRTM4 PXK UGGT2 ANO4 NPAS3 EXOC6B ATP8A1 HIPK2 USP34 GALNT13 MACROD2 SYNDIG1 UNC5C DST TMEM165 GRIA4 SEPTIN7 MED13L TTLL7 PALM2AKAP2 NCKAP5 FRMD4B DPYSL2 TXNDC16 CACNA2D1 LPAR1\n\nPlease identify what cell type this might be, as granular and accurate as possible.\nKeep your response concise and clear.\nAt the end of your response, strictly place the final lines in this format:\n\nCell type: X\n",
         "Okay, let's try to figure out the cell type here. The metadata says it's from the pons of a 29-year-old normal human. The pons is part of the brainstem, involved in functions like sleep and communication between different brain areas.\n\nLooking at the gene list, I notice several genes associated with oligodendrocytes. For example, PLP1 and MBP are myelin-related genes, which are crucial for forming the myelin sheath around neurons. MOBP is another oligodendrocyte marker. There's also MAGI2 and QKI, which are involved in myelination and glial cell differentiation. Genes like ERBB4 and CNTNAP2 (though CNTNAP2 isn't listed, maybe other cell adhesion molecules here) are sometimes linked to glial cells as well.\n\nWait, let me check other genes. NRXN3 and NLGN1 are involved in synaptic function, which might suggest neurons, but since this is the pons, maybe a glial cell with some synaptic support role. However, the strong presence of myelin genes like PLP1 and MBP leans more towards oligodendrocytes. Oligodendrocytes are responsible for myelination in the central nervous system. Also, MOBP and MAG are typically expressed in mature oligodendrocytes.\n\nAre there any other supporting genes? PTPRZ1 is sometimes associated with oligodendrocyte precursor cells, but I don't see that here. But looking at the list, DLG2, DLG1 are part of the discs large family, involved in cell structure, maybe in glial cells. GAB1 and GAB2 could be involved in signaling pathways. The presence of genes like SLC12A2 (a solute carrier) might relate to ion transport, which is important for maintaining the myelin sheath.\n\nWait, there's also NCAM2 and ALCAM, which are cell adhesion molecules. Oligodendrocytes use these for interactions with axons. And ENPP2 (autotaxin) is involved in producing lysophosphatidic acid, which can influence oligodendrocyte differentiation.\n\nNo strong neuronal markers like SYN1 or SNAP25 here. The gene list seems dominated by myelination and glial support genes. So putting this all together, the cell type is most likely an oligodendrocyte. The pons location and the normal, adult stage also fit with mature oligodendrocytes maintaining myelin.",
         "The cell originates from the pons (brainstem) of a healthy adult and expresses key oligodendrocyte-associated genes: **PLP1**, **MBP**, **MOBP**, **MAGI2**, **QKI**, **ERBB4**, and **ALCAM**, which are critical for myelination and glial-neuronal interactions. The absence of neuronal firing or precursor markers (e.g., *OLIG2*) and the prominence of myelin maintenance genes suggest a mature, myelinating oligodendrocyte.\n\nCell type: Oligodendrocyte",
         "434",
         "490",
         "604"
        ],
        [
         "300",
         "276",
         "4307469",
         "CD14-positive monocyte",
         "You are an expert in single-cell biology.\n\nBelow is metadata for one cell, followed by a list of its genes in descending expression:\nTissue: blood\nDisease: normal\nDevelopment stage: 41-year-old human stage\nGenes: FTH1 S100A9 FOS ACTB LYZ FTL TMSB4X MT-CO1 B2M S100A8 HLA-B CD74 TPT1 MT-CO2 TMSB10 VIM RPL10 DUSP1 IFI30 ZFP36 PSAP EEF1A1 HLA-DRA MT-CO3 FOSB CTSS RPS14 RPLP1 HLA-C UBC EIF1 RPL28 S100A6 H3-3A JUNB SAT1 RPS3A TYROBP RPS12 MT-ND4 JUN RPL13 OAZ1 RPL32 RPS8 RPS9 RPS13 RPS4X MT-CYB S100A4 RPS28 ITM2B RPL41 SRGN CST3 RPL34 RPS24 RPL26 MT-ND1 HLA-A COTL1 RPS15A HLA-DRB1 KLF4 MT-ND5 KLF2 UBA52 RPL29 RPS27 MT-ATP6 CD14 GABARAP RPS2 RPL30 GRN RPL8 S100A11 GAPDH RPL19 RPL11 CD52 FCN1 FAU NCF1 RPL37 MNDA FGL2 ARPC1B PTMA RPL18A DDX5 KLF6 RPS16 SRSF7 RPS7 RPLP2 PFN1 RPS18 RPS26 RPL35A\n\nPlease identify what cell type this might be, as granular and accurate as possible.\nKeep your response concise and clear.\nAt the end of your response, strictly place the final lines in this format:\n\nCell type: X\n",
         "Okay, let's tackle this cell type identification problem. The metadata says it's from blood, disease is normal, and the development stage is a 41-year-old human. The gene list is quite long, so I need to pick out the key markers.\n\nStarting with the most highly expressed genes: FTH1, S100A9, FOS, ACTB, LYZ, FTL. S100A9 and S100A8 (also present in the list) are known markers of myeloid cells, especially monocytes and neutrophils. LYZ (lysozyme) is also associated with myeloid lineage. FTH1 and FTL are involved in iron metabolism, common in cells that handle iron, like macrophages or monocytes.\n\nLooking further down, there's HLA-DRA and CD74, which are MHC class II genes. That suggests antigen-presenting cells, like dendritic cells or monocytes. However, the presence of CD14 isn't listed here, but wait, checking the gene list again—yes, CD14 is there towards the end. CD14 is a classic monocyte marker. \n\nOther genes like CST3 (cystatin C) and CTSS (cathepsin S) are also found in monocytes/macrophages. The ribosomal proteins (RPL and RPS genes) are often highly expressed in many cells but don't specify much. TYROBP is involved in immune receptor signaling, seen in myeloid cells. \n\nNo high expression of CD3, CD19, or CD56, which would point to T cells, B cells, or NK cells respectively. The absence of these markers makes me think it's a myeloid cell. Also, genes like FCN1 (Ficolin-1) are markers for a subset of monocytes, specifically classical monocytes. \n\nLooking at the combination: S100A8/S100A9 (calprotectin), CD14, FCN1, CST3, and HLA-DRA. This combination is characteristic of classical monocytes. Additionally, the presence of genes like B2M (beta-2-microglobulin) which is part of MHC class I, but since MHC class II is present, it's more about antigen presentation. \n\nAnother check: Are there any markers that might suggest a different cell type? For example, neutrophils have high S100A8/A9 but also other markers like FCGR3B (CD16), which isn't listed here. Macrophages might have more specialized markers like CD68 or CD163, which aren't prominent here. Dendritic cells might have CD1c or CD141, which aren't present. \n\nThe gene FGL2 is expressed in some monocytes and macrophages. GRN (granulin) is also associated with monocytes. The presence of TMSB4X and TMSB10 (thymosin beta proteins) isn't specific but common in various immune cells. \n\nPutting it all together, the high expression of S100A8/A9, CD14, FCN1, LYZ, and HLA-DRA points towards classical monocytes. They are part of the myeloid lineage, found in blood, and function in phagocytosis and antigen presentation. The absence of markers for other myeloid subsets like CD16 for non-classical monocytes or markers for dendritic cells reinforces this.",
         "The cell exhibits high expression of myeloid markers (S100A8, S100A9, LYZ, FCN1), monocyte-associated genes (CD14, CST3, CTSS), and MHC class II genes (HLA-DRA, CD74), alongside ribosomal proteins. These features, combined with the absence of lineage-specific markers for lymphocytes, neutrophils, or dendritic cells, strongly indicate a **classical monocyte** (CD14++/CD16-).\n\nCell type: Classical monocyte (CD14++/CD16−)",
         "409",
         "666",
         "779"
        ],
        [
         "304",
         "279",
         "45546223",
         "mature alpha-beta T cell",
         "You are an expert in single-cell biology.\n\nBelow is metadata for one cell, followed by a list of its genes in descending expression:\nTissue: blood\nDisease: COVID-19\nDevelopment stage: 51-year-old human stage\nGenes: RPL10 RPS12 RPL28 RPL19 RPL41 RPL13 TMSB4X RPS19 TMSB10 RPS27A RPL30 RPS27 MTRNR2L12 B2M RPL34 EEF1A1 RPL39 MT-CO2 RPL32 RPS4X RPL12 MTRNR2L6 FAU RPL37 RPL11 MTRNR2L8 JUN RPL35A RPL18A RPS14 RPL36 RPLP1 RPS8 RPS15 RPS15A RPL7A RPL3 RPL18 RPS25 RPS5 RPL8 RPS23 RPL6 TNFSF13B RPS7 PTMA MT-CO1 MT-CO3 RPL24 TXNIP RPLP2 RPS3 ISG15 RPL14 RPL21 DDX5 RPS28 RPS24 RPS9 RPL29 IFITM1 FOS RPS13 RPS21 RPL5 RPSA RPS18 GIMAP7 RPL22 ACTB RPS16 HLA-B NACA RPL37A RPL7 RACK1 FXYD5 HLA-C FTL CD3E MT-ND4L MT-CYB RPS2 RPS3A SARAF RPS29 ARID5B RPL13A RPLP0 RPL35 FTH1 RPS6 CD52 ATP5MC2 FYB1 ZNF688 EIF3E PTPRC SH3BGRL3 S100A9\n\nPlease identify what cell type this might be, as granular and accurate as possible.\nKeep your response concise and clear.\nAt the end of your response, strictly place the final lines in this format:\n\nCell type: X\n",
         "Okay, let's see. The task is to identify the cell type based on the given metadata and gene expression. The metadata says the tissue is blood, disease is COVID-19, and the development stage is a 51-year-old human. The genes listed are in descending order of expression.\n\nFirst, I'll start by recalling that in single-cell RNA sequencing, highly expressed genes are often markers for specific cell types. Since the tissue is blood, we're likely looking at a peripheral blood mononuclear cell (PBMC) type, such as lymphocytes, monocytes, or granulocytes. But given the disease is COVID-19, maybe there's an immune response involved, so T cells, B cells, or macrophages might be candidates.\n\nLooking at the genes: There's a lot of ribosomal proteins (RPL and RPS genes), which are common in many cells but might indicate active protein synthesis. However, some genes stand out. For example, B2M (beta-2-microglobulin) is part of MHC class I molecules, present on all nucleated cells. EEF1A1 is involved in translation elongation, again common. \n\nTMSB4X and TMSB10 are thymosin beta family members, which are involved in actin sequestration. These are found in various cells, including T cells. JUN and FOS are immediate early genes, often induced in activated cells. IFITM1 is an interferon-induced transmembrane protein, which is involved in antiviral responses—this could be relevant to COVID-19. \n\nLooking for T cell markers: CD3E is a key marker for T cells. Scanning the gene list, I do see CD3E present. Additionally, genes like FYB1 (FYN binding protein) are involved in T cell receptor signaling. The presence of CD52, which is expressed on lymphocytes including T cells. \n\nOther genes: HLA-B and HLA-C are MHC class I genes, consistent with nucleated cells. ACTB is beta-actin, a cytoskeletal gene. There's also GIMAP7, which is a GTPase implicated in T cell survival. \n\nCheck against markers for other cell types. For B cells, I might expect CD19, CD20 (MS4A1), but those aren't listed here. Monocytes might have CD14, CD16 (FCGR3A), which are also absent. NK cells have markers like NCAM1 (CD56), which isn't present. \n\nSo the presence of CD3E and FYB1 strongly points towards T cells. Additionally, the activation markers like JUN and FOS, along with IFITM1, suggest an activated T cell, possibly in response to viral infection (COVID-19). The ribosomal proteins might indicate active protein synthesis due to cell activation. \n\nAnother thing to consider: The genes MT-CO1, MT-CO2, MT-CO3 are mitochondrial genes, which might relate to metabolic activity. Activated T cells upregulate mitochondrial activity. \n\nPutting it all together: The cell is a T cell from the blood of a COVID-19 patient. The specific subtype might be CD8+ or CD4+, but without more specific markers like CD4 or CD8A, it's hard to tell. However, the presence of CD3E is definitive for T cells. \n\nPossible other genes: Check if there are any other T cell markers. FYB1 is more specific to T cells. Also, PTPRC is CD45, a pan-leukocyte marker. So yes, T cell is the most likely. \n\nFinal answer: T cell. But maybe more specific? If there's CD8 or CD4 markers, but they aren't listed. So the most granular possible here is T cell.",
         "The cell exhibits high expression of ribosomal genes (e.g., RPL/RPS), T cell markers (CD3E, FYB1), activation-related genes (JUN, FOS), and antiviral genes (IFITM1). These features, combined with the absence of monocyte/B cell/NK-specific markers, strongly suggest an activated T cell in the context of COVID-19. The presence of mitochondrial genes (MT-CO1/2/3) aligns with heightened metabolic activity during T cell activation.\n\nCell type: Activated CD3+ T cell",
         "431",
         "762",
         "876"
        ],
        [
         "305",
         "280",
         "37807796",
         "kidney loop of Henle thick ascending limb epithelial cell",
         "You are an expert in single-cell biology.\n\nBelow is metadata for one cell, followed by a list of its genes in descending expression:\nTissue: kidney\nDisease: chronic kidney disease\nDevelopment stage: seventh decade human stage\nGenes: MT-ND3 MT-CO3 MT-CO2 MT-CO1 UMOD DEFB1 MT-ND4 MT-ATP6 MT-CYB MT-ND2 MT-ND4L MT-ND5 FXYD2 SLC12A1 ATP1B1 RPL10 RPS23 S100A6 RPL39 KNG1 ATP1A1 MT-ND1 EGF CXCL12 ATP5F1E COX6A1 ATP6V0B RPL41 COX5B CKB CD24 RPS3A MYL6 ITM2B RPS14 ST13 B2M MGST3 KCNJ1 RPL7 SUCNR1 MRPL52 MUC1 RPL13 NDUFA13 CDH16 SERF2 EEF1A1 PRDX3 CALR RPL28 CTSD RPS26 RPS4X RPL34 CTTN RPS27 RPL26 RPS8 SKP1 NDUFB7 UQCR11 RPL6 FKBP2 RPL27 PRR13 IER3 HERPUD1 LUC7L3 RPS21 RPL27A HSPA5 UCHL1 IGFBP7 RPS27A ANP32E RPL30 SGMS2 MT-ND6 CHCHD10 FTL OCLN NUDT4 CYSTM1 LAMP1 RPS18 ADAM9 TXNL4A HLA-A RPL11 UQCR10 PPM1B PIK3C2A TUFM OSBP ZNHIT1 TMEM72 TPT1 PPP1R1A ISCU\n\nPlease identify what cell type this might be, as granular and accurate as possible.\nKeep your response concise and clear.\nAt the end of your response, strictly place the final lines in this format:\n\nCell type: X\n",
         "Okay, let's see. The metadata says this is a kidney cell from a patient with chronic kidney disease, seventh decade, so probably an older adult. The genes are listed in descending expression.\n\nFirst, I'll look for highly expressed genes that are markers for specific kidney cell types. MT- genes like MT-ND3, MT-CO3 are mitochondrial genes, which are often high in metabolically active cells. But more importantly, I need to focus on kidney-specific markers.\n\nUMOD is a big one. Uromodulin is produced by the thick ascending limb (TAL) of the loop of Henle and early distal convoluted tubule cells. High UMOD expression suggests this cell might be from the TAL. DEFB1 (beta-defensin 1) is also expressed in the loop of Henle and collecting ducts. \n\nSLC12A1 encodes the Na-K-2Cl cotransporter (NKCC2), which is specific to the TAL. FXYD2 is a subunit of the Na+/K+ ATPase, found in distal nephron segments including TAL. KNG1 (kininogen) is another gene associated with the TAL. ATP1A1 and ATP1B1 are part of the Na+/K+ ATPase, which is active in cells involved in ion transport, like TAL cells.\n\nLooking at other genes: EGF is produced in the distal tubule, but maybe some overlap. CXCL12 is seen in various kidney cells. The presence of RPL and RPS genes indicates ribosomal proteins, which are common in many cells but don't specify type.\n\nPutting this together: high expression of UMOD, SLC12A1, FXYD2, KNG1, ATP1A1/B1 strongly points to the thick ascending limb of the loop of Henle. Chronic kidney disease might alter some gene expressions, but the key markers are there. Also, absence of markers for other cell types (like podocytes or proximal tubule markers) supports TAL.",
         "The cell exhibits markers of kidney tubular epithelial cells with specific enrichment for thick ascending limb (TAL) identity. Key TAL markers include *UMOD* (uromodulin), *SLC12A1* (NKCC2), *FXYD2*, *KNG1*, and *ATP1A1/ATP1B1* (Na+/K+ ATPase subunits). Mitochondrial genes (*MT-ND3*, *MT-CO3*) reflect high metabolic activity typical of ion-transporting cells. Chronic kidney disease context aligns with stress-response genes like *HERPUD1* and *HSPA5*. Absence of proximal tubule markers (e.g., *CUBN*, *LRP2*) or distal markers (e.g., *AQP2*, *AVPR2*) further narrows the identity.\n\nCell type: Thick ascending limb epithelial cell",
         "436",
         "417",
         "601"
        ],
        [
         "311",
         "286",
         "29986319",
         "double-positive, alpha-beta thymocyte",
         "You are an expert in single-cell biology.\n\nBelow is metadata for one cell, followed by a list of its genes in descending expression:\nTissue: thymus\nDisease: normal\nDevelopment stage: 12th week post-fertilization human stage\nGenes: EEF1A1 RPLP1 PTMA GAPDH ACTB RPS12 MT-CO2 HMGN2 TMSB4X RPS8 RPL10 MT-CO1 RPL28 RPL13 RPLP0 RPS3A HMGB1 RPS6 RPS3 STMN1 RPS4X RPS23 TUBB ACTG1 RPL18A RPL19 RPS18 HMGB2 RPL41 RPS27 RPL37 PPIA RPL15 RPL3 RPS24 RPL37A RPL7A RPS13 RPS28 RPS19 TUBA1B RPL32 RPS7 RPS21 RPS15 RPL11 RPL23A H3-3A RPL34 RPL29 TPT1 RPL39 HNRNPA1 RPS27A RPS14 RPL30 RPL5 HNRNPA2B1 RPLP2 RPL36 RPS16 RPSA RPL12 RPL18 RPL8 MT-CO3 RPS15A RPL6 RACK1 RPS9 RPS25 RPS26 RPL35A RPL14 MT-ND4L UBE2C RPS2 PFN1 RPL35 RPL10A RPS5 HSP90AA1 RPL13A H2AZ1 RPS29 CALM2 PCBP2 LDHA RPL21 MT-ATP6 RPL4 CD1E EEF1B2 HMGA1 CFL1 NUCKS1 NPM1 CD1B RPL9 TCF7\n\nPlease identify what cell type this might be, as granular and accurate as possible.\nKeep your response concise and clear.\nAt the end of your response, strictly place the final lines in this format:\n\nCell type: X\n",
         "Okay, let's start by looking at the metadata. The cell is from the thymus, which is a key organ for T cell development. The disease is normal, and the development stage is 12 weeks post-fertilization in humans. So, this is a fetal thymus cell.\n\nLooking at the gene list, there are a lot of ribosomal proteins (RPL and RPS genes), which are typically highly expressed in cells with active protein synthesis, like proliferating cells. Then there's ACTB, ACTG1, TUBB, TUBA1B—these are cytoskeletal genes, common in many cells but especially in those that are actively moving or developing.\n\nNow, T cell development markers: TCF7 is a transcription factor important in early T cell progenitors. CD1B and CD1E are involved in lipid antigen presentation, expressed by cortical thymocytes. PTMA (prothymosin alpha) is associated with cell proliferation and found in thymic epithelial cells, but also in developing T cells. HMGB1 and HMGB2 are chromatin proteins, maybe involved in DNA repair during proliferation.\n\nOther genes like STMN1 (stathmin) are involved in cell cycle regulation, indicating proliferation. EEF1A1 is elongation factor, again protein synthesis. There's no mention of CD3 or TCR genes here, which are more mature T cell markers. The presence of CD1E and CD1B suggests cortical thymocytes. Also, the stage is 12 weeks, which is when human thymus is actively producing T cells. \n\nPutting it all together: high ribosomal activity (proliferation), TCF7, CD1 markers, thymus tissue. This is likely a developing T cell in the cortical region, maybe a double-positive (CD4+ CD8+) thymocyte. But since the genes don't show CD4 or CD8 explicitly, maybe a more general early thymocyte progenitor. Alternatively, cortical thymic epithelial cells might express some of these, but CD1 genes are more in T cells. So probably a developing T cell at an early stage, perhaps double-positive thymocyte.",
         "The thymus cell shows high expression of ribosomal proteins (e.g., RPL/RPS genes), cytoskeletal genes (ACTB, TUBB), and proliferation-associated genes (STMN1, HMGB1), consistent with actively dividing cells. Key T-lineage markers include **TCF7** (critical for T-cell commitment) and **CD1B/CD1E** (expressed in cortical thymocytes). The absence of mature T-cell markers (e.g., CD3, TCR genes) and the presence of **PTMA** (prothymosin alpha, linked to thymocyte differentiation) suggest an early-stage T-cell progenitor, likely a **cortical thymocyte** undergoing β-selection or early double-positive (CD4+ CD8+) stage during fetal thymopoiesis.\n\nCell type: Cortical thymocyte (early double-positive stage)",
         "435",
         "433",
         "609"
        ],
        [
         "316",
         "291",
         "42085866",
         "natural killer cell",
         "You are an expert in single-cell biology.\n\nBelow is metadata for one cell, followed by a list of its genes in descending expression:\nTissue: blood\nDisease: COVID-19\nDevelopment stage: human adult stage\nGenes: B2M MT-CO2 MT-CO1 ACTB RPL10 TMSB4X GNLY NKG7 MT-CO3 EEF1A1 HLA-A RPLP1 HLA-B PFN1 RPL28 RPS8 MT-ATP8 TMSB10 RPL7A MT-ND3 RPL32 RPS27 GZMB MT-ND1 RPS13 HLA-C RPS15A RPL13 RPS28 PTMA RPS24 MT-CYB H3-3B CTSW GAPDH MT-ND4L RPS3A IFITM2 MT-ATP6 RPS3 FAU CFL1 HLA-E RPS12 S100A4 CST7 TXNIP CALM1 RPL18A RPS23 RPS21 MT-ND2 UBA52 ATP5F1E IL32 RPL11 RPL21 IFITM1 RPL3 LGALS1 RPS9 RPS27A RPL35A PRF1 RPS6 FTH1 EIF1 RPLP0 RPL30 MYL6 GZMA RPL10A YWHAB RPL23A PTPRCAP RPS19 CD7 RPL19 RPS2 ACTG1 RPLP2 MT-ND5 RPS11 SERF2 SRGN RPL36 RPS5 TYROBP S100A6 UBB HSP90AA1 CIRBP RPS16 PPIA RPL17 RPL8 RPL15 RPL5 RAC2 RPL18\n\nPlease identify what cell type this might be, as granular and accurate as possible.\nKeep your response concise and clear.\nAt the end of your response, strictly place the final lines in this format:\n\nCell type: X\n",
         "Okay, let me try to figure out the cell type here. The metadata says it's from blood, COVID-19, human adult. The genes listed are in descending expression.\n\nFirst, looking at the top genes: B2M is a common marker for MHC class I molecules, which are present on most nucleated cells. Then there's MT-CO2, MT-CO1, which are mitochondrial genes, often high in cells with high energy demands. ACTB is actin, a cytoskeletal gene, pretty ubiquitous. RPL10 and other RPL/RPS genes are ribosomal proteins, so maybe a cell that's actively translating proteins. TMSB4X is thymosin beta 4, involved in actin regulation. \n\nBut then I see GNLY (granulysin), NKG7, GZMB (granzyme B), PRF1 (perforin). These are classic cytotoxic granules found in NK cells and CD8+ T cells. Also, genes like CST7 (cathepsin inhibitor, found in cytotoxic lymphocytes), CD7 is a marker for T and NK cells. PFN1 is profilin, involved in actin dynamics, but also present in cytotoxic cells. \n\nHLA genes (HLA-A, HLA-B, HLA-C, HLA-E) are MHC class I, which again, are on most cells but might be upregulated in certain immune contexts. There's also IL32, which is produced by T cells and NK cells. \n\nLooking at the combination: high cytotoxic molecules (GNLY, NKG7, GZMB, PRF1) and T/NK markers (CD7, CST7), along with ribosomal proteins which might indicate activated cells. The presence of genes like RPL and RPS is common in many cells, but the cytotoxic genes are more specific. \n\nIn COVID-19, cytotoxic T cells and NK cells are involved in the response. But the question is whether it's NK or T. CD8+ T cells would have CD8 markers, but CD8 isn't listed here. However, CD7 is present, which is on both T and NK cells. Also, PTPRCAP is CD45-associated protein, so that's leukocyte common antigen related, present in all hematopoietic cells except maybe mature erythrocytes. \n\nGNLY is more prominent in NK cells and CD8 T cells. The absence of CD3 might be a clue, but the data provided doesn't list CD3 genes (like CD3D, CD3E). Wait, checking the list again: I don't see CD3 genes here. So if CD3 is absent, but cytotoxic genes are present, maybe it's an NK cell. Because T cells would typically have CD3. \n\nNK cells also express NKG7, GNLY, GZMB, PRF1, which are all here. Also, FCGR3A (CD16) is a marker for NK cells, but that's not listed. However, the genes listed here might not be exhaustive. The presence of CD7 and absence of CD3 could point towards NK cell. \n\nAlternatively, maybe a gamma delta T cell, but less likely. Or a cytotoxic CD8+ T cell that's activated. But without CD8 or CD3 markers, leaning more towards NK. \n\nAnother thing: S100A4 is associated with T cells and NK cells. CALM1 is calmodulin, which is general. IL32 is also in T cells. But again, the main point is the cytotoxic granules. \n\nSo putting it all together: high expression of cytotoxic genes, presence of NKG7, GNLY, CD7, absence of T cell receptor genes (like CD3) suggests Natural Killer cell. The ribosomal genes might indicate they're activated, which makes sense in COVID-19 context where NK cells are responding to infection.",
         "The cell exhibits high expression of cytotoxic markers (GNLY, NKG7, GZMB, PRF1), ribosomal proteins (RPL/RPS genes), and MHC class I components (HLA-A/B/C), alongside CD7 and CST7. These features are characteristic of cytotoxic lymphocytes, particularly natural killer (NK) cells, which lack T-cell receptor (CD3) expression. The absence of CD3/CD8 and presence of NK-associated genes strongly point to an activated NK cell in the context of COVID-19 immune response.\n\nCell type: Natural Killer cell (NK cell)",
         "419",
         "782",
         "903"
        ],
        [
         "321",
         "296",
         "17365913",
         "oligodendrocyte",
         "You are an expert in single-cell biology.\n\nBelow is metadata for one cell, followed by a list of its genes in descending expression:\nTissue: midbrain\nDisease: normal\nDevelopment stage: 50-year-old human stage\nGenes: PCDH9 IL1RAPL1 CADM2 DLG2 MBP MAGI2 PLP1 CTNNA3 MAN2A1 PDE4B QKI ST18 RBFOX1 FMNL2 NKAIN2 LRP1B MAP7 ELMO1 CNTNAP2 RNF220 WWOX MOBP PEX5L FRMD5 NPAS3 PTPRD NCKAP5 TMEM144 NLGN1 SLC5A11 GPM6B AGAP1 PRUNE2 PLCL1 SLC24A2 DST NTM ZBTB20 SHTN1 SLC44A1 PPP2R2B TMTC2 LSAMP FRYL HS3ST5 SPOCK3 DOCK10 SEPTIN7 NRXN1 BBS9 EDIL3 DPYD DOCK4 ATP8A1 PIP4K2A MVB12B AKAP6 PTPRK DNM3 ZNF536 FBXL7 SIK3 GNAQ GPHN RTN4 PHLPP1 GAB1 AK5 TTLL7 ANK3 ENPP2 TRIM2 NAALADL2 PKP4 SHROOM4 PDE1C ADGRB3 ANK2 UBE2E2 CLASP2 GLDN TF PICALM DLG1 PTK2 ZSWIM6 PXK ZEB2 SYNJ2 RERE RAPGEF5 FOLH1 KIF13B NCAM1 SAMD12 SLC39A11 PDE8A UNC5C CHD9 MAP4K4\n\nPlease identify what cell type this might be, as granular and accurate as possible.\nKeep your response concise and clear.\nAt the end of your response, strictly place the final lines in this format:\n\nCell type: X\n",
         "Okay, let's try to figure out the cell type based on the provided metadata and gene list. The tissue is midbrain, the disease state is normal, and the development stage is a 50-year-old human. So, we're looking for a mature cell type in the midbrain.\n\nFirst, I'll go through the list of genes and see which ones are markers for specific cell types. The midbrain includes various neurons, glial cells like oligodendrocytes, astrocytes, and maybe microglia. Let's see.\n\nLooking at the genes: MBP, PLP1, MOBP. These are all myelin-related genes. MBP (Myelin Basic Protein) and PLP1 (Proteolipid Protein 1) are classic markers for oligodendrocytes, which produce myelin in the central nervous system. MOBP (Myelin-Associated Oligodendrocyte Basic Protein) is also specific to oligodendrocytes. Then there's QKI (Quaking), which is involved in myelination and oligodendrocyte differentiation.\n\nOther genes like CNTNAP2 and ERMN might be associated with neurons, but the strong presence of myelin genes suggests glial cells. Also, MAGI2 (MAGUK family protein) and DLG2 are involved in synaptic structures but can be present in glial cells too. Wait, but MAG is another myelin-associated glycoprotein, but here it's MAGI2, which might be different. \n\nLooking further, genes like GPM6B (Glycoprotein M6B) are expressed in oligodendrocytes. ENPP2 (Autotaxin) is involved in producing lysophosphatidic acid, which can influence oligodendrocyte differentiation. \n\nThere's also NRXN1 (Neurexin 1), which is usually in neurons, but maybe cross-talk or some expression in glia. However, the dominance of myelin genes points more towards oligodendrocytes. \n\nConsidering the age, 50 years old, so it's a mature cell. Oligodendrocytes in the midbrain would be responsible for myelinating axons. Are there any other markers that might indicate a different cell type? Let me check other genes. RTN4 is Reticulon 4, also known as Nogo, which is expressed in oligodendrocytes. WWOX is a tumor suppressor but not specific. \n\nAre there any astrocyte markers like GFAP? Not listed here. Microglia markers like AIF1 (IBA1) also not present. Neuronal markers like SYT1 or SNAP25 aren't prominent here. So, the strongest signals are from oligodendrocyte markers. \n\nTherefore, the cell type is likely an oligodendrocyte. But maybe more specifically, a mature oligodendrocyte given the age. Alternatively, an oligodendrocyte precursor cell (OPC) would express different markers like PDGFRA or SOX10, but those aren't in the list. The presence of MBP, PLP1, MOBP suggests a myelinating oligodendrocyte.",
         "The cell exhibits strong expression of myelin-related genes (MBP, PLP1, MOBP, QKI) and oligodendrocyte-associated genes (CNTNAP2, GPM6B, ENPP2, RTN4), alongside markers of mature CNS cells (NRXN1, DLG2). These features, combined with the midbrain tissue origin and adult age, strongly indicate a myelinating oligodendrocyte. The absence of neuronal activity markers (e.g., SYT1) or astrocyte/microglia-specific genes further supports this classification.\n\nCell type: Oligodendrocyte (myelinating)",
         "431",
         "616",
         "743"
        ],
        [
         "326",
         "300",
         "20353853",
         "lymphoid lineage restricted progenitor cell",
         "You are an expert in single-cell biology.\n\nBelow is metadata for one cell, followed by a list of its genes in descending expression:\nTissue: bone marrow\nDisease: normal\nDevelopment stage: 14th week post-fertilization human stage\nGenes: PTMA HSP90AA1 RPL10 EEF1A1 HMGB1 MT-ATP6 MT-CO1 FOS RPS6 RPS3A RPS12 RPS8 TPT1 RPS27A RPL19 RPS24 RPS23 RPL29 ACTB MT-CO2 MT-CYB RPL11 RPLP2 HMGB2 RPS4X RPS15A RPL3 RPL21 MT-ND4 RPS27 RPL15 RPL26 RPS13 RPS3 H4C3 RPL32 RPL39 RPL41 RPL13A RPSA RPLP1 STMN1 GAPDH RPL28 RPL18 RPL13 H3-3B RPS5 RPS14 RPS19 H3-3A TMSB10 RPL30 MT-CO3 RPS18 RPL34 RPLP0 RPS11 RPS29 RPL9 RPS9 RPL36A TMSB4X TUBA1B TUBB ACTG1 CD74 RPL24 RPL7A RPS28 B2M H1-2 RPL23A PPIA NACA RPL6 RPL37 H1-3 RPL18A UBA52 SH3BGRL3 RPL35A RPL27 IGLL1 TYMS FAU RPS26 RPL17 RPL27A RPL7 RPS21 HNRNPA1 H2AZ1 RPS7 MT-ND3 PPDPF RPS2 DUSP1 RPL12 RPL10A\n\nPlease identify what cell type this might be, as granular and accurate as possible.\nKeep your response concise and clear.\nAt the end of your response, strictly place the final lines in this format:\n\nCell type: X\n",
         "Okay, let's see. I need to figure out the cell type based on the provided metadata and gene list. The tissue is bone marrow, disease is normal, and the development stage is 14 weeks post-fertilization human. So it's a developing human bone marrow cell.\n\nLooking at the genes listed, a lot of ribosomal proteins like RPL and RPS genes are highly expressed. That's common in cells that are actively translating proteins, maybe proliferating cells. Also, there's ACTB, GAPDH, TUBA1B, TUBB, which are cytoskeletal genes often found in many cell types but can indicate structural proteins.\n\nHmm, there's FOS and DUSP1, which are early response genes, often upregulated in activated cells. But in the context of bone marrow, maybe hematopoietic cells? Also, genes like CD74 and B2M are MHC class II related, which might suggest antigen-presenting cells, but I need to check if they're present in other cell types.\n\nWait, MT- genes are mitochondrial, which are present in cells with high energy needs. But that's not specific. Let me think about specific markers for bone marrow cell types. Progenitor cells, erythroblasts, lymphocytes, myeloid cells?\n\nLooking for more specific markers. IGLL1 is Immunoglobulin Lambda Like Polypeptide 1. That's involved in B-cell development. But in the 14th week, human fetal development, B-cell progenitors might be present in the bone marrow. CD74 is part of the invariant chain of MHC II, which is in B cells and other antigen-presenting cells. B2M is beta-2-microglobulin, part of MHC I. Hmm.\n\nOther genes like TMSB4X (Thymosin beta 4) is involved in actin sequestration, found in many cells but also in hematopoietic cells. STMN1 (Stathmin 1) is involved in cell cycle regulation, high in proliferating cells.\n\nThe presence of IGLL1 might point towards pre-B cells. Pre-B cells express IGLL1 as part of the surrogate light chain during B-cell receptor development. Also, CD74 is expressed in B cells. Other ribosomal proteins are high in cells that are rapidly dividing, which fits with developing lymphocytes in the bone marrow.\n\nAt 14 weeks, human fetal bone marrow is starting to be a site for hematopoiesis, so B-cell progenitors would be present. The combination of IGLL1, CD74, B2M, and ribosomal proteins suggests a developing B-cell. Also, genes like RPL and RPS are highly expressed in many hematopoietic progenitors due to high protein synthesis needs.\n\nSo putting it all together: the cell is likely a Pro-B cell or early B-cell progenitor in the bone marrow at this fetal stage. The markers like IGLL1 and CD74 support B-lineage, and the ribosomal genes suggest active proliferation.",
         "The cell exhibits high expression of ribosomal proteins (RPL/RPS), mitochondrial genes (MT-), and cytoskeletal markers (ACTB, TUBA1B), indicative of active protein synthesis and proliferation. Key markers include **IGLL1** (critical for pre-B cell receptor formation), **CD74** (MHC II chaperone), and **B2M** (MHC I component), which collectively point to early B-cell development. The absence of mature B-cell markers (e.g., CD19, CD20) and the fetal bone marrow context suggest a progenitor stage.  \n\nCell type: Pro-B cell",
         "436",
         "599",
         "726"
        ],
        [
         "336",
         "310",
         "38066960",
         "kidney loop of Henle thick ascending limb epithelial cell",
         "You are an expert in single-cell biology.\n\nBelow is metadata for one cell, followed by a list of its genes in descending expression:\nTissue: cortex of kidney\nDisease: acute kidney failure\nDevelopment stage: 36-year-old human stage\nGenes: ERBB4 PLCB1 CCSER1 PTPRG PLCL1 ARHGAP6 KCNIP4 SAT1 ESRRG UMOD ENOX1 FARP1 IGFBP7 PTGER3 MSI2 FGD4 MECOM WWC1 PRKD1 SPP1 KAZN RANBP3L COBLL1 FGF14 RORA APP MAML2 FHIT MAGI1 EFNA5 DCDC2 SHISA9 CDH16 PKHD1 SGPP2 PDE1A ARHGAP24 MGAT5 RBPMS CGNL1 NAALADL2 TPST1 NR3C2 BICC1 CACNA2D3 HIF1A PARD3 PATJ WWOX RERE ADAMTS16 LRMDA LRBA PDE4D GPC5 PLEKHA7 ZBTB20 RBM47 ZFAND3 DNM3 SHROOM3 PRKG1 CPQ BCAS3 TBC1D5 TRMT9B RALGPS2 ARHGEF12 PTH2R ITGB6 TLN2 SHANK2 CDC42SE2 PRKCE TRIO DENND2B FGF13 SNX29 ARHGEF38 IGF1R ITPR2 PCCA ANK3 LPCAT3 EXT1 PKP4 PLEKHG1 UBE3C IMMP2L ZFP36L2 KCNJ16 PPM1L LIFR BTBD3 MFHAS1 PLEKHA5 BTBD11 DIAPH1 SIK3 INSR\n\nPlease identify what cell type this might be, as granular and accurate as possible.\nKeep your response concise and clear.\nAt the end of your response, strictly place the final lines in this format:\n\nCell type: X\n",
         "Okay, let's try to figure out the cell type here. The metadata says it's from the kidney cortex of a 36-year-old with acute kidney failure. The genes listed are in descending order of expression.\n\nFirst, I remember that the kidney cortex contains structures like the proximal tubules, distal tubules, glomeruli, and collecting ducts. Each of these has specific marker genes. Let me go through some key genes mentioned.\n\nUMOD stands out. Uromodulin, encoded by UMOD, is a major protein produced by the thick ascending limb of the loop of Henle (TAL) and early distal convoluted tubule. That's a strong indicator. Also, CDH16 (cadherin-16) is a known marker for kidney distal tubules. Then there's PKHD1, which is associated with the collecting ducts in some contexts, but mutations here cause ARPKD, so maybe not the primary here.\n\nLooking at other genes: KCNJ16 is a potassium channel involved in potassium transport, which is important in the TAL and collecting ducts. SPP1 (osteopontin) is expressed in the loop of Henle and distal tubules. ERBB4 has roles in kidney development, possibly in tubular cells. IGFBP7 is involved in fibrosis and might be upregulated in injury, which fits with acute kidney failure.\n\nOther genes like PTPRG and PLCL1 are expressed in various nephron segments but aren't as specific. ARHGAP6 and others might relate to cell structure or signaling. Considering the high expression of UMOD and CDH16, along with KCNJ16 and SPP1, this points toward the thick ascending limb (TAL) cells of the loop of Henle. The presence of acute kidney failure might alter some gene expressions, but the core markers still suggest TAL cells.\n\nWait, CDH16 is more distal. Maybe this is a transitional area or a specific segment. Alternatively, some cells in the distal nephron might co-express these markers. But UMOD is very specific for TAL. Let me confirm: UMOD is synthesized in the TAL, and CDH16 is found in distal tubules. Hmm, conflicting markers? Maybe there's a subset or a specific state. Alternatively, in disease states, some markers might be ectopically expressed. But in acute injury, maybe dedifferentiation occurs. However, the presence of both UMOD and CDH16 could suggest a hybrid or a transitional cell type. Alternatively, maybe the cell is from the connecting tubule or cortical collecting duct, but those usually have different markers like AQP2. Alternatively, maybe it's a principal cell or intercalated cell, but those markers aren't prominent here.\n\nAlternatively, could it be a proximal tubule cell? Proximal tubules express genes like SLC34A1, which isn't listed here. The absence of proximal markers and presence of UMOD and CDH16 points away from proximal. So maybe it's a thick ascending limb cell. But why CDH16? Wait, CDH16 is also known as KSP-cadherin, which is expressed in the distal nephron, including distal convoluted tubule, connecting tubule, and collecting ducts. So if the cell has both UMOD and CDH16, perhaps it's a transitional cell between TAL and DCT, or maybe a cell that's part of the distal convoluted tubule. Alternatively, perhaps the cell is from the macula densa, which is part of the TAL but has distinct functions. But macula densa markers like NOS1 aren't listed here.\n\nAnother angle: look for other genes. KCNJ16 (Kir5.1) is expressed in the distal convoluted tubule, connecting tubule, and collecting ducts. But in combination with UMOD, maybe it's a TAL cell. Alternatively, in some contexts, cells might co-express markers. Maybe the cell type is the cortical thick ascending limb cell. Alternatively, considering the disease state, maybe some markers are upregulated. But given the metadata, the most specific markers are UMOD and CDH16. Perhaps the cell is a distal tubule cell, but UMOD is more TAL. Maybe this is a transitional cell type. Alternatively, the cell could be a principal cell with some upregulated genes, but that's less likely.\n\nAlternatively, some studies show that CDH16 can be expressed in TAL under certain conditions. Alternatively, perhaps the cell is a part of the distal nephron but with some TAL markers due to injury. However, the strongest indicator here is UMOD, which is very specific for TAL. So I'll lean towards thick ascending limb cells of the loop of Henle in the kidney cortex. The presence of CDH16 might indicate some overlap or a specific subset, but given the context, TAL is the most likely.",
         "The cell's expression of **UMOD** (uromodulin), a hallmark of the thick ascending limb (TAL) of the loop of Henle, and **CDH16** (distal tubule marker) suggests a cortical TAL cell. Additional genes like **KCNJ16** (potassium transport) and **SPP1** (osteopontin) align with TAL function, while acute kidney injury may drive stress-related genes (e.g., **IGFBP7**). Co-expression of distal markers could reflect regional heterogeneity or transitional states, but UDOM dominance is definitive.\n\nCell type: Thick ascending limb cell (cortical nephron)",
         "428",
         "1006",
         "1147"
        ],
        [
         "337",
         "311",
         "42092161",
         "natural killer cell",
         "You are an expert in single-cell biology.\n\nBelow is metadata for one cell, followed by a list of its genes in descending expression:\nTissue: blood\nDisease: COVID-19\nDevelopment stage: human adult stage\nGenes: B2M ACTB TMSB4X RPS27 NKG7 RPLP1 TMSB10 HLA-C EEF1A1 HLA-A IFITM1 RPL10 SH3BGRL3 RPS12 PFN1 RPS15A RPL28 RPS15 RPL34 RPL32 HLA-B TYROBP RPS19 RPS27A RPL13 RPS25 GZMH RPL36 RPS23 RPS29 RPS2 S100A4 HLA-E RPS3 RPL35A IL32 CFL1 IFITM2 RPL39 CCL5 RPS14 GZMA RPL17 RPL26 RPL30 RPS28 RPS8 RPL23A RPL37A RPL11 ACTG1 MT-CO2 RPL21 TPT1 RPS21 CYBA RPS6 ARPC2 CD74 RPS18 RPL19 RPL35 PTMA RPS24 FTL MT-CO1 RPL37 SERF2 RPS7 RPLP2 RPS3A MYL12A FTH1 VIM RPS13 CORO1A CST7 RPL8 RAC2 H3-3B ATP5F1E LY6E CLIC1 KLRD1 HCST CTSW RPL27 FAU COX6A1 ITGB2 RPS4X RPL7A RPL18 NACA S100A6 RPL6 ARHGDIB MT-ATP8 MT-CO3 OST4\n\nPlease identify what cell type this might be, as granular and accurate as possible.\nKeep your response concise and clear.\nAt the end of your response, strictly place the final lines in this format:\n\nCell type: X\n",
         "Okay, let's see. The cell is from blood tissue, and the disease is COVID-19. Development stage is human adult. The genes listed are in descending order of expression. I need to figure out the cell type based on these genes.\n\nFirst, I'll look for highly expressed genes that are markers for specific immune cells. B2M and ACTB are housekeeping genes involved in cell structure and basic functions, so they might not be specific. Then there's TMSB4X, which is thymosin beta-4X, involved in actin sequestration. But let's look for immune-related genes.\n\nNKG7 stands out. I remember that NKG7 is a marker for natural killer (NK) cells and cytotoxic T cells. Then there's GZMH and GZMA, which encode granzymes H and A. Granzymes are serine proteases found in the granules of cytotoxic T cells and NK cells, involved in inducing apoptosis in target cells. CCL5 (RANTES) is a chemokine produced by T cells and NK cells. CD74 is involved in antigen presentation, which is found in B cells and some other antigen-presenting cells, but maybe here it's part of a different context.\n\nLooking at other genes: HLA genes like HLA-C, HLA-A, HLA-B, HLA-E. These are MHC class I molecules, which are present on all nucleated cells, but their expression might be upregulated in certain immune contexts. TYROBP is a signaling molecule that's part of the DAP12 complex, involved in NK cell activation. KLRD1 encodes CD94, which pairs with NKG2 family members in NK cells. CST7 is cystatin F, associated with cytotoxic lymphocytes.\n\nThe presence of genes like IFITM1 and IFITM2 suggests interferon-induced proteins, which are often upregulated during viral infections like COVID-19. LY6E is another interferon-stimulated gene. This aligns with the disease being COVID-19, as the immune response would involve these genes.\n\nPutting this together: high expression of NKG7, GZMH, GZMA, CCL5, CST7, KLRD1, TYROBP. These are all indicative of cytotoxic lymphocytes. Since NKG7 is more prominent in NK cells and CD8+ T cells, but given the combination with KLRD1 (CD94) and TYROBP, which are more NK cell-associated, this cell is likely an NK cell. Additionally, CD8+ T cells might share some markers, but the presence of genes like FCER1G (though not listed here) is more NK. However, in the given list, TYROBP (DAP12) is a key component in NK cell receptors. Also, the lack of CD3 genes (like CD3D, CD3E) which are present in T cells, suggests it's not a T cell. \n\nSo the cell type is most likely a natural killer (NK) cell. But let me check if there are other possibilities. Are there any other markers here? RPL and RPS genes are ribosomal proteins, which are common in many cells. CCL5 is also produced by NK cells. Another gene is GNLY, which isn't listed here, but maybe not necessary. The combination of NKG7, GZMs, and TYROBP points strongly to NK cells. Additionally, in COVID-19, NK cells are part of the antiviral response. \n\nCell type: Natural Killer (NK) cell",
         "The cell exhibits high expression of cytotoxic markers (NKG7, GZMH, GZMA, CCL5, CST7) and NK-associated genes (TYROBP, KLRD1, LY6E), alongside interferon-stimulated genes (IFITM1/2) consistent with antiviral response. The absence of T-cell receptor or B-cell-specific markers (e.g., CD3, CD19) and presence of MHC class I (HLA-A/B/C) further support NK cell identity, which aligns with blood tissue and COVID-19 context.\n\nCell type: Natural Killer (NK) cell",
         "415",
         "725",
         "852"
        ],
        [
         "340",
         "313",
         "25777779",
         "CD8-positive, alpha-beta T cell",
         "You are an expert in single-cell biology.\n\nBelow is metadata for one cell, followed by a list of its genes in descending expression:\nTissue: lung\nDisease: lung adenocarcinoma\nDevelopment stage: 73-year-old human stage\nGenes: B2M TMSB4X GNLY RPS14 RPS19 TMSB10 RPLP1 RPS2 CD52 RPL13A RPS18 ACTB RPL41 RPL21 PFN1 RPS15 S100A4 RPS27 RPL15 CCL5 RPS29 S100A6 RPL10 RPL7 GZMB RPL18A CALM2 PRF1 RPL39 IL32 CD74 EEF1A1 HLA-A CFL1 RPL3 EEF1D RPL32 RPS9 RPL34 SH3BGRL3 RPL31 OST4 DUSP2 EIF1 RPL35A HLA-B RPL18 MYL12A CD3D SRI RPS3 RPS3A RNF166 CTSW CYBA LGALS1 RPL27A LYAR RPS6 RPS4X JUNB HNRNPA3 RPS15A RPS28 NFKBIA HCST TGFBR3 RGS1 BHLHE40 RPL38 SERF2 RPL36AL CLEC2D SNRPD2 SUMO1 GZMH H3-3B RPS27L NOL7 ITGB1 PTMA OGFR HLA-C HLA-E ETS1 CCT8 ATP5MC2 RPS20 CALM1 RUNX3 HMGB1 DDX24 RPL36 RPS25 CHMP4A RPL10A RPL30 SEPTIN7 UBC TAGLN2\n\nPlease identify what cell type this might be, as granular and accurate as possible.\nKeep your response concise and clear.\nAt the end of your response, strictly place the final lines in this format:\n\nCell type: X\n",
         "Okay, let's see. I need to figure out the cell type based on the given metadata and gene expression. The tissue is lung, disease is lung adenocarcinoma, and the development stage is a 73-year-old human. The gene list is in descending order of expression.\n\nFirst, I'll recall that lung adenocarcinoma is a type of non-small cell lung cancer, often involving epithelial cells. But the question is about the cell type of this particular cell, which could be part of the tumor microenvironment.\n\nLooking at the top genes: B2M, TMSB4X, GNLY, RPS14, RPS19, TMSB10, RPLP1, RPS2, CD52, RPL13A. Some of these are ribosomal proteins (RPS and RPL genes), which are often highly expressed in many cells due to their role in protein synthesis. But CD52 is interesting—it's a marker found on lymphocytes, especially T cells and some B cells. GNLY (Granulysin) is associated with cytotoxic activity, found in NK cells and CD8+ T cells. CCL5 is a chemokine produced by T cells. PRF1 (Perforin) and GZMB (Granzyme B) are also cytotoxic molecules from CD8+ T cells and NK cells. \n\nOther genes like CD3D are specific to T cells. IL32 is produced by T cells and NK cells. HLA genes (HLA-A, HLA-B, etc.) are involved in antigen presentation, which is typical of immune cells. \n\nHowever, the presence of genes like S100A4 and S100A6 might indicate some activation or a specific subset. But given the strong expression of cytotoxic molecules (GNLY, PRF1, GZMB), CD3D, and CD52, this seems to point towards a T cell with cytotoxic function. \n\nSince it's from a lung adenocarcinoma, tumor-infiltrating lymphocytes (TILs) are common. The high expression of cytotoxic genes suggests it's a CD8+ cytotoxic T cell. But wait, could it be an NK cell? NK cells also have GNLY, PRF1, GZMB. But CD3D is a T cell marker, not NK. So CD3D presence would indicate T cell lineage. Therefore, this is likely a cytotoxic CD8+ T cell.\n\nDouble-checking other genes: RGS1 is involved in T cell activation. BHLHE40 is a transcription factor in T cells. The lack of markers like CD4 (for helper T cells) isn't listed here, but CD8 isn't in the gene list either. However, CD8 might not be among the top expressed genes. Alternatively, sometimes CD8 subunits (CD8A or CD8B) are not listed, but the presence of CD3D and cytotoxic genes is more definitive. \n\nSo putting it all together: cytotoxic CD8+ T cell infiltrating the tumor in lung adenocarcinoma.",
         "The cell exhibits high expression of cytotoxic markers (GNLY, PRF1, GZMB, CCL5), T cell receptors (CD3D, CD52), and ribosomal proteins. These features, combined with the absence of epithelial or stromal markers, strongly indicate an activated cytotoxic T cell within the tumor microenvironment of lung adenocarcinoma. The presence of HLA class I genes (HLA-A, HLA-B, HLA-C) and immune activation markers (IL32, RGS1) further supports this identity.\n\nCell type: Cytotoxic CD8+ T cell",
         "415",
         "610",
         "724"
        ],
        [
         "346",
         "319",
         "330800",
         "luminal epithelial cell of mammary gland",
         "You are an expert in single-cell biology.\n\nBelow is metadata for one cell, followed by a list of its genes in descending expression:\nTissue: breast\nDisease: normal\nDevelopment stage: mature stage\nGenes: MGP AREG AZGP1 RPL41 TPM1 RPLP1 MT-CO3 RPS18 IER3 MT2A RPS2 RPS8 HSP90AA1 RPS4X RPL3 RPL34 MT-CO1 ACTB RPL30 RPS23 TPT1 RPL13 RPL28 RPS27A ACTG1 RPL21 SAT1 RPL23A FTH1 RPS28 RPS27 HSP90AB1 RPL11 MT-CO2 RPS3A RPL24 RPL18 MT-ATP6 RPS15A RPL35A RPL37A RPL37 EEF1A1 RPL8 RPL12 RPL14 KRT18 DNAJA1 RPLP0 RPS16 RPS12 RPS3 RPL9 MT-ND3 RPL23 RPS6 RPL13A RPS7 FAU EIF1 B2M RPL32 RPL18A RPS13 RPS26 RPL29 RPL5 MYL12B SERF2 PTMA RPS25 RPL26 RPS19 RPLP2 HSPB1 RPS24 RPL36 PALLD RPL6 RPS11 MT-ND4 MYL6 RPL10 GADD45A TNFRSF12A RPL39 RPL7A RPL35 RPL19 RPS15 RPL15 KRT17 RPL7 ANXA2 TUBB4B ERRFI1 TFF1 RPS14 RPS5 PTHLH\n\nPlease identify what cell type this might be, as granular and accurate as possible.\nKeep your response concise and clear.\nAt the end of your response, strictly place the final lines in this format:\n\nCell type: X\n",
         "Okay, let's try to figure out the cell type here. The metadata says it's a breast tissue cell from a normal, mature stage. So, I need to focus on breast cell types. The genes listed are mostly highly expressed ones. Let me start by looking at the genes mentioned.\n\nFirst, I notice a lot of ribosomal proteins like RPL and RPS genes. Those are usually involved in protein synthesis and are commonly found in cells with high metabolic activity. But they might not be cell-type specific. Then there's KRT18 and KRT17, which are keratins. Keratins 18 and 17 are markers for epithelial cells. In the breast, epithelial cells can be either luminal or basal. Luminal cells often express KRT18, while basal cells might express KRT8/18 and others. \n\nLooking further, there's MGP, which is Matrix Gla Protein. I recall that MGP is expressed in various tissues, including mammary gland. AREG is Amphiregulin, which is involved in growth and repair of epithelial tissues. AZGP1 is associated with some luminal cells, maybe in secretory functions. TFF1 is Trefoil Factor 1, which is a marker for luminal epithelial cells in the breast, especially those involved in secretory functions like milk production.\n\nHSP genes like HSP90AA1 and HSPB1 are stress proteins, but again, not specific. ACTB and ACTG1 are cytoskeletal proteins, common in many cells. FAU and EEF1A1 relate to translation, so maybe active in protein-producing cells.\n\nNo strong markers for myoepithelial cells like ACTA2 or CD10 here. Also, the lack of hormone receptors like ESR1 or PGR mentioned, but maybe they're just not in the top expressed genes listed. But TFF1 is a good indicator of luminal cells. PTHLH is Parathyroid Hormone-Like Hormone, which can be associated with lactation or certain breast cancers, but since it's normal tissue, maybe part of normal function.\n\nPutting this together: the cell has luminal epithelial markers (KRT18, TFF1, AREG, AZGP1) and lacks basal/myoepithelial markers. The presence of genes related to protein synthesis and secretion suggests it's a secretory luminal epithelial cell. Since it's mature breast tissue, possibly a luminal epithelial cell involved in milk production, like a lactocyte, but in a normal, non-lactating state? Wait, the development stage is mature, but not specified as lactating. However, TFF1 is also expressed in luminal cells even outside lactation. Maybe a mature luminal epithelial cell of the breast duct. Alternatively, a ductal cell. But need to be more precise.\n\nAnother angle: AZGP1 is also known as zinc-alpha-2-glycoprotein, which is secreted and found in breast epithelial cells. MGP might be involved in extracellular matrix. RPL and RPS are high, indicating active protein synthesis, which fits with secretory cells. So, combining the markers, the most specific ones here are TFF1, KRT18, AREG, AZGP1. These are characteristic of the luminal epithelial cells in breast ducts. Since it's normal and mature, likely a mammary gland luminal epithelial cell. But sometimes they are categorized as ductal cells. However, in breast, the main epithelial types are luminal (ductal) and basal/myoepithelial. Given the markers, this is a luminal epithelial cell. But to be more granular, maybe a ductal epithelial cell of the luminal subtype. Alternatively, given TFF1 and other markers, perhaps a luminal secretory cell.",
         "The cell exhibits markers of epithelial origin (KRT18, KRT17, TFF1) with luminal features (AZGP1, AREG, TFF1) and high ribosomal/protein synthesis activity (RPL/RPS genes). These align with secretory luminal epithelial cells in mammary ducts. Key genes like TFF1 (trefoil factor 1) and PTHLH further support a hormone-responsive, secretory role in normal breast tissue.\n\nCell type: Mammary gland luminal epithelial cell",
         "417",
         "762",
         "867"
        ],
        [
         "357",
         "330",
         "41581045",
         "non-classical monocyte",
         "You are an expert in single-cell biology.\n\nBelow is metadata for one cell, followed by a list of its genes in descending expression:\nTissue: blood\nDisease: COVID-19\nDevelopment stage: human adult stage\nGenes: FTH1 ACTB FTL B2M CD74 TMSB10 TMSB4X IFI27 HLA-DRA RPLP1 VIM MT-CO1 HLA-B RPL28 CST3 IFITM3 HLA-DRB1 MT-CO2 PFN1 S100A4 SH3BGRL3 RPS12 PSAP LYZ HLA-DRB5 EEF1A1 RPL39 COTL1 TYROBP S100A11 RPL11 HLA-A RPL18A RPS19 RPL37 S100A6 RPL10 MYL6 RPL41 RPS24 HLA-C RPS23 LY6E RPL13 RPS13 RPL19 RPS15A SAT1 S100A9 FCN1 IFITM2 HLA-DPA1 RPS8 FCER1G CFL1 SERF2 RPS18 FAU RPL30 MT-ND4L MT-ATP6 RPS9 RPL34 CD52 MT-ND3 RPL32 RPL8 RPLP2 S100A8 GAPDH OAZ1 RPS15 SRGN CTSS AIF1 RPS7 RPS27 LGALS1 CYBA ACTG1 RPS28 S100A10 NPC2 RPS27A APOBEC3A RPL36 SERPINA1 UBA52 MT-ND5 MT-CO3 RPL12 TYMP IFITM1 RPL14 LST1 RPS14 RPS25 NFKBIA TPT1 PTMA\n\nPlease identify what cell type this might be, as granular and accurate as possible.\nKeep your response concise and clear.\nAt the end of your response, strictly place the final lines in this format:\n\nCell type: X\n",
         "Okay, let's try to figure out the cell type here. The metadata says it's from blood, COVID-19, and human adult. The genes listed are in descending expression.\n\nStarting with the top genes: FTH1 and FTL are involved in iron metabolism. ACTB is actin, a common cytoskeletal gene. B2M is beta-2-microglobulin, part of MHC class I. CD74 is associated with MHC class II, often found in antigen-presenting cells like monocytes or B cells. Then there's HLA-DRA and HLA-DRB1, which are MHC class II genes again, pointing towards immune cells involved in antigen presentation.\n\nLooking at other genes: IFI27 and IFITM3 are interferon-induced, which makes sense in viral infection like COVID-19. CST3, LYZ, and CTSS are lysosomal proteins, common in myeloid cells like monocytes. TYROBP is a signaling molecule in myeloid cells. S100A family genes (S100A4, S100A6, S100A8, S100A9, S100A10, S100A11) are also associated with monocytes and inflammation.\n\nThere's a lot of ribosomal proteins (RPL and RPS genes), which can be a bit confusing, but sometimes activated cells have high ribosomal content. Also, genes like AIF1 (allograft inflammatory factor 1) are markers for macrophages and monocytes. FCER1G is part of the Fc receptor, involved in phagocytosis, again pointing to myeloid lineage.\n\nHLA genes (HLA-DRA, HLA-DRB1, HLA-DPA1) are MHC II, so antigen-presenting cells. CD52 is present on lymphocytes and monocytes. FCN1 is a monocyte marker. CFL1 is cofilin, involved in cytoskeleton, but not cell-specific.\n\nPutting it all together: High MHC II, lysosomal enzymes, interferon response genes, monocyte markers (FCN1, CST3, LYZ), and S100A proteins. This seems like a monocyte-derived cell. Given the context of COVID-19, might be activated or inflamed. Could be a classical monocyte, but sometimes during infection, monocytes differentiate into macrophages. However, since it's blood, more likely a monocyte. Alternatively, a dendritic cell, but HLA-DR genes are strong in monocytes too. Also, CD14 isn't listed here, but FCN1 is a marker for a subset of monocytes, like non-classical or intermediate. Wait, FCN1 is often associated with classical monocytes. Maybe a classical monocyte. But let me check some markers. CD14+ monocytes have CD14, but if CD14 isn't in the gene list, maybe CD16+? Alternatively, FCN1 is a marker for classical monocytes. Also, genes like S100A8/S100A9 (calprotectin) are highly expressed in neutrophils and monocytes. Since this is blood, not tissue, and given the presence of HLA-DR genes, it's more likely a monocyte rather than neutrophil (neutrophils usually have lower MHC II). Also, LYZ (lysozyme) is in monocytes and macrophages. CTSS (cathepsin S) is in antigen-presenting cells.\n\nSo the cell type is likely a classical monocyte, or maybe an activated monocyte in COVID-19. Since the question asks for as granular as possible, maybe a CD14+ classical monocyte. But FCN1 is a marker for classical monocytes. Alternatively, in COVID-19, there's been reports of inflammatory monocytes with specific markers. But without more specific markers like CD16 (FCGR3A), which isn't in the list, it's safer to say classical monocyte. Alternatively, considering the high HLA-DR expression and interferon response, it could be an activated monocyte. But the standard answer would probably be classical monocyte. However, let me check if there's a more specific type. The presence of CST3, FCN1, and S100A proteins aligns with classical monocytes. So the answer is likely a classical monocyte.",
         "The cell exhibits high expression of MHC class II genes (HLA-DRA, HLA-DRB1), monocyte-associated markers (FCN1, CST3, LYZ, S100A family), interferon-response genes (IFI27, IFITM3), and lysosomal proteins (CTSS, PSAP), consistent with an antigen-presenting myeloid cell. The absence of neutrophil-specific genes (e.g., FCGR3B) and lymphoid markers, coupled with COVID-19-related inflammation signatures (e.g., S100A8/A9, IFITMs), strongly points to an activated monocyte subset. The prominence of FCN1 and classical monocyte markers (e.g., HLA-DR, CD74) suggests a classical (CD14++/CD16−) monocyte, likely in a pro-inflammatory state due to infection.\n\nCell type: Classical monocyte (CD14++/CD16−)",
         "415",
         "846",
         "1034"
        ],
        [
         "358",
         "331",
         "44354855",
         "CD14-positive, CD16-negative classical monocyte",
         "You are an expert in single-cell biology.\n\nBelow is metadata for one cell, followed by a list of its genes in descending expression:\nTissue: blood\nDisease: normal\nDevelopment stage: 33-year-old human stage\nGenes: S100A9 MT-CO1 MT-CO2 FTL RPLP1 TMSB4X FTH1 SAT1 S100A8 B2M NFKBIA S100A4 MT-CO3 MT-ND4 SRGN MT-ND1 S100A6 ACTB MT-CYB RPL28 MT-ATP6 G0S2 EIF1 CST3 AMFR CCL20 FOS RPL41 SERF2 CD74 TMSB10 HLA-DRA EEF1A1 ZNF688 RPS27 RPL30 TPT1 RPL13 MTRNR2L12 TYROBP TNFSF13B S100A11 HLA-DRB1 RPS28 PPP1R15A LYZ BCL2A1 RPL34 HLA-B ARID5B RPS19 PFN1 RPLP2 CLDN11 RPS24 RPS8 RPL39 CXCL8 PLAUR MT-ND2 RPS15 IER3 CFL1 RPS12 CCL4 RPL37 RPS13 IL1B PLEK RPS23 SCYL3 RPL35A MT-ND3 CCL4L2 RPS15A H3-3B FCN1 RPS9 RPL11 H3-3A GADD45B DAAM1 COX6B1 COX4I1 IRF1 RPS11 OAZ1 HLA-A RPL32 PTMA S100A12 RPL37A SH3BGRL3 COX7A2 RPS27A RPL18A CSTA RPS3 RPL10 STXBP2\n\nPlease identify what cell type this might be, as granular and accurate as possible.\nKeep your response concise and clear.\nAt the end of your response, strictly place the final lines in this format:\n\nCell type: X\n",
         "Okay, let's try to figure out what cell type this is based on the provided metadata and gene list. The tissue is blood, disease is normal, and the development stage is a 33-year-old human. So we're looking at a normal blood cell from an adult.\n\nLooking at the genes listed, some stand out. The S100A9 and S100A8 genes are part of the S100 family, which are often expressed in myeloid cells like neutrophils. Also, there's LYZ, which encodes lysozyme, commonly found in monocytes and macrophages. FTH1 and FTL are involved in iron storage, typical in cells that handle iron metabolism, such as monocytes or macrophages.\n\nThen there's HLA-DRA and HLA-DRB1, which are MHC class II molecules. These are usually expressed in antigen-presenting cells like dendritic cells, B cells, or monocytes. But since the genes like CD74 (associated with MHC II) are present, that points towards monocytes or dendritic cells.\n\nLooking at other markers: CST3 (cystatin C) is found in monocytes. TYROBP is involved in immune receptor signaling, seen in myeloid cells. CCL4 and CCL20 are chemokines produced by macrophages and dendritic cells. The presence of FCN1 (Ficolin-1) is a strong indicator of classical monocytes. Also, genes like S100A4 and S100A6 are associated with monocyte activation.\n\nNow, checking for absence of other markers. If this were a neutrophil, I might expect higher expression of MPO (myeloperoxidase) or ELANE (elastase), which aren't listed here. B cells would have CD19 or CD79A, T cells CD3D or CD8. NK cells might have NCAM1 or GNLY. None of these are present, so myeloid lineage seems more likely.\n\nPutting it all together: High S100A8/S100A9, LYZ, FCN1, HLA-DR genes, and other monocyte-related markers. The cell type is likely a classical monocyte, specifically CD14+ monocyte. They express S100 proteins, have MHC II components, and FCN1 is a key marker for classical monocytes in human blood.",
         "The cell exhibits high expression of myeloid markers (S100A8, S100A9, LYZ, FTH1, FTL), MHC class II genes (HLA-DRA, HLA-DRB1, CD74), and monocyte-associated genes (FCN1, CST3, TYROBP). The absence of canonical markers for neutrophils (e.g., MPO), lymphocytes, or platelets further supports a monocytic identity. Elevated FCN1 specifically indicates a classical monocyte subset.\n\nCell type: Classical CD14+ monocyte",
         "436",
         "460",
         "573"
        ]
       ],
       "shape": {
        "columns": 9,
        "rows": 1439
       }
      },
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>index</th>\n",
       "      <th>soma_joinid</th>\n",
       "      <th>cell_type_ground_truth</th>\n",
       "      <th>prompt</th>\n",
       "      <th>reasoning</th>\n",
       "      <th>response</th>\n",
       "      <th>prompt_token</th>\n",
       "      <th>reasoning_token</th>\n",
       "      <th>completion_token</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>3</td>\n",
       "      <td>12826196</td>\n",
       "      <td>T cell</td>\n",
       "      <td>You are an expert in single-cell biology.\\n\\nB...</td>\n",
       "      <td>Okay, let's try to figure out what cell type t...</td>\n",
       "      <td>The cell exhibits high expression of mitochond...</td>\n",
       "      <td>429</td>\n",
       "      <td>1288</td>\n",
       "      <td>1454</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10</th>\n",
       "      <td>8</td>\n",
       "      <td>37809921</td>\n",
       "      <td>kidney loop of Henle thick ascending limb epit...</td>\n",
       "      <td>You are an expert in single-cell biology.\\n\\nB...</td>\n",
       "      <td>Okay, let's try to figure out what cell type t...</td>\n",
       "      <td>The cell exhibits high expression of mitochond...</td>\n",
       "      <td>437</td>\n",
       "      <td>458</td>\n",
       "      <td>592</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>19</th>\n",
       "      <td>15</td>\n",
       "      <td>53765774</td>\n",
       "      <td>endothelial cell</td>\n",
       "      <td>You are an expert in single-cell biology.\\n\\nB...</td>\n",
       "      <td>Okay, let's see. The metadata says the cell is...</td>\n",
       "      <td>The cell shows high expression of endothelial ...</td>\n",
       "      <td>420</td>\n",
       "      <td>629</td>\n",
       "      <td>770</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>22</th>\n",
       "      <td>18</td>\n",
       "      <td>45007111</td>\n",
       "      <td>B cell</td>\n",
       "      <td>You are an expert in single-cell biology.\\n\\nB...</td>\n",
       "      <td>Okay, let's tackle this. The metadata says the...</td>\n",
       "      <td>The cell exhibits high expression of ribosomal...</td>\n",
       "      <td>426</td>\n",
       "      <td>1157</td>\n",
       "      <td>1266</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>24</th>\n",
       "      <td>20</td>\n",
       "      <td>35895143</td>\n",
       "      <td>naive thymus-derived CD4-positive, alpha-beta ...</td>\n",
       "      <td>You are an expert in single-cell biology.\\n\\nB...</td>\n",
       "      <td>Okay, let's tackle this question. The user pro...</td>\n",
       "      <td>The cell exhibits high expression of ribosomal...</td>\n",
       "      <td>413</td>\n",
       "      <td>1467</td>\n",
       "      <td>1611</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9958</th>\n",
       "      <td>8963</td>\n",
       "      <td>44984624</td>\n",
       "      <td>B cell</td>\n",
       "      <td>You are an expert in single-cell biology.\\n\\nB...</td>\n",
       "      <td>Okay, let's tackle this. The cell is from bloo...</td>\n",
       "      <td>The cell exhibits high ribosomal (RPL/RPS) and...</td>\n",
       "      <td>421</td>\n",
       "      <td>311</td>\n",
       "      <td>458</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9967</th>\n",
       "      <td>8971</td>\n",
       "      <td>41268000</td>\n",
       "      <td>amacrine cell</td>\n",
       "      <td>You are an expert in single-cell biology.\\n\\nB...</td>\n",
       "      <td>Okay, let's tackle this. The metadata says the...</td>\n",
       "      <td>The cell originates from the peripheral retina...</td>\n",
       "      <td>426</td>\n",
       "      <td>1856</td>\n",
       "      <td>2011</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9969</th>\n",
       "      <td>8973</td>\n",
       "      <td>14030343</td>\n",
       "      <td>astrocyte</td>\n",
       "      <td>You are an expert in single-cell biology.\\n\\nB...</td>\n",
       "      <td>Okay, let's try to figure out the cell type ba...</td>\n",
       "      <td>The cell exhibits strong astrocytic markers (S...</td>\n",
       "      <td>431</td>\n",
       "      <td>3564</td>\n",
       "      <td>3699</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9976</th>\n",
       "      <td>8979</td>\n",
       "      <td>37179446</td>\n",
       "      <td>CD8-positive, alpha-beta T cell</td>\n",
       "      <td>You are an expert in single-cell biology.\\n\\nB...</td>\n",
       "      <td>Okay, let's see. I need to figure out the cell...</td>\n",
       "      <td>The cell exhibits high expression of ribosomal...</td>\n",
       "      <td>418</td>\n",
       "      <td>2254</td>\n",
       "      <td>2411</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9982</th>\n",
       "      <td>8985</td>\n",
       "      <td>35269729</td>\n",
       "      <td>natural killer cell</td>\n",
       "      <td>You are an expert in single-cell biology.\\n\\nB...</td>\n",
       "      <td>Okay, let's see. The metadata says it's a bloo...</td>\n",
       "      <td>The cell exhibits high expression of ribosomal...</td>\n",
       "      <td>422</td>\n",
       "      <td>352</td>\n",
       "      <td>482</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>1439 rows × 9 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "      index  soma_joinid                             cell_type_ground_truth  \\\n",
       "3         3     12826196                                             T cell   \n",
       "10        8     37809921  kidney loop of Henle thick ascending limb epit...   \n",
       "19       15     53765774                                   endothelial cell   \n",
       "22       18     45007111                                             B cell   \n",
       "24       20     35895143  naive thymus-derived CD4-positive, alpha-beta ...   \n",
       "...     ...          ...                                                ...   \n",
       "9958   8963     44984624                                             B cell   \n",
       "9967   8971     41268000                                      amacrine cell   \n",
       "9969   8973     14030343                                          astrocyte   \n",
       "9976   8979     37179446                    CD8-positive, alpha-beta T cell   \n",
       "9982   8985     35269729                                natural killer cell   \n",
       "\n",
       "                                                 prompt  \\\n",
       "3     You are an expert in single-cell biology.\\n\\nB...   \n",
       "10    You are an expert in single-cell biology.\\n\\nB...   \n",
       "19    You are an expert in single-cell biology.\\n\\nB...   \n",
       "22    You are an expert in single-cell biology.\\n\\nB...   \n",
       "24    You are an expert in single-cell biology.\\n\\nB...   \n",
       "...                                                 ...   \n",
       "9958  You are an expert in single-cell biology.\\n\\nB...   \n",
       "9967  You are an expert in single-cell biology.\\n\\nB...   \n",
       "9969  You are an expert in single-cell biology.\\n\\nB...   \n",
       "9976  You are an expert in single-cell biology.\\n\\nB...   \n",
       "9982  You are an expert in single-cell biology.\\n\\nB...   \n",
       "\n",
       "                                              reasoning  \\\n",
       "3     Okay, let's try to figure out what cell type t...   \n",
       "10    Okay, let's try to figure out what cell type t...   \n",
       "19    Okay, let's see. The metadata says the cell is...   \n",
       "22    Okay, let's tackle this. The metadata says the...   \n",
       "24    Okay, let's tackle this question. The user pro...   \n",
       "...                                                 ...   \n",
       "9958  Okay, let's tackle this. The cell is from bloo...   \n",
       "9967  Okay, let's tackle this. The metadata says the...   \n",
       "9969  Okay, let's try to figure out the cell type ba...   \n",
       "9976  Okay, let's see. I need to figure out the cell...   \n",
       "9982  Okay, let's see. The metadata says it's a bloo...   \n",
       "\n",
       "                                               response  prompt_token  \\\n",
       "3     The cell exhibits high expression of mitochond...           429   \n",
       "10    The cell exhibits high expression of mitochond...           437   \n",
       "19    The cell shows high expression of endothelial ...           420   \n",
       "22    The cell exhibits high expression of ribosomal...           426   \n",
       "24    The cell exhibits high expression of ribosomal...           413   \n",
       "...                                                 ...           ...   \n",
       "9958  The cell exhibits high ribosomal (RPL/RPS) and...           421   \n",
       "9967  The cell originates from the peripheral retina...           426   \n",
       "9969  The cell exhibits strong astrocytic markers (S...           431   \n",
       "9976  The cell exhibits high expression of ribosomal...           418   \n",
       "9982  The cell exhibits high expression of ribosomal...           422   \n",
       "\n",
       "      reasoning_token  completion_token  \n",
       "3                1288              1454  \n",
       "10                458               592  \n",
       "19                629               770  \n",
       "22               1157              1266  \n",
       "24               1467              1611  \n",
       "...               ...               ...  \n",
       "9958              311               458  \n",
       "9967             1856              2011  \n",
       "9969             3564              3699  \n",
       "9976             2254              2411  \n",
       "9982              352               482  \n",
       "\n",
       "[1439 rows x 9 columns]"
      ]
     },
     "execution_count": 18,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "r1_response.iloc[index]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 20,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Okay, let's try to figure out what cell type this is. The metadata says it's from blood, COVID-19, and a 4-year-old human. The genes listed are in descending expression order.\n",
      "\n",
      "First, I'll look for immune cell markers. Blood cells are typically myeloid or lymphoid. Let's check the genes. High expression of B2M and ACTB are common housekeeping genes, so not specific. Then there's TMSB4X, which is involved in actin regulation, found in various cells. \n",
      "\n",
      "Looking further, RPS and RPL genes are ribosomal proteins, present in most cells, but maybe not helpful here. Then NKG7 stands out—it's associated with cytotoxic cells like NK cells and CD8+ T cells. GNLY (granulysin) and GZMB (granzyme B) are also cytotoxic markers. CCL5 is a chemokine produced by T cells and NK cells. CST7 (cystatin F) is another marker for cytotoxic lymphocytes. \n",
      "\n",
      "HLA genes (HLA-B, HLA-C, HLA-A) are MHC class I, expressed in most nucleated cells but might indicate antigen presentation, though cytotoxic cells have them. CD7 is a T-cell and NK cell marker. GZMA is another granzyme, supporting cytotoxic function. \n",
      "\n",
      "There's also FAU, which I'm less familiar with, but maybe not critical. S100A4 is seen in some T cells and monocytes. VIM is a mesenchymal marker but can be in activated lymphocytes. \n",
      "\n",
      "No CD3 markers listed, but CD8 isn't mentioned either. However, NK cells don't require CD3. The presence of NKG7, GNLY, GZMB, CST7, and CCL5 points towards a cytotoxic cell. Since CD7 is present, which is on both T and NK cells, but the lack of CD3 (assuming it's not in the list) might lean towards NK cells. \n",
      "\n",
      "Also, the disease is COVID-19. Studies show that NK cells are involved in the response. The high expression of ribosomal genes might indicate active protein synthesis, typical in immune cells responding to infection. \n",
      "\n",
      "So putting it all together: cytotoxic genes, NK and T cell markers, but absence of T-cell receptor genes (like CD3 subunits). More likely an NK cell. Granularity—maybe a mature, activated NK cell in the context of COVID-19.\n"
     ]
    }
   ],
   "source": [
    "print(r1_response.iloc[129, 4])"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "scgpt",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.8.18"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
